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AP - alkaline phosphatase
ATP - adenosine 5'-triphosphate
pgal - p-galactosidase
bp - base pair
BPB - bromophenol blue
BSA - bovine serum albumin
C - cytidine
°C - degrees Celsius
cDNA - complementary DNA
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DIG - digoxygenin
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DNase - deoxyribonuclease
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EDTA - diaminoethanetetra-acetic acid
g -gram
G - guanosine
GST - glutathione S-transferase
hr - hour
HEPES - N-[2-Hydroxyethyl]piperazine-N'-[2-ethane-sulphonic acid]









































































Tris - tris (hydroxymethyl) aminomethane
U - uridine
UAS - upstream activator sequence
	- microgram
	- microlitre 
UV - ultraviolet 
v - volt 
v - volume 
v/v - volume per volume 
w/v - weight per volume 
w-t - wild type 
X-gal - 5-bromo-4-chloro-3-indol-p-D-galactopyranoside






































































The ubiquitin system forms the major pathway for selective degradation of 
abnormal, damaged and short-lived proteins in eukaryotes. Ubiquitin becomes attached to 
substrate proteins to target them for degradation via three types of enzyme: ubiquitin 
activating enzymes (El), ubiquitin conjugating enzymes (E2), and ubiquitin protein ligases 
(E3). El enzymes are only necessary to activate ubiquitin and transfer it to an E2 enyzme. 
Many E2s are present within a eukaryote, and some can ubiquitinate substrates without the 
aid of an E3 enzyme. Studies in Saccharomyces cerevisiae have shown particular E2s 
function in processes as diverse as DNA repair, peroxisome biogenesis and cell cycle 
control. Much of the substrate specificity for ubiquitination is thought to reside within 
ubiquitin conjugating enzymes.
Control of protein levels by selective degradation is important for cell 
differentiation and developmental processes. To allow specific spatial and temporal 
distribution of proteins which are key regulators of development, highly selective 
degradation is required. Ubiquitin-dependent proteolysis also appears essential for 
developmentally programmed cell death. The experiments in this thesis describe attempts 
to address the role of the ubiquitin system in development using Drosophila melanogaster 
as a model system. As ubiquitin conjugating enzymes are thought to each ubiquitinate a 
subset of proteins, these were the enzymes investigated.
Four E2 enzyme genes had previously been cloned in Drosophila, and a further E2 
was identified by a polymerase chain reaction screen. The gene was cloned, sequenced 
and named UbcD4 (ubiquitin conjugating enyzme in Drosophila number 4). UbcD4 
encodes a protein homologous to bovine E225K and yeast UBC1. All five E2 genes were 
investigated for developmentally regulated transcription. High levels of E2 mRNA were 
observed in adult females, early embryos and larvae, suggesting specific developmental 
roles for the ubiquitin system at these stages. Ubiquitination may have a major function in 
the developing central nervous system, as RNA from all known E2s was found to be 
abundant in this tissue in embryos.
Ubiquitin conjugating enzymes become linked to ubiquitin via a thiol ester bond to 
an active site cysteine residue within the E2. As a first step to determining the function of 
E2s in Drosophila, active site mutants of the Drosophila E2 DHR6 were overexpressed. 
This resulted in lethality, probably at the late pupal stage of development. Dhr6 is the
Vlll
homologue of the Saccharomyces cerevisiae RAD6 gene, which is essential for various 
DNA repair functions. Results suggest Dhr6 is also an essential gene.
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1.1.1 WHY IS PROTEIN DEGRADATION NECESSARY?
Although DNA stores the genetic information necessary to make an 
organism, most of this information is translated into proteins. It is proteins that 
determine the shape and structure of cells, and proteins are the main mediators of 
molecular recognition and catalysis.
Many different types of protein exist in an organism, ranging from structural 
proteins and "housekeeping" enzymes necessary for vital functions in all cells, to 
cell-specific regulatory proteins. Some of these proteins are practically stable 
molecules, whilst others have half-lives of a few minutes. The half-life of a protein is 
determined by highly selective intracellular protein degradation. Most structural 
proteins are relatively stable, whereas regulatory proteins have concentrations which 
change promptly with alterations in the state of the cell. These proteins must have 
short half-lives so that their levels can be rapidly changed in response to appropriate 
stimuli.
Cells do not always produce components of protein complexes in precise 
amounts, and must selectively degrade any protein component left unassembled 
(figure 1.1). A system to identify and destroy abnormally assembled proteins is 
required. Denatured, damaged or misfolded proteins, and those containing oxidized 
or other abnormal amino acids, must also be recognised and degraded. The 
proteolytic system must be able to distinguish complete proteins in abnormal 
conformations, from nascent polypeptides on ribosomes.
The ubiquitin system is the major pathway for selective protein degradation 
within eukaryotic cells (Ciechanover et al., 1984), performing all the above 
functions. However, important degradation pathways also operate in the endoplasmic 
reticulum (E.R.) and lysosomes in eukaryotic cells, and most prokaryotes do not 
have ubiquitin.
1.1.2 THE UBIQUITIN PATHWAY:
A schematic diagram of the ubiquitin pathway (reviews: Finley and Chau, 
1991; Jentsch, 1992; Ciechanover, 1994; Deshaies, 1995a.) is shown in figure 1.2. 
Ubiquitin becomes attached to target proteins via three types of enzyme. First the 






Fig. 1.1 Extra components of protein complexes are degraded to prevent 












Fig. 1.2 The Ubiquitin Pathway (after Hochstrasser, 1992).
A. Activation of ubiquitin via an El enzyme.
B. Transfer of ubiqutin to a ubiquitin conjugating enzyme (E2).
C. Conjugation of ubiquitin to the protein substrate from an E2, sometimes requiring an E3
ubiquitin protein ligase.
D. Multiubiquitination of the protein substrate by repeating A., B., and C., and addition of
ubiquitin moieties to Lys48 of the previous ubiquitin.
E. Cleavage of the multiubiquitinated protein to peptides by the 26S proteasome.
F. Removal of ubiquitin chains, and cleavage of the chains by ubiquitin carboxyl-terminal
hydrolases (UCH) to ubiquitin monomers which are recycled in the pathway.
involves formation of a ubiquitin adenylate, followed by transfer of the C-terminus 
to a thiol group on the active site Cys residue of a ubiquitin activating enzyme, or 
El, which catalyzes the activation reaction (Haas and Rose, 1982; Haas et al., 1982). 
Ubiquitin is then transferred to one of several ubiquitin conjugating enzymes, or E2s, 
to generate a similar thiol-ester linkage between ubiquitin and an active site Cys 
residue in the E2 (Pickart and Rose, 1985). The El enzyme probably binds to the N- 
terminus of the E2 during the transfer of ubiquitin (Cook et al., 1992). E2s donate 
ubiquitin to an acceptor Lys of the target protein (Chau et al, 1989), sometimes with 
the aid of a ubiquitin-protein ligase or E3 for substrate recognition (Ciechanover and 
Schwartz, 1989). E3s may also bind ubiquitin via a thiol-ester linkage (see 1.8). The 
process can then be repeated, and the first ubiquitin is ubiquitinated on Lys48 (Chau 
et al., 1989). Multiubiquitination of the substrate protein, via Lys48 isopeptide 
linkage, is sufficient for degradation (Gregori et al., 1990) and greatly enhances the 
process (Chau et al., 1989).
The multiubiquitinated protein is degraded via the 26S proteasome complex 
(see 1.9). Ubiquitin itself is a stable protein, and is recycled in the pathway after 
cleavage from the chains by ubiquitin C-terminal hydrolases (UCHs: see 1.10).
1.1.3 PROKARYOTIC PROTEASES:
Although some eubacteria and archaebacteria have been found to contain 
ubiquitin and proteasomes (see 1.2.1), most prokaryotes degrade proteins via 
different classes of ATP-dependent proteases (review: Gottesman and Maurizi, 
1992). Low-like proteases are multimers of identical polypeptide chains, each with a 
single proteolytic site, and an ATPase site. C//?-like proteases have a single type of 
proteolytic subunit, ClpP, associated with one or more ATPase hydrolysing units, 
ClpA. This forms a high molecular weight multimer (Maurizi, 1994), thought to be 
similar to eukaryotic 26S proteasomes.
1.1.4 EUKARYOTIC NON-UBIQUITIN PROTEIN DEGRADATION:
1.1.4.1. Protein degradation in the endoplasmic reticulum (E.R.):
Membrane proteins and lysosomal hydrolases are synthesised in the rough 
E.R. For exit of a protein from the E.R., it must be correctly folded and assembled.
Abnormally folded or assembled proteins are retained in the E.R., either bound to the 
special binding protein (BiP), or in aggregates, and are eventually degraded.
The signal for degradation of proteins in the E.R. is exposure of internal 
domains, usually buried when the protein has adopted the correct conformation. 
These are exposed in assembly intermediates, but are also the sites for BiP binding 
(Schmitz et al., 1995). BiP suppresses degradation of normal protein assembly 
intermediates by masking the internal domains, which are signals both for BiP 
binding and degradation.
E.R. protein degradation was thought to be separate from ubiquitin-dependent 
protein degradation, which was mainly thought to occur in the cytoplasm. However, 
the Saccharomyces cerevisiae ubiquitin conjugating enzyme (E2) UBC6 (see 
1.7.1.5) localises to the E.R., and appears to mediate selective degradation of E.R. 
membrane proteins (Sommer and Jentsch, 1993). This suggests a role for the 
ubiquitin system in E.R. protein degradation.
1.1.4.2 Lysosomal protein degradation:
Lysosomes contain acid hydrolase proteases. Proteins to be digested can 
come from the external medium via endocytosis, autophagy of organelles, or specific 
import of cytosolic proteins bearing KFERQ signals on their surfaces (Terlecky and 
Dice, 1993).
The ubiquitin pathway was previously thought to be separate from lysosomal 
degradation (figure 1.3). Ubiquitination has now been shown to be involved in 
receptor mediated endocytosis (review: Hurtley, 1996; see 1.12.3) and the 
proteolytic events responsible for transformation of autolysosomes to residual bodies 
(Leek et al., 1992). This implies that lysosomal-mediated protein degradation often 
requires protein ubiquitination.
Ubiquitination may be a universal signal for protein degradation in 
eukaryotes.
1.2 THE UBIQUITIN PROTEIN:
Ubiquitin is an abundant, 76 amino acid protein, first isolated from bovine 
thymus (Goldstein et al., 1975), and found in all eukaryotic cells screened. It has one 















Fig. 1.3 Protein degradation via the ubiquitin pathway, and lysosomes. 
These two systems were thought to be separate, but ubiquitin has now been shown to be 
involved in some lysosomal protein degradation. Also degradation of long-lived proteins 
may require the proteasome, if not other parts of the ubiquitin pathway.
fungi, plants and vertebrates (Foster el al., 1990). Ubiquitin is a highly compact 
globular protein (figure 1.4) with three faces, acidic, basic and hydrophobic. Only 
the four C-terminal residues, the site of ubiquitin-protein conjugation, protrude from 
the core (Vijay-Kumar et al, 1987).
The strict evolutionary conservation of ubiquitin suggests each residue has an 
essential role in folding, stability, or function. The C-terminal Gly forms an 
isopeptide bond with the e-amino group of a specific Lys residue in the target protein 
(Chau et al., 1989). When Gly is changed to Ala at this position in Saccharomyces 
cerevisiae, ubiquitin becomes irreversibly bound to proteins, and phenotypes 
expected for ubiquitin-deficiency, such as slow growth and sensitivity to 
environmental stress, are seen (Ecker et al., 1987; Hodgins et al., 1992). 
Polyubiquitin chains form when further ubiquitin monomers become covalently 
linked, by their C-terminal Gly residues, which are again essential (Hodgins et al., 
1992), to Lys48 of the previous monomers (Chau et al, 1989). If Lys48 is altered, it 
acts as an inhibitor of ubiquitin dependent protein degradation (Bachmair et al., 
1990). Three Arg residues (42, 72, 74) are necessary for interactions with El (Burch 
and Haas, 1994), but most specific residues appear necessary just to produce the 
tight globular structure.
1.2.1 UBIQUITIN IN VIRUSES AND PROKARYOTES:
The ubiquitin system is not wholly confined to eukaryotes. Ubiquitin 
conjugating enzymes have been found in viruses (e.g. Hingamp et al., 1992) 
probably as a means for exploiting host regulatory mechanisms. The ubiquitin 
protein is present in eubacteria (Durner and Boger, 1995) and archaebacteria (Wolf 
et al., 1993). A proteasome, architecturally indistinguishable from that of eukaryotes, 
but simpler in subunit composition (see 1.9), is also present in archaebacteria 
(Dahlmann et al., 1989), and a 20S eubacterial proteasome was recently discovered 





Fig. 1.4 The three-dimensional structure of ubiquitin 
(after Vijay-Kumar^a/., 1985).
1.3 CONTROL OF FUNCTION OF THE UBIQU1TIIN PATHWAY:
1.3.1 POLYUBIQUITIN CHAINS:
The Lys48-linked polyubiquitin chains play a crucial role in protein 
degradation in vivo (Finley et al, 1994). The structure of tetraubiquitin shows these 
chains can be formed as repeating diubiquitin subunits, with multiple hydrophobic 
contacts amongst all four ubiquitins (Cook et al., 1994). However, polyubiquitin 
chains may not always be linked via Lys48, as these chains were not necessary for 
the survival of stress in Saccharomyces cerevisiae (Finley et al., 1994). Instead 
Lys63-linked chains appeared to play an important role (Arnason and Ellison, 1994). 
Under stress conditions, Lys29-linked chains may also be present, and Lys29, but 
not Lys48, was found to be necessary for degradation of an artificially made short- 
lived protein (Johnson et al., 1995). Structurally different multiubiquitin chains may 
have distinct functions in ubiquitin-dependent protein degradation. However, most of 
this work involved mutating the Lys residues of ubiquitin, and observing the effects 
of degradation of a specific protein under different conditions. It is not known if 
these different chains do actually exist in these experiments, and if they do, they may 
be artifacts due to the Lys48 residue not being present for attachment of further 
ubiquitin monomers, and a different Lys residue having to be used. Gregori et al. 
(1990) mutated all the Lys residues of ubiquitin separately and found only Lys48 
was essential.
Homopolymeric ubiquitin chains of 8-12 ubiquitin monomers, conjugated to 
a substrate Lys, result in ten times faster degradation than monoubiquitin (Chau et 
al., 1989). Ubiquitin residues Lys8, Ile44 and Val70 do not affect attachment of 
ubiquitin to substrates, but are necessary for degradation of the resulting conjugates 
(Beal et aL, 1996). The human proteasome regulatory subunit S5a binds Lys48- 
linked multiubiquitin chains, of four or more ubiquitins, with increasing affinity as a 
function of chain length (Deveraux et al., 1994), and the ubiquitin residues 
mentioned above are necessary for this binding (Beal et al., 1996). The amino acids 
Lys8, Ile44 and ValTO form repeating patches on the surface of multiubiquitin 
chains, implying hydrophobic interactions between the patches and S5a contribute to 
the enhanced proteolytic targeting of multiubiquitin chains. An Arabidopsis 
homologue of S5a has been found (Vannocker et al., 1996), and similar proteins are 
also present in yeast, C.elegans and rice. This protein is an essential ubiquitin 
recognition component of the 26S proteasome.
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1.3.2 MONOUBIQUITINATION:
Not all proteins that become monoubiquitinated proceed to be 
polyubiquitinated and degraded. Some proteins remain stable as monoubiquitinated 
forms. The first protein found conjugated to ubiquitin was histone H2A (uH2A; 
Goldknopf and Busch, 1977). Fifteen percent of H2A and two percent of H2B are 
monoubiquitinated in mammalian cells, and the degree of ubiquitination varies with 
the cell cycle (Raboy et al., 1986), decreasing in metaphase cells. In slime mould, 
cleavage of ubiquitin from uH2A and uH2B is a very late event in chromosome 
condensation to metaphase chromosomes, and ubiquitination is an early event in 
their decondensation (Mueller et al, 1985).
Monoubiquitination may modulate the activity of proteins, rather than 
labelling them for degradation. Other proteins shown to be stably monoubiquitinated 
include calmodulin (Parag et al., 1993) and actin in Drosophila flight muscles (Ball 
et al., 1987). The function of these monoubiquitinations is unknown.
1.3.3 PHOSPHORYLATION CONTROL:
Protein ubiquitination is regulated by phosphorylation. Phosphorylation may 
make a protein susceptible to degradation; phosphorylation of Ser residues in 1KB a 
targets the protein to the ubiquitin-proteasome pathway (Chen et al., 1995; see 
1.11.1). Alternatively, ubiquitin pathway enzymes can be activated by 
phosphorylation: a rabbit reticulocyte El increases in enzymic activity on 
phosphorylation (Kong and Chock, 1992). A HeLa cell E2, E232K> when 
phosphorylated leads to an increase in ubiquitination of H2A (Kong and Chock, 
1994) which may in turn play a role in cell cycle control. Clam cyclin specific E3-C 
is a ubiquitin protein ligase found as a complex known as the cyclosome, which is 
necessary for degradation of cyclins at the end of metaphase (see 1.11.4). The E3 
activity of the cyclosome is activated by cdc kinase, and inactivated by phosphatase 
(Lahavbaratz et al., 1995). Phosphorylation control has not been fully investigated, 
but may be a general means of activating ubiquitin-dependent degradation pathways.
1.4 UBIQUITIN-ENCODING GENES:
Ubiquitin is encoded by a gene family whose primary translation products are 
fusion proteins. Ubiquitin genes code for an amino terminal ubiquitin fused to a large 
or small ribosomal subunit protein, or for head-to-tail polyubiquitin fusion proteins
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with no spacer regions between ubiquitin moieties. Ubiquitin is released, for 
conjugation to proteins, by C-terminal hydrolases (see 1.10) which cleave C-terminal 
of ubiquitin moieties (Ozkaynak et al, 1984). The C-terminal ubiquitin moiety of 
polyubiquitin gene products has at least one additional amino acid at the C-terminus 
(Ozkaynak et al., 1984) to prevent unprocessed polyubiquitin proteins being 
conjugated to substrates.
Arabidopsis thaliana has 14 ubiquitin-encoding genes:- 5 polyubiquitin 
genes, 4 ubiquitin-ribosomal protein genes, and 5 ubiquitin-like genes, thought to be 
pseudogenes (Callis et al., 1995). Humans also have three types of ubiquitin- 
encoding genes (Wiborg et al., 1985; Cowland et al, 1988):- ubiquitin-ribosomal 
fusions, polyubiquitin genes with 9 repeats, and polyubiquitin genes with 3-4 repeats 
of ubiquitin. The tetrameric gene is a pseudogene, possibly created by unequal 
crossing-over of ancestral trimeric genes. Multiple polyubiquitin genes in eukaryotes 
probably arose from gene duplication and unequal crossing-over events.
1.4.1 S.CEREVISIAE UBIQUITIN-ENCODING GENES:
A family of four ubiquitin-encoding loci are present in yeast (Ozkaynak et 
al., 1984; Ozkaynak et al., 1987). UBI1, 2 and 3 are ubiquitin monomer genes 
(Ozkaynak et al., 1987) fused to ribosomal protein encoding regions (Finley et al., 
1989). UBI1 and 2 encode the same essential large ribosomal subunit protein of 52 
amino acids, and UBI3 encodes an essential small ribosomal subunit protein of 76 
amino acids (Finley et al., 1989), as well as ubiquitin. The ubiquitin moiety of the 
ribosomal fusion proteins facilitates ribosome assembly, and may act as a molecular 
chaperone (Finley et al., 1989; Finley and Chau, 1991). Fusion of ubiquitin to 
ribosomal proteins allows co-regulation of the ubiquitin system with the translational 
activity of the cell (Redman and Rechsteiner, 1989).
Other eukaryotes have the same ubiquitin fusion proteins as those in yeast. 
The larger C-terminal extension protein (CEP) in rats is 40S ribosomal subunit 
protein S27a (Redman and Rechsteiner, 1989), and human HUbCEPSO can 
complement yeast ubi3 mutants. Complementation does not occur when only CEP80 
is expressed (Monia et al., 1990), again suggesting ubiquitin increases the 
translational efficiency or stability of the cotranslated ribosomal proteins.
The yeast polyubiquitin gene, UBI4, has five head-to-tail ubiquitin-coding 
repeats (Ozkaynak et al., 1987). It is strongly induced in stress conditions, such as 
starvation and high temperature, to satisfy the increased ubiquitin requirement
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(Ozkaynak et aL, 1987), and is an essential component of the stress response (Finley 
etaL, 1987).
1.4.2. DROSOPHILA UBIQUITIN-ENCODING GENES:
The ubiquitin-encoding genes of Drosophila melanogaster are shown in 
figure 1.5. Again a multigene family is present.
The polyubiquitin gene, Ubip, was isolated from an early ecdysone puff at 
63F (Izquierdo et al., 1984). Expression of the gene is constant throughout 
development for a particular strain of Drosophila melanogaster (Arribas et aL, 
1986). The gene is polymorphic among different stocks and strains, containing either 
15 or 18 tandem repeats depending on the stock analysed (Lee et aL, 1988). The C- 
terminal ubiquitin repeat of the polyubiquitin fusion protein has three extra amino 
acids:-Ala, Gin, and He. Expression of the polyubiquitin gene is not tissue specific, 
but is induced under heat shock conditions (Lee et aL, 1988).
Two Drosophila ubiquitin monomer genes have been cloned and 
characterised. DUb52 (Cabrera y Poch et aL, 1990) has a 52 amino acid extension 
protein, found to be a 60S ribosomal subunit protein (Redman et aL, 1994). DUb52 
is expressed constitutively throughout development and is particulary abundant in 
ovaries (Cabrera et aL, 1992). The Drosophila homologue of UBI3, DUbSO, encodes 
a ubiquitin monomer fused to the equivalent 40S ribosomal protein of UBI3 (Lee et 
aL, 1988; Barrio et aL, 1994). It has a constitutively expressed 0.9kb mRNA, 
particularly abundant under conditions of high protein synthesis, such as in ovaries 
and exponentially growing cells (Barrio et aL, 1994), but is not inducible by heat 
shock (Lee et aL, 1988).
Izquierdo (1994) reported another polyubiquitin gene on the X chromosome 
of CantonS Drosophila melanogaster. In polytene chromosomes, ubiquitin was 
found to be mainly associated with the compact and stabilised DNA of bands, rather 
than the more decondensed DNA of puffs and interbands (Izquierdo, 1994) 
suggesting that ubiquitination may stabilise histones. The pattern of immunostaining 
with ubiquitin matched the banding pattern of polytene chromosomes, but there was 
also weaker staining of interbands and puffs. The bands may stain more strongly due 
to the greater concentrations of DNA and therefore higher amounts of histones 










Fig. 1.5 The proteins encoded by Drosophila ubiquitin genes.
= Ubiquitin = C-terminal fusion
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1.5 SUBSTRATE SELECTION:
The method of substrate selection for ubiquitination is still unsolved 
(reviews: Ciechanover and Schwartz, 1989; Rechsteiner, 1991; Hershko and 
Ciechanover, 1992; Ciechanover, 1994). This section describes various models, and 
signals that appear to be important.
1.5.1. THE N-END RULE: A BIPARTITE SIGNAL:
The in vivo half-life of a protein can be determined by the amino acid residue 
at the N-terminal position: the N-end rule (review: Varshavsky, 1992). Measurement 
of the in vivo half-lives of 20 different species of (3-galactosidase proteins in 
S.cerevisiae revealed they vary from more than 20hr to less than 3 min (table 1.1), 
depending on the N-terminal amino acid, which was then classified as "stabilising" 
or "destabilising" (Bachmair et al., 1986). This reflects the affinity of an E3 protein, 
UBR1 or N-recognin in S.cerevisiae, for the N-terminal residues of proteolytic 
substrates (Bartel etal., 1990).
UBR1 selects N-end rule substrates by binding to primary destabilising N- 
terminal residues (table 1.1). It has at least two substrate binding sites, Type I 
specific for basic residues Arg, Lys, and His, Type II specific for bulky hydrophobic 
residues Phe, Leu, Trp, and He (Reiss et al., 1988; Gonda et al., 1989). Tertiary 
destabilising N-terminal residues Asn and Gin are so named because they are first 
converted by N-terminal amidase, encoded by the NTA1 gene (Baker and 
Varshavsky, 1995) to secondary destabilising residues Asp and Glu. These in turn 
are conjugated to Arg, a primary destabilising residue, by Arg-tRNA-protein 
transferase (the ATE1 gene product; Ferder and Ciechanover, 1987) to allow 
recognition by UBR1.
The degradation signal does not consist solely of the N-terminal amino acid. 
A second determinant, a specific Lys which becomes polyubiquitinated, is also 
essential (Bachmair and Varshavsky, 1989). The sequences surrounding the Lys are 
not important, and the two determinants can be located on different subunits of a 
multisubunit protein, and still target the protein for degradation via "trans 
recognition" (Johnson etal., 1990), provided they are in spatial proximity. Only the 
subunit containing the available Lys is proteolysed. The site for recognition of the 
Lys may be on an E2 as UBC2 functions with UBR1 in the N-end rule pathway. 
UBC2 is physically associated with UBR1 via its 23 acidic C-terminal amino acids 

































Table 1.1 Half life of p-galactosidase with different N-terminal 
amino acids in Saccharomyces cerevisiae (after Bachmair et al., 1986; 
Bachmair and Varshavsky, 1989; Gonda et al, 1989).
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The cellular importance of the N-end rule pathway is unclear, as ubrl 
mutants, which lack this proteolytic route, are almost phenotypically normal (Bartel 
et al., 1990). The majority of cellular proteins are acetylated at their N-termini, so 
are blocked for N-end rule degradation. Degradation of N-acetylated proteins is El- 
dependent (Mayer et al., 1989), so they must be recognised for ubiquitin-dependent 
degradation via a different signal.
1.5.2 SPECIFIC AMINO ACID SEQUENCES AS DEGRADATION 
SIGNALS:
1.5.2.1 PEST sequences:
Rogers et al. (1986) noticed that short-lived proteins have stretches of amino 
acids enriched in Pro, Glu, Ser, and Thr (PEST regions), flanked by clusters of 
positively charged amino acids. Thirty out of thirty-two short-lived proteins with 
known sequences were found to contain one or more PEST sequences (Rechsteiner, 
1990). PEST sequences appear to be signals for rapid degradation, but neither the 
mechanism of how the signal targets for degradation, nor the system recognising the 
signal has been identified.
1.5.2.2. Deg1 and Deg2:
The short-lived MAToc2 represser is degraded by the ubiquitin system 
(Hochstrasser et al., 1991; see 1.7.1.6 and 1.11.1). It has 2 degradation signals, one 
requiring residues 53-67 in the N-terminal region (Degl), the other residing in 
residues 136-140 in the C-terminal domain (Deg2; Hochstrasser and Varshavsky, 
1990). Degl is dependent on a complex between the E2s UBC6 and UBC7 which 
must be membrane bound for MATa2 degradation (Chen et al., 1993; see 1.7.1.6), 
and a proteasomal subunit (Hochstrasser, 1994). Both Degl and Deg2 signals appear 
specific to this protein.
1.5.2.3 The Destruction Box:
Another proteolytic signal for the ubiquitin system is the "destruction box". 
This is a conserved motif of nine amino acids with the consensus RXALGXIXN 
(where X is any amino acid). It is required for degradation of mitotic cyclins via the
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ubiquitin pathway (Glotzer et al, 1991). All mitotic cyclins characterised have this 
signal, and Lys-rich sequences C-terminal to it, suggesting these may act as the site 
of ubiquitination. The proteins of the cyclosome recognize the destruction box.
Other proteins such as CDC25p, the Ras exchange factor, are also 
destabilised via sequences similar to cyclin destruction boxes (Kaplon and Jacquet, 
1995), but these may not be recognised by the cyclosome.
1.5.3 MONOUBIQUITINATION AND UBIQUITIN-LIKE DOMAINS:
The requirement for a degradation signal can be bypassed if one ubiquitin 
molecule is already attached to the substrate protein. In engineered fusion proteins 
containing ubiquitin, the ubiquitin acts as a target for further ubiquitination, 
dependent on the E2 UBC4, and leads to rapid degradation of the multiubiquitinated 
protein (Johnson et al., 1992). The UFD (ubiquitin fusion degradation) pathway, 
recognises fused ubiquitin as a degradation signal, and controls the ubiquitin- 
dependent degradation of these fusion proteins (Johnson et al., 1995). Lys29-linked 
multiubiquitin chains may be important for this pathway.
Some proteins have ubiquitin-like domains at their C-termini, for example 
BAG-1 (Takayama et al, 1995). BAG-1 is a short-lived protein, and this domain 
may act, like fused ubiquitin, as a signal for ubiquitin-dependent degradation.
1.5.4 MULTIPLICITY OF E2 ENZYMES:
There are many E2 enzymes present within a eukaryote (see 1.7), perhaps 
because each one is responsible for the ubiquitination, and subsequent degradation, 
of a subset of cellular proteins. Different E2s may be induced during differentiation 
of cells in order to degrade specific proteins (Wefes et al., 1995), and different 
classes of artificial degradation signal are recognised by different sets of E2s (Sadis 
etal, 1995).
The C-termini of E2s are often necessary for recognition of target proteins. 
When the C-terminal tail of S.cerevisiae E2 RAD6 is deleted, yeast are defective in 
sporulation (Morrison et al., 1988). Gosink and Vierstra (1995) made chimeric E2s 
by fusing specific protein-binding peptides to their C-termini. They specifically 
recognised and ubiquitinated their binding partners, and one protein was even 
degraded via the ubiquitin pathway. This does not actually show C-termini are
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responsible for substrate recognition, as the same results may have been obtained by 
fusing the peptides to the N-termini, and it is not known that C-terminal domains of 
normal E2s are protein binding domains, but it again suggests C-terminal domains 
are involved in substrate selection. Also, a chimeric E2 of S.cerevisiae RAD6 linked 
to the C-terminal domain of another E2, CDC34, can perform the functions of 
CDC34 (Kolman et al., 1992).
1.5.5 DISCUSSION:
All proteins require an available Lys residue for ubiquitin attachment to 
initiate degradation via the ubiquitin pathway. Signals for degradation are probably 
all bipartite, requiring the Lys in spatial proximity to the other part of the signal. The 
N-terminus may be the degradation signal for foreign proteins in the cell, and 
proteins in the wrong compartment within the cell. Abnormal or damaged proteins 
may be recognised by exposure of hydrophobic domains that are usually hidden 
within the protein. Recognition of lysosome by the ubiquitin pathway requires 
reduction of a disulphide bond which results in localised unfolding at the C- 
terminus, exposing the putative acceptor Lys (Hill et al, 1993).
Proteins which need to be precisely regulated with respect to half-life, are 
probably recognised because they contain binding sites for specific E2 and/or E3 
enzymes.
1.6 UBIQUITIN ACTIVATING ENZYMES:
Ubiquitin activating enzymes, or Els, (review: Hershko and Ciechanover, 
1992) are abundant proteins of the cytosol and nucleus (Ciechanover et al., 1982; 
Cook and Chock, 1991a.), and mediate the first step in the ubiquitin pathway. Genes 
encoding Els have been cloned from various organisms, and appear to encode 
proteins with nucleotide-binding domains, matching the consensus GlyXGlyXXGly 
(McGrath et al., 1991). This is probably the site where ATP is bound in ubiquitin 
activation reactions. El enzymes act as homodimers (Ciechanover et al., 1982), and 
also form complexes with individual E2 enzymes. The active site Cys of an El, 
which becomes covalently linked to ubiquitin, is found in a region with low 
homology to several E2 enzymes (Hershko and Ciechanover, 1992).
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1.6.1 YEAST UBIQUITIN ACTIVATING ENZYMES:
UBA1, a Saccharomyces cerevisiae gene, was cloned by McGrath et al. 
(1991), and shown to encode a 114 kDa El. The protein contains a nuclear targeting 
signal, and is 53% identical to the El protein encoded by the gene at the human 
A1S9 locus, and 45% identical to wheat UBA1 protein, showing UBA1 homologues 
are strongly conserved in evolution. The UBA1 gene of S.cerevisiae is essential for 
viability of both spores and vegetative cells.
As an El is necessary for all ubiquitinations, and UBA1 is an essential gene, 
it was thought to be the only S.cerevisiae El. However, a second gene encoding a 
protein similar to UBA1 has been cloned and named UBA2 (Dohmen et al., 1995). 
The proteins have extensive similarity both in the putative ATP-binding sites, and in 
the region of the active site Cys. UBA2 is located mainly in the nucleus and is an 
essential protein. UBA1 and 2 cannot complement each other, even when subcellular 
localisation is altered by mutagenesis, implying that they each perform distinct 
essential functions (Dohmen et al., 1995). The putative active site Cys of UBA2 is 
essential for viability, but, as yet, no El activity has been shown for the protein.
1.6.2 PLANT UBIQUITIN ACTIVATING ENZYMES:
Ubiquitin activating enzymes are encoded by a multigene family in wheat 
(Hatfield and Vierstra, 1989; Hatfield et al., 1990), dispelling the belief that only one 
El would be present in each eukaryote. However, wheat is a hexaploid, so if there is 
one El per diploid genome, three would be expected in wheat, and three different 
genes are found, encoding three El proteins: UBA1 and 2 which are almost identical, 
and UBA3 which is significantly different (Hatfield and Vierstra, 1992). All 3 
catalyse ATP-dependent activation of ubiquitin, and the active site Cys has been 
identified in UBA1. Domains of homology between the proteins are present for the 
sites of ubiquitin linkage, nuclear localisation and nucleotide binding. An El has also 
been found in Arabidopsis (Leyser et al., 1993), and is encoded by an auxin- 
resistance gene.
1.6.3 MAMMALIAN UBIQUITIN ACTIVATING ENZYMES:
There are multiple El enzymes in mammals, possibly due to the increase in 
number of cell types compared to yeast. If some specificity for substrate selection for
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ubiquitination resides in Els, then a different subset of proteins could be degraded in 
each differentiated tissue by virtue of tissue-specific ubiquitin activating enzymes.
In humans a UBA1 homologue, from the A1S9 locus, was cloned by 
Zachsenhaus and Shenin (1990), and another El which appeared to have general 
functions was cloned by Handley et al., (1991). The second El has a single mRNA, 
seen in all tissue and cell lines tested. However, it encodes two proteins with 
different subcellular locations: one is found mainly in the cytoplasm, and the other 
exclusively in the nucleus (Handley-Gearhart et al, 1994)
Two human El proteins, ElnoK and El H7K, discovered in HeLa cells, 
were found to differ in proportion to one another depending on cell type (Cook and 
Chock, 1992). They correspond in size to the Els observed by Handley-Gearhart et 
al, (1994), and are probably the same proteins. There is also a testes specific El 
(Cook and Chock, 1992), probably the homologue of the mouse El which is a 
candidate for the spermatogenesis gene, and is found on the Y chromosome (Kay et 
al, 1991;Mitchell^fl/., 1991).
1.6.4 DROSOPHILA UBIQUITIN ACTIVATING ENZYMES:
A UBA1 homologue in Drosophila, Dubal, has been cloned in our laboratory 
by Dr P. zur Lage. Fragments of the gene were amplified by the polymerase chain 
reaction, using primers annealing to the nucleotide binding motif, and the active site 
Cys region. The gene, and its encoded protein, have not yet been characterised, but 
so far the sequence shows 66% identity to the human A1S9 gene.
1.6.5 E1 AND THE CELL CYCLE:
The first indication that ubiquitin activating enzymes were involved in cell 
cycle progression was the discovery that a mouse cell line, t.s.85, mutant for the cell 
cycle, was temperature sensitive due to a thermolabile El (Finley et al, 1984). When 
t.s.85 cells are shifted to the non-permissive temperature, cell cycle arrest occurs at 
early G2 phase, and mitosis is completely inhibited. This could be due to failure to 
degrade cell cycle controlling proteins. Els have another putative cell cycle role in 
histone ubiquitination. Histones are ubiquitinated in interphase (see 1.3.2.), and 
rapidly deubiquitinated at metaphase when chromosomes condense. Els are 
associated with condensed chromosomes during mitosis (Cook and Chock, 1991b.), 
perhaps so that they are ready to ubiquitinate histones for rapid decondensation after
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telophase. Grenfell el al (1994) also saw cell cycle dependent nuclear localisation of 
ubiquitin activating enzymes. A differential distribution of eight El isoforms was 
found throughout the cell cycle, some of which were assumed to be inactive. 
Conversion of inactive El to active forms may be another mechanism for regulation 
of ubiquitin-mediated proteolysis.
1.7 UBIQUITIN CONJUGATING ENZYMES:
Ubiquitin conjugating enzymes, or E2s (reviews: Jentsch et al, 1990; 
Jentsch, 1992), take activated ubiquitin from El enzymes and transfer it to the 
substrate with or without the aid of an E3. Sequence comparisons revealed all E2s 
have a conserved central domain of 16kDa, the UBC domain (ubiquitin conjugating 
domain; figure 1.6). This domain exhibits at least 35% identity in all E2s and 
includes the essential central active site Cys residue, required for thiol-ester linkage 
to ubiquitin. Sequences bracketing this Cys are highly conserved, as is a proline-rich 
element located N-terminal to the conserved Cys. At the N-terminal end of the UBC- 
domain is a conserved domain rich in basic residues, thought, due to deletion 
analysis, to be the region where El binds (Sullivan and Vierstra, 1991). X-ray 
crystallographic studies on UBC1 of Arabidopsis thaliana agree with this being the 
El binding region (Cook et al., 1992).
E2s can be divided into three classes with respect to extensions to the UBC 
domain (Jentsch et al., 1990). Class I consist almost entirely of the UBC domain, and 
are barely able to transfer ubiquitin from the El to test proteins in vitro, suggesting 
they require E3s for substrate recognition. C-terminal extensions to the UBC domain 
are present in Class II E2s, and they contribute to the substrate specificity of these 
enzymes. E2 target recognition can be redefined by engineering E2s to contain 
specific protein binding peptides fused to their C-termini (Gosink and Vierstra, 
1995). This could be a useful tool in biological research, allowing the depletion of a 
specific cellular protein. C-terminal extensions can also function in cellular 
localisation. Class III E2s have N-terminal extensions to the UBC domain, but no C- 
terminal ones (Jentsch et al., 1991). The function of N-terminal extensions is 
unknown.
Typically, ubiquitin conjugating enzymes are small proteins of 14-32kDa 
(Hershko and Ciechanover, 1992), and E3s are much larger (100-300kDa). An 




Fig. 1.6 The UBC domain of E2 enzymes.
The central active site Cys is shown, and conserved regions are indicated by the
dark lines.
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catalyse ubiquitination via an intramolecular thiol relay mechanism, suggesting it 
functions as an E2-E3 hybrid (Berleth and Pickart, 1996).
E2s have been most thoroughly studied in S.cerevisiae.
1.7.1 SACCHAROMYCES CEREVISIAE E2S:
According to several sources, twelve E2s have been found so far in yeast, 
although it appears only ten have been published. Table 1.2 shows the diverse 
functions of the published yeast E2s.
1.7.1.1 UBC1, UBC4, UBCSand homologues:
UBC4 and UBC5 genes were cloned by Seufert and Jentsch (1990), and the 
encoded proteins mediate selective protein degradation of short-lived and abnormal 
proteins. UBC4 and 5 are closely related in sequence, and complementary in 
function. When both genes are mutant, there is a slow growth phenotype. Both are 
induced by high temperature, and double mutants are in viable at high temperature 
(Seufert and Jentsch, 1990). These enzymes are the major E2s for stress response 
ubiquitin-dependent degradation.
A third member of this functional class of E2s is UBC1 (Seufert et al., 1990). 
All three are functionally overlapping, and together constitute an enzyme family 
essential for cell growth and viability, due to their functions as the major E2s for 
bulk degradation of short-lived and abnormal proteins. Unlike UBC4 and 5, UBC1 is 
not induced by heat shock, but overexpression of UB Cl can improve growth of 
ubc4ubc5 mutants and restore growth of these mutants under stress conditions such 
as elevated temperatures (Seufert et al., 1990).
Yeast cells mutant for UBC1 show a moderate slow growth phenotype, but 
are markedly impaired in growth after germination (Seufert et al., 1990). The 
degradation of certain proteins may be crucial at this point in yeast life cycle. A 
similar, but more severe, phenotype is seen for ubclubc4 double mutants, but 
ubclubc5 mutants show the same phenotype as ubcl mutants, proving UBC5 is 
dispensible as long as UBC4 is present.
The UBC4 enzyme is monoubiquitinated in vivo, dependent on the expression 
of active UBC4, indicating that there is a homodimer interaction resulting in 
ubiquitination (Gwozd et al., 1995). E2-E2 homo- and hetero- interactions have
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Vital functions with UBC4 and UBC5
DNA repair, induced mutagenesis, 
sporulation, N-end rule pathway.
Gl-S cell cycle control
Bulk degradation of short-lived and 
abnormal proteins
Vital functions with UBC1 and UBC4
E.R. membrane protein, secretory 
pathway functions
Confers cadmium resistance
No known mutant phenotype
Probably involved in S and M phase 
B-type cyclin degradation
Peroxisome biogenesis
Table 1.2 Saccharomyces cerevisiae ubiquitin conjugating enzymes.
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been reported elsewhere (e.g. Chen et aL, 1993), and may serve to increase the 
repertoire of substrate specificity in the ubiquitin system. Multiubiquitination of a 
protein by a complex of two E2 enzymes (homo- or hetero- dimers) could be a 
general mechanism, and two ubiquitin moieties can be added at a time due to the two 
ubiquitin binding sites present.
Homologues of UBC1, 4 and 5 have been found in Arabidopsis (see 1.7.2), 
wheat (Girod and Vierstra, 1993), C.elegans (Chen et aL, 1993), Drosophila (see 
1.7.3), and humans (Jensen et al., 1995). This implies that this is a highly conserved 
gene family, whose encoded enzymes perform essential functions in all eukaryotic 
cells. The proteins are so functionally conserved across evolution, they can 
complement yeast mutant for these genes. Higher eukaryotes have more members of 
this E2 subfamily than yeast. In humans, genes UbcH5A-C (Jensen et al., 1995) and 
UbcH6 (Nuber et al, 1996) are members of the UBC4I5 family, and Southern 
transfer experiments show there are likely to more members (Jensen et al., 1995).
1.7.1.2 UBC2/RAD6and homologues:
The RAD6 gene of S.cerevisiae is required for postreplication repair of 
damaged DNA, for induced mutagenesis and for sporulation (Reynolds et al., 1985). 
It encodes a class II ubiquitin conjugating enzyme (Jentsch et al., 1987) with a 
highly acidic C-terminal extension containing a tract of 13 consecutive aspartate 
residues. Ubiquitination of chromosomal proteins by RAD6, which is a nuclear 
protein (Watkins et aL, 1993), may be responsible for specific alterations in 
chromatin structure required for DNA repair and sporulation.
Mutating the active site Cys88 of RAD6 to Val results in an enzyme which is 
unable to bind to ubiquitin. The mutant phenotype seen was the same as that of a 
rad6 null allele (Sung et al., 1990). This suggests all the biological functions of 
RAD6 require its E2 activity. The carboxyl-terminal acidic domain extends freely as 
a tail to the globular core of RAD6 (Morrison et al., 1988) and is essential for 
multiubiquitination of histones in vitro (Sung et al, 1988) and sporulation (Morrison 
et al, 1988; Sung et al, 1988), but not for DNA repair functions. The polyacidic tail 
may recognise and bind to basic histones by ionic interactions.
RAD6IUBC2 has been implicated in the N-end rule pathway (see 1.5.1). The 
ubiquitination of N-end rule substrates requires UBC2 and the E2 is physically 
associated with UBR1 (N-recognin) (Dohmen et al, 1991). The yeast UBC2 can also 
function as an N-end rule-mediating ubiquitin-conjugating enzyme in a heterologous
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cell-free system such as rabbit reticulocyte lysates (Sung et al, 1991). The physical 
stability of UBR1-UBC2 interaction was seen by Madura et a/. (1993) to require the 
C-terminal tail of UBC2, and Watkins et al. (1993) showed it required the nine 
amino terminal amino acids, so both may be involved. An 170 residue C-terminal 
domain of UBR1 binds UBC2 (Madura et al, 1993).
Among the spontaneous mutations found in rad6 mutants are insertional 
mutations due to transposition of Ty retrotransposons (Picologlou et al, 1990). 
There is a more than 100-fold increase in spontaneous retrotransposition, though 
there is no increase in Ty message level. This could be due to alterations in 
chromatin structure of rad6 cells, allowing greater access for transposition. Ty 
transposition does not account for the entire increase in spontaneous mutation in 
rad6 mutants. Enhancement of G.C to T. A transversion, and both types of base-pair 
transition account for most of the increase in mutations (Kang et al, 1992), whilst 
mismatch repair is unaffected. A similar phenotype to that of rad6 mutants is seen in 
radlS mutants, and the encoded proteins may function by interacting with one 
another (Kang et al, 1992).
RAD6 homologues have been found in Drosophila (see 1.7.3.4), rabbits 
(Wing et al, 1992), S.pombe (Reynolds et al, 1990), and humans (Koken et al, 
199 lb.; Kaiser et al, 1994). These proteins are very similar to RAD6, though all 
lack the C-terminal acidic domain. They can all functionally complement rad6 
mutants for DNA repair defects, but not for sporulation which requires the 
poly acidic tail.
S.pombe has one RAD6 homologue, rhp6 (Reynolds et al, 1990), but humans 
have at least three (Koken et al, 19915.; Kaiser et al, 1994) showing higher 
eukaryotes again have multiple E2 enzymes for a particular function. UbcHl (Kaiser 
et al, 1994) has not been fully characterised. HHR6A and 6B are 95% identical 
(Koken et al, 1991b.) and the locations of their genes within the human genome 
have been found (Koken et al, 1992). HHR6A and 6B are both expressed in all 
mammalian tissues and cell types examined (Koken et al, 1996), but have elevated 
levels in testis. Like RAD6, both proteins are located in the nucleus, and under the 
electron microsope are seen associated with transcriptionally active regions in 
euchromatin (Koken et al, 1996). The HHR6 genes may have overlapping functions 
related to DNA repair.
The RAD6 protein is a highly conserved protein, probably present, and 
performing a similar role, in all eukaryotic cells.
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1.7.1.3. UBC3/CDC34and homologues:
CDC34 is an essential gene in S.cerevisiae, necessary for the transition from 
Gl to S phase. Temperature sensitive (t.s.) cdc34 mutants arrest with numerous 
elongated buds at the nonpermissive temperature. The spindle pole body duplicates, 
but fails to undergo the separation required for spindle formation. CDC34 was found 
to encode a class II ubiquitin conjugating enzyme and was renamed UBC3 (Goebl et 
aL, 1988). It has substantial similarity to RAD6 both within the UBC domain, and the 
poly acidic C-terminal extension. The C-terminal domain is 125 amino acids long, 
and the 39 residues adjacent to the catalytic domain are necessary and sufficient for 
full cell cycle functions (Ptak et aL, 1994).
When the active site Cys of CDC34 is mutated to Ser, cell growth is blocked, 
but no multi-budded phenotype is seen (Banerjee et aL, 1995). The block is relieved 
by overexpression of wild type CDC34, so the mutant probably sequesters CDC34 
substrates. This shows CDC34 cell cycle functions are dependent on it functioning as 
an E2 enzyme.
The cdc34 mutant phenotype can be partially suppressed by overexpression 
of wild type ubiquitin (Prendergast et aL, 1995). This may be due to CDC34 
catalysing its own ubiquitination, as a homodimer, via an intramolecular transfer of 
its thiol-ester linked ubiquitin to a Lys (Banerjee et aL, 1993). This is similar to the 
homodimer interaction of UBC4 except CDC34 becomes polyubiquitinated, 
suggesting one function of the enzyme is to target its own degradation. The physical 
interaction between CDC34 monomers is dependent on the same region of the C- 
terminal extension necessary for cell cycle functions (Ptak et aL, 1994). When 
CDC34 catalytic and tail domains are expressed separately, they only partially 
function (Silver et aL, 1992). The cell cycle functions of CDC34 are dependent on 
the ability of CDC34 monomers to interact with each other.
When S.cerevisiae cells reach a critical size, they initiate bud formation, 
spindle pole body duplication, and DNA replication almost simultaneously. This is 
the region of the cell cycle where CDC34 is necessary. All three events require 
activation of the CDC28 protein kinase by Gl cyclins CLN1, 2, and 3. CLN3 is a 
very unstable protein, due to a C-terminal PEST sequence (Tyers et aL, 1992). It 
associates with CDC28 to form an active kinase complex that phophorylates CLN3 
itself. A mutant CDC34 enzyme is seen to dramatically increase CLN3 associated 
kinase activity, but does not affect CLN3 half-life. However, CLN2, which also
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binds to CDC28 kinase, stimulates kinase activity and becomes phophorylated, is 
ubiquitinated and degraded in a CDC34 dependent manner (Deshaies et al, 1995).
DNA replication also requires activation of CDC28 kinase by B-type cyclins 
CLB1-6 (Schwob et al, 1994). Mutants for all six B-type cyclins arrest as multi- 
budded Gl cells resembling cdc34 t.s. mutants. Schwob et al. (1994) found cdc34 
mutants could not enter S phase because they fail to mediate the degradation of 
p40SIC l, a potent inhibitor of CLB forms of the CDC28 kinase. Gl to S phase 
transition therefore requires CDC34 mediated degradation of p4()SICl 5 a protein 
which appears at the end of mitosis, disappears before S-phase, and is a cyclin- 
specific inhibitor of CDC28 kinase.
A key component of the yeast centromere kinetochore is the protein complex 
CBF3. CBF2 encodes a subunit of CBF3, and CBF2 protein is another substrate for 
CDC34 mediated ubiquitination (Yoon and Carbon, 1995), implying ubiquitination 
of a kinetochore protein plays a regulatory role in kinetochore function.
Kornitzer et al. (1994) demonstrated CDC34 is also necessary for the rapid 
turnover of GCN4, a regulator of amino acid biosynthesis. This is a non-cell cycle 
function for CDC34 indicating it is a multifunctional regulator.
The first ubiquitin conjugating enzyme suppressor, UBS1, has been cloned 
and is a general positive regulator of CDC34 (Prendergast et al., 1996). When 
overexpressed, UBS1 suppresses mutant cdc34 cell cycle defects, as well as the 
inability to degrade GCN4. Deletion of UBS1 in a cdc34 mutant accentuates the cell 
cycle defect. UBS1 may regulate CDC34 activity by independently interacting with a 
represser of CDC34 via regions of similarity found between CDC34 and UBS1 
(Prendergast et al., 1996). CDC34 is phosphorylated and ubiquitinated (Goebl et al, 
1994), so activation/repression of the E2 could act by posttranslational modification.
CDC34 homologues have been found in rabbit (Haas et al, 1993) and 
humans (Plon et al, 1993). The human homologue is necessary for late Gl to S 
transition, and can functionally substitute for CDC34 (Plon et al, 1993). Southern 
transfer experiments showed the humanCDC34 DNA cross hybridised to DNA from 
other eukaryotes, suggesting this E2 has been highly conserved across evolution.
1.7.1.4 UBC2and UBC3 chimeric E2s:
When a chimeric E2 consisting of the RAD6 catalytic domain, and the 125 
amino acids comprising the C-terminal tail of CDC34 was expressed in yeast, it
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performed CDC34 functions and complemented the growth defects, U.V. sensitivity 
and sporulation defects of rad6 mutants (Kolman et aL, 1992). The 74 amino acids 
of the CDC34 tail neighbouring the catalytic domain were also able to perform these 
functions in the chimeric protein (Kolman et aL, 1992; Silver et aL, 1992). The cell 
cycle functions of CDC34 are probably partly encoded by the tail domain, and partly 
in a conserved region of the catalytic domain shared between RAD6 and CDC34. 
The CDC34 catalytic domain cannot substitute for the DNA repair functions of 
RAD6 (Silver et al., 1992). This again shows substrate specificity of E2 enzymes can 
reside in C-terminal extensions to the UBC domain.
1.7.1.5C/SC&
UBC6 is a class II E2 enzyme with a membrane anchor signal in its C- 
terminal extension. The encoded protein localises to the endoplasmic reticulum 
(E.R.) with the catalytic domain facing the cytosol (Sommer and Jentsch, 1993). Null 
mutants of UBC6 are viable, but suppress protein translocation defects of sec61 
mutants. SEC61 encodes a necessary component of a multisubunit protein 
translocation apparatus of the E.R.. The sec61 mutant phenotype is only seen when 
UBC6 is expressed (Sommer and Jentsch, 1993). UBC6 may mediate ubiquitin- 
dependent proteolysis of E.R. membrane proteins, and sec61 translocation defects 
may be due to proteolysis of the other components of the mutant translocation 
apparatus.
Degradation of E.R. membrane proteins may be related to E.R. protein 
degradation systems and may be a general function of the ubiquitin system. UBC6 
could be responsible for mediating degradation of various aberrant membrane 
proteins that are degraded in the E.R..
1.7.1.6 UBC7:
UBC7 shows similarity to the UBC1,4, and 5 group of E2s, but ubc? mutants 
are viable and grow at wild type rates (Jungmann et aL, 1993). UBC7 mediated 
functions are not required under normal growth conditions, but ubc7 mutants are 
specifically cadmium hypersensitive (Jungmann et aL, 1993). Wild type cells require 
a functional proteasome for cadmium resistance, and UBI4, UBC5 and UBC7 are all 
cadmium inducible genes. This suggests that a major reason for cadmium toxicity is 
the formation of abnormal proteins, and that the ubiquitin pathway is induced to
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degrade these proteins. In order to mediate cadmium resistance, it may be necessary 
forUBC? to be active to degrade abnormal proteins.
UBC6 and UBC7 associate as a complex to target Degl dependent 
degradation of MAToc2 (Chen et al., 1993). The interaction between the E2 enzymes 
does not require the UBC6 membrane anchor, but membrane association of the 
complex is required for Z)eg7-mediated proteolysis. This shows that there can be an 
overlap in substrate specificity among diverse E2s, and one mechanism of substrate 
selection may be by combinatorial association of different ubiquitin conjugating 
enzymes. UBC7 proteins may also interact with one another (Chen et al., 1993).
1.7.1.7 UBC8:
UBC8 (Qin et al., 1991) has no detectable mutant phenotype. It has an acidic 
C-terminal extension to the UBC domain, as does its human homologue, UbcH2 
(Kaiser et al., 1994). The UBCH2 C-terminal domain is thought to interact with 
substrates for ubiquitination (Kaiser et al., 1995). UBC8 may, like UBC7, be 
necessary for conferring resistance to specific toxic substances which produce 
abnormal proteins.
1.7.1.8 UBC9 and cell cycle control:
B-type cyclin degradation in yeast requires the activity of the essential, 
nuclear ubiquitin conjugating enzyme UBC9 (Seufert et al., 1995). Repression of 
UBC9 synthesis prevents cell cycle progression at G2 or early M phase, resulting in 
large budded cells with one nucleus, a short spindle and replicated DNA. Both 
CLB5, an S-phase cyclin, and CLB2, an M-phase cyclin, are stabilised in ubc9 
mutants (Seufert et al., 1995). CLB5 is short-lived throughout the cell cycle in wild- 
type cells, and CLB2 is stable during S and M phase, but is extremely short-lived in 
pre-start Gl cells. UBC9 protein is necessary at different points in the cell cycle to 
degrade different B-type cyclins. Therefore, cell cycle specific cyclin proteolysis 
must require distinct degradation signals, probably the "destruction boxes", and 
regulated interaction with ubiquitin system enzymes.
The hus5 gene of S.pombe is probably a homologue of UBC9 (Al-Khodairy 
et al., 1995). Deletion mutants of hus5 have very slow growth and exhibit high levels 
of abortive mitoses. Wild type hus5 may be involved in chromosome segregation.
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Entry into S phase, separation of sister chromatids during anaphase, and exit 
from mitosis all require the degradation of specific proteins via ubiquitin-dependent 
proteolysis. Cell cycle control by ubiquitin is reviewed in Pines (1994), Deshaies 
(1995b.) and Murray (1995).
Another yeast ubiquitin conjugating enzyme is encoded by the gene PAS2, 
renamed UBC10, and is required for peroxisome biogenesis (Wiebel and Kunau, 
1992). Peroxisomes are small membrane-bounded organelles that use oxygen to 
oxidize organic molecules. They contain enzymes to produce and degrade hydrogen 
peroxide. When a PAS gene is mutant, it leads to the absence of functional 
peroxisomes. Site-directed mutagenesis of the active site Cys of PAS2 resulted in a 
protein unable to complement pas2 mutant strains, but still associating with 
peroxisomes (Wiebel and Kunau, 1992). The C-terminal extension to the UBC 
domain probably targets PAS2 protein to the peroxisome membrane. There is a 
crucial role for the ubiquitin-conjugation pathway in peroxisome formation as pas2 
mutants lead to the mislocalisation of peroxisome matrix enzymes.
1.7.2 ARABIDOPSIS THALIANA E2S:
More E2s have been cloned in Arabidopsis thaliana than S.cerevisiae, but 
their functions have not been well characterised. Genes for sixteen E2s have been 
cloned, and they can be divided into 6 groups as shown in table 1.3 (Vierstra, 1994). 
AtUBCl-7 encode four structurally and functionally distinct subfamilies of E2s 
(Sullivan and Vierstra, 1991; Girod et al., 1993) and AtUBC8-12 are members of a 
multigene family encoding homologues of S.cerevisiae UBC1, 4, and 5 E2s (Girod et 
al., 1993).
The expression of AtUBCS, 8, and 9 was investigated by Genschik et al. 
(1994). All three are under control of complex mechanisms and are differentially 
regulated with respect to the lifetime of the cell, different organs in the plant, and 
development of the plant. None of them have coordinated expression with ubiquitin.
1.7.3DROSOPHILAE2S:





UBC 4, 5, 6
UBC 7, 13, 14

























Fig. 1.7 Drosophila melanogaster E2 enzymes arranged to show the different structural classes. 
UBC domains are shaded.
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1.7.3.1 UbcD1:
UbcDl was cloned by PCR amplification with degenerate primers (Treier et 
al., 1992). The encoded protein is a class I E2, and is very similar in sequence to 
UBC4 and UBC5. When UBC4 is precisely replaced with the UbcDl ORE in a 
ubc4ubc5 double mutant strain, it rescues the growth defects and temperature 
sensitivity (Treier et al., 1992). UbcDl mediates the multiubiquitination of 
proteolytic substrates, as most of the high molecular weight ubiquitin conjugates, 
absent in ubc4ubc5 double mutants, are restored in the UBCD1 expressing cells. 
UBCD1 can also degrade abnormal proteins produced by the presence of canavine.
UBCD1 is an E2 probably responsible for bulk-degradation of short-lived 
and abnormal proteins in Drosophila. It has a transcript of 1.5kb (Treier et al., 1992, 
results not shown), and maps to 88D in the Drosophila genome (Matuschewski et 
al, 1996).
1.7.3.2 UbcD2and Other Class III E2s:
The UbcD2 gene was also cloned by PCR amplification with degenerate 
primers, and encodes a class III E2 with an N-terminal extension to the UBC domain 
(figure 1.7). Class III E2s form a novel family of ubiquitin conjugating enzymes, all 
from higher eukaryotes, which are related in function and sequence to yeast UBC4/5 
(Matuschewski et al., 1996). The UBC domains of these enzymes (encoded by 
UbcD2 in Drosophila, UbcM2 and M3 in mouse, and UbcH6, 8 and 9 in humans) are 
94% identical. The amino-terminal extensions show little sequence similarity, except 
UbcH9 and UbcM2 which are homologues. This E2 family has at least four distinct 
members.
UBC domains of class III E2s are approximately 64% identical to that of 
UBC4, as opposed to UbcDl, the Drosophila UBC4 homologue,which is 80% 
identical. Class II E2s, with or without the N-terminal domain, can partially 
complement ubc4ubc5 mutants (Matuschewski et al., 1996), so may have some 
substrates in common.
No homologues to these genes have been found in yeast, and, as their UBC 
domains are so conserved within the group, it is likely this family evolved late and is 
unique to multicellular organisms. The significance of N-terminal extensions is 
unknown.
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According to Matuschewski etal. (1996) UbcD2 has a 1.5kb transcript, and 
maps to 32A/B in the Drosophila genome.
1.7.3.3 bendless/UbcD3:
The bendless (ben} gene was first discovered as an X chromosome mutation 
in Drosophila melanogaster, which alters patterns of connections in the central 
nervous system (C.N.S.; Thomas and Wyman, 1984).
The giant fibre (GF) neuron mediates the escape jump response in 
Drosophila. It receives input from the visual and olfactory senses, and upon 
stimulation drives the tergotrochanter (TTM), dorsal longitudinal (DLM) and 
dorsoventral muscles (DVM). Mutant ben genes affect the neuronal connection 
between the GF and the TTM motor neuron (TTMmn; Thomas and Wyman, 1984). 
In ben~ flies the GF fails to bend to make the connection with the TTMmn, and flies 
are defective in the escape jump response. The DLM is unaffected. The bendless 
gene product appears essential for the formation of a single synapse, and the ben 
mutation causes a defect in the recognition event leading to GF and TTMmn synapse 
formation (Muralidhar and Thomas, 1993). Mosaic analysis showed that the ben~ 
phenotype corresponds to a presynaptic GF defect, probably involving a growth cone 
dysfunction (Euk Oh etal., 1994).
Other phenotypes are seen in ben~ mutants:- abnormal grooming behaviour, 
lack of coordination, failure to climb the sides of culture vials, and failure to fly 
when dropped from a height (Euk Oh et al., 1994). Also 60% of mutant pupae 
cannot successfully eclose, and often die during emergence. Some of these 
phenotypes may be due to visual defects found in ben~ flies (Muralidhar and 
Thomas, 1993; Euk Oh et al., 1994). BENDLESS protein affects photoreceptor 
axons, which, like GF in ben~ flies, initially project normally, but fail later in their 
pathways.
The bendless gene was cloned (Muralidhar and Thomas, 1993; Euk Oh et al. , 
1994) and found to encode a class I E2. The same gene was found in a PCR 
amplification screen for Drosophila E2s (Matuschewski et al., 1996) and named 
UbcD3. It locates to 12D1-2 in the Drosophila genome, and has two transcripts of 
1.2 and 2.0kb (Muralidhar and Thomas, 1993). The BENDLESS protein may 
represent a distinct subclass of E2 as it is not a homologue of any E2 cloned so far. It 
appears to be most similar to the UBC1 , 4, 5 class of E2s, but is unable to rescue 
ubc4ubc5 mutants (Matuschewski et al., 1996, results not shown).
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One ben~ mutation was found to be a point mutation, causing a Pro to be 
changed to a Ser at position 97 (Muralidhar and Thomas, 1993). This Pro residue is 
found in the same position in all known E2s, and is within the strictly conserved 
consensus of the UBC active site region. This suggests the bendless gene product 
carries out its functions by acting as an E2 enzyme and mediating ubiquitination of 
other proteins.
Both bendless transcripts are expressed during development, with peak levels 
during pupation and in adults (Muralidhar and Thomas, 1993, results not shown). 
RNA in situ hybridisations show a low level of uniform expression throughout 
development, until the eleventh hour of development when a dramatic increase in 
ben expression is observed restricted to the nervous system. Most neurons of the 
C.N.S. and P.N.S. (peripheral nervous system) express high levels of ben. In third 
instar larvae high levels of expression are detected in developing brain and the 
ventral nerve cord (Muralidhar and Thomas, 1993). The GF circuit becomes active, 
and synapses between photoreceptor neurons and their targets form during the last 
third of pupal development. At this stage, high level ben expression is seen in the 
retina, neurons of the esophogeal ganglia of the brain, where the GF cell body is 
located, and in the thoracic ganglion (Muralidhar and Thomas, 1993). The fact 
bendless expression is restricted to the nervous system raises the possibility other 
E2s are differentially expressed and play specific roles in tissue development or 
function.
As bendless functions as an E2 enzyme, normal nervous system development 
must require specific proteins to be functionally modified or degraded via 
ubiquitination. In the GF circuit, synaptic connectivity is disrupted. Ubiquitin 
mediated signals could be necessary for activating or stabilising adhesive 
interactions allowing the growth cone to extend towards its target.
It has recently been reported that one target of the oncogene MYC in mice is 
a ubiquitin conjugating enzyme with homology to bendless (Bernards, 1996). This 
suggests similar interactions may occur between BENDLESS and Drosophila MYC 
proteins.
1.7.3.4 Dhr6:
Dhr6 is the Drosophila RAD6 homologue. It was discovered by homologous 
probing using the RAD6 gene (Koken et al., 199la.), and encodes a class I E2, 
lacking the polyacidic C-terminal tail of RAD6. Dhr6 has two transcripts of 1.3 and
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2.1kb, differing at their 3' ends due to alternative polyadenylation sites. The Dhr6 
gene is located at 82D in the Drosophila genome.
When expressed under the RAD6 promoter, DHR6 increases the U.V. 
resistance of a rad6 deletion strain. It also complements the y-ray sensitivity and 
restores the wild type level of U.V. induced mutagenesis (Koken et al, 199la.). 
Dhr6 could not rescue the sporulation defects as it lacks the necessary acidic C- 
terminal domain. The structure and function of the protein encoded by Dhr6 has 
been highly conserved among eukaryotes.
A gene encoding a fifth Drosophila E2 has recently been cloned and is a 
member of the alpha-esterase cluster of genes (Robin etal. , 1996).
1.8 UBIQUITIN-PROTEIN LIGASES:
Where a ubiquitin protein ligase (E3) is necessary for ubiquitination of the 
substrate protein, a thiol-ester linkage of ubiquitin to the enzyme is often, if not 
always, an intermediate in the reaction. Specificity in ubiquitin conjugation is partly 
due to the existance of multiple E2s and E3s. E2s are small proteins, and E3s are 
relatively large (100-300kDa) and specifically and tightly bind protein substrates 
(Reiss and Hershko, 1990; Scheffner et al, 1993). It seems likely E3s bind to the 
substrates, and E2s bind to E3s to allow the transfer of ubiquitin. In the large 
E2230K> both E2 and E3 activities reside within the same protein (Berleth and 
Pickart, 1996), and a thiol relay is seen between the two Cys residues in the protein.
1.8.1 N-END RULE E3S: E3cc, E3|i AND UBR1:
The first E3s characterised were those involved in recognising the N- 
terminus of protein substrates for degradation via the "N-end rule" ubiquitin - 
dependent pathway (see 1.5.1; review: Hershko, 1991).
E3a was isolated from rabbit reticulocytes (Hershko et al., 1983), and 
purified by affinity chromatography on immobilized Type I or Type II protein 
substrates for the N-end rule (Reiss et al., 1988). E3a is therefore thought to 
recognise the amino-terminal residues of proteins. It promotes the addition of 
multiple ubiquitins to the substrate protein (Hershko and Heller, 1985), and contains 
specific binding sites for proteins prior to ubiquitination. N-terminal recognition is
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based on the specificities of E3a binding sites (Reiss et al., 1988). It has one binding 
site for Type I basic N-terminal residues, and one for Type II bulky hydrophobic 
residues. E3p was isolated in the same screen as E3a. It recognizes N-end rule 
substrates with free, small uncharged N-termini (Heller and Hersko, 1989).
The yeast homologue of E3a was cloned by Bartel et al. (1990). The gene, 
UBR1, encodes a protein required for in vivo degradation of test proteins with basic 
or bulky-hydrophobic N-termini, and contains separate binding sites for each. Null 
ubrl mutants are viable, but grow slightly more slowly than wild type cells, and are 
slightly defective in sporulation. UBR1 has binding sites for and interacts with the 
UBC2/RAD6 protein (see 1.7.1.2; Madura et al., 1993).
1.8.2 ESS WITH KNOWN SPECIFIC SUBSTRATES:
E3s other than those for N-end rule functions have been discovered. A cyclin 
specific E3, E3-C, is present in clam embryos as the cyclosome complex or anaphase 
promoting complex (APC), activated at the end of mitosis by cdc2 kinase 
(Lahavbaratz et al., 1995). A similar E3 targetting cyclinB destruction in mitosis (M) 
is present in Xenopus embryos (King etal , 1995).
An E3, different both structurally and functionally from all other known 
ligases, was found in rabbit muscle (Gonen et al., 1996). It was named E3L, and 
recognises muscle proteins actin, troponin T and MyoD. It may be specific for 
muscle protein degradation, as it is found in other mammals, but not in wheat. 
Higher eukaryotes may require many E3 enzymes for differentiation of different 
tissues.
Calmodulin is monoubiquitinated with the aid of UBC4 and a putative 
specific E3 (Parag et al, 1993) in S.cerevisiae. Ubiquitinated calmodulin does not 
appear to be degraded, so the putative E3 may be necessary for ubiquitination to 
modify the activities of the protein.
1.8.3 "HECT" DOMAIN ESS:
The human E6-AP (E6 associated grotein) gene was discovered as part of the 
mechanism by which the E6 protein of human papillomaviruses inactivates the p53 
tumour suppressor gene. E6-AP is an essential factor in mediating complex 
formation of E6 and p53 (Huibregtse et al., 1991) and is an E3 enzyme (Scheffner et
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al., 1993). E6-AP forms a thiol-ester with ubiquitin, dependent on a Cys residue near 
the C-terminus (Scheffner et al., 1995), which is also necessary for p53 
ubiquitination. Ubiquitin is transferred in a "thiol-ester cascade" from El to a 
specific E2, to E6-AP which transfers it to the protein substrate.
Several eukaryotic proteins show similarity to E6-AP at their carboxyl- 
terminal ends (Scheffner etaL, 1995; Huibregtse etaL, 1995). This region includes 
the active site Cys necessary for E6-AP function, and this residue is conserved in all 
of these proteins. These proteins are known as hect domain proteins (homologous to 
the E6-AP carboxyl terminus; Huibregtse et al., 1995), and two, a rat lOOkDa 
protein and the yeast RSP5, have been shown to share the ability to form thiol-ester 
links to ubiquitin (Huibregtse etaL, 1995).
Regions of E6-AP-related proteins amino-terminal to the hect domain are 
generally divergent. In E6-AP this region is involved in binding substrates, 
suggesting that the hect domain targets specific substrates for ubiquitination due to 
protein-protein interactions directed by the amino-terminal region.
One member of this family, rat pi00, has a region of similarity to a conserved 
element of £ory(A) RNA binding proteins (PABPS) N-terminal to the hect domain 
(Huibregtse et al., 1995). It has large regions of similarity to another hect protein, the 
Drosophila hyperplastic discs (hyd} gene product (see 1.8.4). The regions of 
similarity include the PABPS element, implying E3 activities of pi00 and HYD may 
target similar proteins for ubiquitination.
The structural and biochemical similarities between E6-AP and the hect 
domain proteins suggests they represent a class of E3 ubiquitin protein ligases.
1.8.4 DROSOPHILA ESS: HYPERPLASTIC DISCS:
The hyd gene is located at 85E1-10 in the Drosophila genome (Mansfield et 
al., 1994) and was identified as a temperature sensitive (t.s.) mutation causing 
imaginal disc overgrowth in larvae at the restrictive temperature. Accumulation of 
the 9.5kb hyd transcript during development reflects the expression patterns of HYD 
protein. They are present at all stages, with high levels at embryonic and pupal 
stages (Mansfield etaL, 1994).
In situ hybridization to endogenous hyd transcript shows it is relatively 
abundant and evenly distributed throughout embryo development (Mansfield et al.,
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1994). In second and third instar larvae, the transcript becomes restricted to imaginal 
tissues, and is only present in cells growing by proliferation.
The hyd gene appears to be required in the initiation and maintenance of 
imaginal disc proliferation, as well as the termination of proliferation. Null alleles 
cause imaginal discs to be smaller than normal, whereas t.s. or hypomorphic alleles 
cause imaginal disc overgrowth (Amanai and Shearn, 1996).
A hect domain protein is encoded by the hyd gene (see 1.8.3). HYD can bind 
to bendless protein, so appears to act as an E3 in Drosophila (Amanai and Shearn, 
1996). The yeast two-hybrid system was used to find HYD associated proteins, and 
the D14-3-3 product of the Leonald gene was found by this screen (Amanai and 
Shearn, 1996). The 14-3-3 proteins have regulatory roles in intracellular signalling, 
and bind to oncogene and proto-oncogene products. 14-3-3 is part of the complex 
containing Raf which becomes translocated to the plasma membrane in the presence 
of Ras-GTP as part of the MAPK cascade. Raf is activated by 14-3-3. HYD may 
control imaginal disc cell proliferation by degradation of the 14-3-3 component in 
this multiprotein complex. However, binding of D14-3-3 to HYD was only 
discovered via the yeast two-hybrid system (Fields and Song, 1989), which often 
produces false positives. Binding has yet to be confirmed with purified proteins and 
in vivo.
1.9 THE 26S PROTEASOME:
The proteasome is the part of the ubiquitin system mediating the degradation 
of ubiquitin-protein conjugates in vivo (reviews: Goldberg, 1995; Jentsch and 
Schlenker, 1995; Rubin and Finley, 1995). Proteins tagged with multiubiquitin 
chains are degraded by the proteasome yielding small peptides in an ATP-dependent 
manner. Proteasomes are abundant (up to 1% of cellular protein) multisubunit 
particles (review: Peters, 1994) found in the cytosol and nucleus of eukaryotes.
The catalytic core of the 26S proteasome is the 20S protease (see figure 1.8; 
Peters, 1994), the structure of which has been determined by X-ray crystallography 
(Lowe et al., 1995). In addition to the 20S protease, protein degradation requires 
19S regulatory particles (figure 1.8; De Martino et al., 1994), and together these 
constitute 26S proteasomes. One subunit of the 19S particle is S5a, mediating 







Fig. 1.8 Structure of the 26S proteasome (after Rubin and Finley, 1995).
A. Contour map.
B. Schematic cross section. Circles show the position of peptidase active sites in the
Thermoplasma acidophilum proteasome.
C.Schematic diagram to show subunit arrangement.
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The 20S protease consists of four rings, each of seven subunits, arranged as a 
hollow cylinder (figure 1.8). Lowe el al. (1995) show in the archaebacterium 
Thermoplasma acidophilum proteasome, the subunits are either a or p, and are 
arranged in outer and inner rings respectively (figure 1.8). In eukaryotes each a and 
P subunit is encoded by a different gene, and the genes can be differentiated into 
families. In S.cerevisiae there are seven a and seven P genes (Hilt and Wolf, 1995).
Inhibitors of the archaebacterial proteasome bind to p subunits, showing 
these are proteolytically active (Fenteany et al, 1995). The active site residue is 
threonine; when it is mutated to Ser in the archaebacterial p subunit, the protease is 
sensitive to Ser protease inhibitors (Seemiiller et al, 1995). In the eukaryotic 
proteasome there are at least three distinct peptidase specificities (Hilt et al., 1995), 
and only three of the seven p subunits appear proteolytically active. The eukaryotic 
proteasome apppears to have separate active sites which cleave after basic, 
hydrophobic or acidic residues, and there is cooperative interaction between p 
subunits. In S.cerevisiae PRE1, 2, 3, and 4 genes encode p subunits (Hilt et al, 
1995). PRE 3 and 4 are necessary for cleavage after acidic residues, and PRE1 and 2 
are responsible for chymotrypsin-like activity (Heinemeyer etal, 1993).
In mammals the three active p subunits are found in distinct basal and 
inducible forms, and are regulated by cytokines (Fehling et al, 1994). Differences in 
proteolytic activity and P subunit patterns can be seen in different tissues (Cardozo et 
al, 1995).
The immune system of higher vertebrates utilizes MHC class I and classll 
molecules to display peptides, derived from intra- and extra-cellular antigens 
respectively, at the cell surface for recognition by T cells. The ubiquitin pathway 
provides peptides for binding to MHC class I molecules (Michalek et al, 1993; 
Rock et al, 1994), and the genetics of proteasomes and antigen processing is 
reviewed by Monaco and Nandi (1995). The mediator of the immune response, y- 
interferon (IFNy), enhances antigen presentation, and induces expression of three p 
subunits including MHC-encoded proteins LMP2 and LMP7 (Driscoll and Goldberg, 
1990). These are incorporated into proteasomes in place of homologous normal 
subunits, resulting in a proteasome which cleaves preferentially after basic and 
hydrophobic residues. This favours the production of oligopeptides with 
hydrophobic or basic C-termini, which are preferentially transported into the E.R. by 
the TAP transporter molecule, also induced by IFN-y, and bind tightly to MHC class 
I molecules (Neefjes et al, 1993). Peptide specificity of proteasomes, TAP, and 
class I molecules is coordinated, and genes for LMP2, LMP7, TAP and class I heavy
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chains are linked in the major histocompatibility complex (MHC) (Monaco and 
McDevitt, 1986).
The active sites of the T.acidophilum proteasome face the central cavity 
(figure 1.8; Lowe et al., 1995). The hydrophobic channel in the middle is 
approximately 13 A in diameter, so folded proteins cannot pass through it (Wenzel 
and Baumeister, 1995). The 19S particle has a channel continuous with that of the 
proteasome, and contains six distinct ATPase subunits (Dubiel et al., 1995). The 
interaction of 19S with the proteasome is ATP-dependent (Eytan et al, 1989), and 
the ATPases may mediate protein unfolding. The muliple ATPases probably have 
different binding specificities, endowing the 26S proteasome with the capacity to 
interact with and degrade a diverse range of ubiquitinated proteins.
Ubiquitin chains of conjugates are anchored to 19S subunit 5a (Deveraux et 
al., 1994), and substrates probably remain anchored until ATPases have unfolded 
parts of the protein and initiated translocation of the protein into the 20S protease 
channel. Thus, only ubiquitinated proteins are degraded. The ubiquitin protein is 
very stable, so must resist the unfolding enzymes in the 19S particle. At a certain 
stage the multiubiquitin chain must be removed to allow complete translocation of 
the substrate into the proteasome. Yeast DOA4, a ubiquitin carboxyl-terminal 
hydrolase (see 1.10), is a likely candidate for this activity, as mutants accumulate 
multiubiquitinated substrates that appear partially degraded (Papa and Hochstrasser, 
1993). The multiubiquitin chains are cleaved to single moieties by isopeptidase T 
(Hadari etal., 1992; see 1.10), and the unfolded substrate is degraded in the central 
chamber of the proteasome.
Proteasomes may also mediate the processing of precursors into active 
proteins. The p50 subunit of NF-KB is generated by a ubiquitin and proteasome 
dependent reaction, involving the degradation of the C-terminal portion of its 
precursor (Palombella^fl/., 1994; see 1.11.1).
The proteasome undergoes changes in intracellular localization during the 
cell cycle (Kawahara and Yokosawa, 1992; Amsterdam etal., 1993). The observed 
spatial and temporal distribution pattern during mitosis is like that of cyclins (Pines 
and Hunter, 1991), suggesting proteasomes play a role in degrading cyclins.
The control of proteasomes may be by exchange of p subunits, which could 
affect cleavage site specificity. Raising the activity of P subunits could result in the 
generation of smaller fragments, and increasing the activity of ATPases could 
accelerate protein translocation into the proteasome, and so yield larger peptides.
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1.9.1 THE PROTEASOME IN DROSOPHILA:
The Drosophila 26S proteasome has been purified (Udvardy, 1993), and 
shown to degrade ubiquitin-protein conjugates. The 19S particle (or JLI particle) is 
incorporated in to the 26S proteasome in an ATP-dependent manner. Synthesis of 
the 19S particle is developmentally regulated, with the highest levels present in 
embryos.
Cloned genes encoding proteasomal subunits include an a subunit, Dm25 
(Haass et al., 1990) which can be incorporated and functionally substitute for a 
mouse proteasomal subunit. Functional substitution is dependent on the N-terminal 
hydrophobic domain (Seelig etal., 1993). This shows proteasomal subunits are also 
conserved across species.
Drosophila proteasomes can be isolated from transcriptionally inactive early 
embryos, so may be important for early stages of embryogenesis (Haass and 
Kloetzel, 1989). Proteasome accumulation in the embryo occurs in cells involved in 
morphogenetic movements, and the presence of proteasomes is often concomitant 
with the establishment of mitotic domains (Klein et al., 1990). The proteasome may 
therefore be involved in cell specific proteolytic events required for cell proliferation 
and morphogenesis during early Drosophila development. However, it is difficult to 
interpret the results presented, as antibodies to the proteasome hybridise almost 
everywhere throughout the embryo, but are sometimes found in higher 
concentrations within particular cells. At later stages of embryonic development, 
proteasomes were detected at high concentrations in the ventral nerve cord (Klein et 
al., 1990).
1.10 UBIQUITIN CARBOXYL-TERMINAL HYDROLASES (UCHS):
The recycling of free ubiquitin is essential in ubiquitin-dependent proteolysis. 
Several ubiquitin carboxyl-terminal hydrolases (UCHs) have been found, which 
specifically hydrolyse ester or amide bonds linked to Gly76 of ubiquitin (review: 
Hersko and Ciechanover, 1992). They are essential to release ubiquitin from the 
isopeptide linkage with Lys residues of the protein substrate, and to disassemble the 
polyubiquitin chains, at the final stage of the proteolytic process. Hydrolases may 
also have a function to release proteins which have been incorrectly ubiquitinated. 
Abnormal polyubiquitin chains may be "trimmed" by UCHs to enable recognition 
and binding to the 26S proteasome. As ubiquitin genes are arranged in linear 
polyubiquitin arrays, or fused to ribosomal proteins (see 1.4), hydrolases are required
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for processing these ubiquitin precursors. Another hydrolase may be required to 
remove the one or more extra amino acids at the C-terminus of polyubiquitin gene 
products (see 1.4). Products from the interaction of high energy E1-, E2- or E3- 
ubiquitin thiol-esters reacting with intracellular nucleophiles could rapidly deplete 
free ubiquitin pools in the cell, so must be quickly cleaved by ubiquitin carboxyl- 
terminal hydrolases. An appropriate hydrolase may be responsible for removing 
ubiquitin from mono ubiquitinated proteins.
Most ubiquitin carboxyl-terminal hydrolases are thiol proteases (Wilkinson, 
1994). They are encoded by two gene families. One family has relatively small gene 
products of 25-30kDa, and these enzymes prefer a small leaving group in the 
reactions they catalyse. The other gene products are approximately lOOkDa and 
prefer a large leaving group (Wilkinson, 1994). The small enzymes are probably 
responsible for cleaving ubiquitin from the fusion proteins encoded by ubiquitin- 
coding genes.
Mammalian 30kDa enzymes UCH-L1, -L2 and -L3 have been found (Mayer 
and Wilkinson, 1989). UCH-L3 was found in humans (Wilkinson etal., 1989), and 
is the major 30kDa UCH in mammals. UCH-L1 is PGP9.5, a protein present at high 
levels in neuronal tissue. Testes, liver, heart and kidney express high levels of UCH- 
L2 (Wilkinson, 1994), showing that each 30kDa enzyme may be tissue specific. 
Different tissues probably contain different ubiquitinated proteins. All three enzymes 
have an active site Cys residue, and catalytically essential His residues which 
probably bind metal ions. The 30kDa class of C-terminal hydrolases is conserved in 
evolution: YUH1 is the yeast homologue of UCH-L3. Null mutants of YUH1 are 
viable, possibly due to complementation within UCH enzyme families. YUH1 
cleaves the isopeptide linkage between ubiquitin and small proteins (Miller et al., 
1989), as does UCH-L3.
Fusions of ubiquitin to larger proteins can be cleaved by larger yeast UCHs: 
ubiquitin specific riroteases (UBP) 1, 2 and 3 (Wilkinson, 1994). DOA4 is another 
member of this group (Papa and Hochstrasser, 1993), and was found to function by 
cleaving ubiquitin chains from substrate remnants still bound to the proteasome. 
These proteins have recently been found to belong to the ubiquitin C-terminal 
hydrolase family 2 (UCH2: Falquet et al., 1995). This family was defined on the 
basis of the Cys and His domains found in DOA4 (Papa and Hochstrasser, 1993), 
which are involved in de-ubiquitinating activity, and probably bind metal ions. An 
aspartic acid domain is also conserved (Falquet et al., 1995), but its function is
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unknown. The UCH2 family includes the Drosophila FAT FACETS (FAF) protein 
(see 1.10.1).
A pseudo KEKE domain was found in a UCH2 family member (Falquet et 
al., 1995). These domains mediate non-covalent association between proteins 
(Realini et al., 1994), and may mediate binding of UCH2 family proteins to the 26S 
proteasome. It seems reasonable to speculate some of these UCHs are present in the 
19S regulatory particle of the 26S proteasome, and are responsible for cleaving 
polyubiquitin chains from partially degraded substrates. Eytan et al. (1993) 
characterised an ATP-dependent hydrolytic activity that is an integral part of the 26S 
proteasome complex. The enzyme cleaves isopeptide bonds, and appears to release 
ubiquitin in the terminal stages of degradation. Other UCHs in this family may be 
responsible for breakdown of the polyubiquitin chains. They may be associated with 
the 26S protease complex, perhaps via non-covalent interaction through pseudo 
KEKE domains, as the protein found containing this domain is probably isopeptidase 
T (Falquet et al., 1995; see below).
Isopeptidase T (Hadari et al., 1992) is a monomeric ubiquitin-binding 
protein, with two ubiquitin-binding sites, which acts on polyubiquitin chains, 
converting them to free ubiquitin. The role of this isopeptidase is to remove 
polyubiquitin chains following degradation of the protein substrate by the 26S 
proteasome (Hadari et al., 1992). It disassembles the branched chains by a sequential 
exo- mechanism, requiring a free C-terminal Gly of the proximal ubiquitin moiety 
(Wilkinson et al., 1995). This implies the UCH in the 26S proteasome complex must 
cleave polyubiquitin chains from the substrate before isopeptidase can act.
1.10.1 DROSOPHILA UCHS:
1.10.1.1 Uch-D:
A Drosophila UCH named uch-D, was cloned due to its enriched expression 
on the ventral side of the oocyte and in nurse cells during oogenesis (Zhang et al., 
1992). It is a member of the family of 30kDa UCHs, so may be responsible for 
cleaving ubiquitin from the DUb52, DUbSO and Ubip (see 1.4.2) gene products.
Uch-D locates to 98F in the Drosophila genome (Zhang et al., 1992). A 
l.lkb uch-D transcript is seen at all stages of development, but is elevated in 0-4hr 
embryos, ovaries and testis. The high level of transcripts in the ovary and young 
embryo are typical of a maternal mRNA stored in the oocyte and used during
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embryogenesis. A role for uch-D at this stage could be the release of ribosomal 
proteins from ubiquitin fusion proteins, for the rapid assembly of ribosomes during 
embryogenesis.
1.10.1.2 Fat facets (faf):
The fat facets (faf} gene is a Drosophila UCH2 family ubiquitin carboxyl- 
terminal hydrolase (see above: Falquet et aL, 1995; Huang et al., 1995). The FAF 
protein is required in cell communication pathways that negatively regulate neural 
determination in the developing compound eye (Fischer-Vize et al., 1992). Null faf 
mutants are viable, but have abnormal eye morphology due to a misdetermination 
event, where cells become neurons that do not normally do so, resulting in more than 
the wild type eight photoreceptors in each eye facet (Fischer-Vize et al., 1992). 
Mutant females lay embryos which never reach cellularisation, implying faf is also 
required during oogenesis. The first 392 amino acids of the FAF protein localise it to 
the posterior pole of oocytes, dependent on the presence of wild type oskar function 
(Fischer-Vize et al., 1992), and ovary-specific functions may be due to this 
localisation.
The FAF protein can cleave ubiquitin from fusions to (3-galactosidase in 
E.coli, (Huang et al., 1995) and mutations of the active site Cys residue to Ser 
destroy this ability. FAF also functions as a ubiquitin carboxyl-terminal hydrolase in 
Drosophila as mutation of the Cys or either of the two essential His residues 
severely impairs faf functions in flies (Huang et al., 1995).
Reducing the amount of proteasome subunit 1(3)73 Ai by half results in strong 
suppression of the faf mutant phenotype, but FAF does not appear to associate with 
the proteasome (Huang et al., 1995). This suggests FAF activity antagonises 
proteasome function, possibly by deubiquitinating a specific regulatory protein 
targeted for degradation, before it reaches the proteasome.
Fat facets is a cell type specific UCH, and acts as a regulator of cell fate 
decision in Drosophila melanogaster.
1.11 PROTEINS DEGRADED BY THE UBIQUITIN SYSTEM:
The ubiquitin system is involved in the bulk degradation of short-lived and 
abnormal proteins. The proteasome is also involved in the bulk degradation of long-
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lived proteins (Rock et aL, 1994), but as lack of El function does not appear to 
affect degradation of long-lived proteins (Cropper et aL, 1991), it may be ubiquitin- 
independent. This section shows some examples of proteins targeted by the ubiquitin 
system.
1.11.1 TRANSCRIPTION FACTORS:
1.11.1.1 MAT c/2 represser:
The MAToc2 represser is a short-lived nuclear transcriptional regulator of 
mating type switching in S.cerevisiae. It has two degradation signals (see 1.5.2.2; 
Hochstrasser and Varshavsky, 1990), and is degraded by the ubiquitin system 
(Hochstrasser et al., 1991). The rate of MAToc2 degradation is significantly lower in 
a yeast ubc4ubc5 deletion strain, and UBC6 and UBC7 are also involved (Chen et 
aL, 1993). UBC6 and UBC7 proteins form a complex together (see 1.7.1.6) and 
target MATcc2 for degradation via the Degl signal. UBC4 and UBC5 can also 
ubiquitinate MAToc2, but recognise an unknown signal. As t/5C67£/BC7-dependent 
degradation requires membrane association of the complex, MATa2 is probably 
degraded in this manner at spatially restricted sites in the cell. This may be a method 
for degrading abnormal MATa2 protein which has not been translocated to the 
nucleus.
1.11.1.2NF-KBandlKBo:
In response to a wide variety of extracellular signals, the transcription factor 
NF-KB is activated, and results in a variety of transcriptional responses (Thanos and 
Maniatis, 1995). In non-inducing conditions, NF-KB resides in the cytoplasm in 
inactive complexes with iKBa. If NF-KB is in precursor form (p!05), this also 
prevents translocation to the nucleus. Ixfia is related to the C-terminal prodomain of 
pi05, and both mask the NF-KB nuclear localisation signal. NF-KB is activated by 
processing of p!05 and by destruction of IKBa, both of which occur via the 
ubiquitin-proteasome pathway (reviews: Deshaies, 1995a.; Hochstrasser, 1996).
Palombella et al. (1994) showed that processing of pi05 is dependent on 
ATP, polyubiquitination and the 26S proteasome. p!05 is partially degraded to 
active p50, which still requires degradation of IKBa for nuclear transportation. 
Degradation of IxBa requires signal-induced phosphorylation of two Ser residues
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near its amino terminus (Chen et al., 1995) by a specific IicBa kinase (Chen et al., 
1996). UBC4 and UBC5 are necessary for ubiquitination of iKBa, and also for iKBcc 
kinase activity (Chen et al., 1996). Multiubiquitination of an unknown factor, 
probably part of the IKBa kinase complex, must occur before phosphorylation and 
subsequent ubiquitination and degradation of IicBa (Chen et al., 1996). 
Ubiquitinated IKBa remains associated with NF-KB until it is degraded. NF-KB can 
then move to the nucleus, and act as a transcription factor.
The ubiquitin-dependent control of NF-KB is interesting as during 
Drosophila development, dorsal-ventral axis specification requires the DORSAL 
transcription factor, which is homologous to NF-KB. DORSAL is normally 
maintained in an inactive state in the cytoplasm by the 1KB homologue CACTUS. 
The TOLL signalling pathway triggers the degradation of CACTUS (Belvin et al., 
1995) to allow nuclear import of DORSAL. This pathway may also be regulated by 
phosphorylation-dependent ubiquitin-mediated proteolysis.
1.11.2 PHYTOCHROME:
The phytochrome protein exists in two interconvertible forms; the Pr form, 
absorbing light at 670nm (P670) is converted to Pfr, P730, following exposure to far 
red light. The photoconversion initiates processes adapting plants to photosynthetic 
light, and results in about a 100 fold increase in the degradation of phytochrome 
(Shanklin et al., 1987). A concomitant increase in ubiquitin-phytochrome conjugates 
is seen (review: Callis, 1995). Following irradiation, phytochrome aggregates. 
Perhaps only aggregated phytochrome is recognised by the ubiquitin system, or a 
phytochrome specific E3 may also be light activated.
1.11.3ONCOPROTEINS:
Alterations in the rate of ubiquitin-dependent proteolysis of certain proteins 
may play an important role in the development of certain cancers.
The concentration of the p53 tumour suppressor protein is dramatically 
reduced in cells infected with oncogenic human papillomaviruses (HPVs) even 
though normal levels of protein are synthesised (Scheffner et al., 1993). Physical 
association of HPV-encoded E6 protein with p53 accelerates p53 degradation via 
ubiquitination. Ubiquitination requires human E2s UbcH4 and UbcH5, which 
transfer ubiquitin to a cellular E6-binding protein known as E6-AP (Scheffner et al.,
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1995). E6-AP is a hect domain E3 (see 1.8.3), and transfers ubiquitin to p53. 
Reduced levels of p53 may deregulate growth control and apoptosis in infected cells, 
resulting in malignancy.
Regulation of c-Jun activity is important for normal cell growth, and 
overexpression can lead to cellular transformation. Ubiquitin-dependent degradation 
maintains c-Jun protein at low levels in normal cells (Treier et al, 1994). A 27 
amino acid region known as the 8 domain is necessary for c-Jun ubiquitination and 
degradation. Other proto-oncoproteins c-Fos (Staniscovski et al. , 1995) and c-Mos 
(Nishizaura etal , 1993) are also degraded in a ubiquitin-dependent fashion.
1.11.4CYCLINS:
Cyclins, several types of which exist, are proteins involved in cell cycle 
control in eukaryotes. They act by regulating the activity of cdc2 protein kinase. 
Mitotic cyclins are rapidly degraded at the end of metaphase to enable cells to exit 
mitosis and divide. Analysis of degradation targetting signals revealed the 
"destruction box" (Glotzer et al., 1991; see 1.5.2.3). Cyclins are degraded by 
ubiquitin-dependent proteolysis (Glotzer et al., 1991; Hershko et al., 1991). 
Ubiquitination of mitotic cyclins requires a constitutively active E2, and an E3 in the 
1000-1500kDa cyclosome or anaphase promoting complex (APC) which is a large 
multisubunit complex, active in mitotic, but not interphase cell extracts, necessary 
for degradation of mitotic B type cyclins and progression of the cell cycle to 
anaphase (Hershko etal., 1994; Sudakin etal, 1995; King etal, 1995).
B-type cyclin degradation is mediated by UBC9 in S.cerevisiae (see 1.7.1.8). 
Genes CDC16, CDC23, andCSEl were seen to be involved in this proteolysis as 
mutants stabilize cyclin B-pgalactosidase chimeras in yeast cells depleted of Gl 
cyclins (Irniger et al, 1995). These genes were previously identified as being 
required for chromosome segregation and anaphase. CDC16, CDC23 and CDC27, 
another protein implicated in chromosome segregation (Lamb et al., 1994), are 
subunits of the anaphase promoting complex. CDC16, 23 and 27 are highly 
conserved, and perform the same functions in humans (Tugendreich et al., 1995), 
S.pombe (Samejima and Yanagida, 1994) and Aspergillus nidulans (Mirabito and 
Morris, 1993), suggesting they are part of the APC in all eukaryotes. Anti CDC27Hs 
antibodies immunodeplete the APC from Xenopus extracts (King et al, 1995). 
Activation of cyclin degradation in mitosis is triggered by phosphorylation of the
APC. CDC16 and CDC27 show an increase in mass on entry to mitosis (King et al., 
1995), implying these are the phosphorylated APC subunits.
Non-degradable cyclin B blocks S.cerevisiae cell cycle in late anaphase 
(Surana et al., 1993), but cells with t.s. CDC16, CDC23 (Irniger et al., 1995) or 
proteasomal (Ghislain etal, 1993; Friedman and Snyder, 1994; Gordon etal, 1993) 
gene products arrest in metaphase at the non-permissive temperature. Chromosome 
segregation is blocked by non-degradable cyclin in Xenopus extracts (Holloway et 
al., 1993). These observations imply the APC promotes degradation of both cyclin B 
and a protein involved in sister chromatid cohesion (Holloway et al., 1993), another 
role in the cell cycle for ubiquitin-dependent proteolysis.
1.11.4.1 Cyclin degradation and the Drosophila cell cycle:
During the first seven mitotic divisions of Drosophila embryogenesis, the 
levels of cyclin B and activity of cyclin-Bp34cdc2 do not oscillate (Edgar et al., 
1994). Cycles 8-13 show a progressive increase in the extent of cyclin degradation 
during mitosis, which leads to increasing fluctuations in CDC2 kinase activity. 
Cyclin B degradation may be spatially restricted to the nuclear areas in the early 
divisions, as the APC subunits localise to the centrosome and mitotic spindle 
(Tugendreich etaL, 1995; Mirabito and Morris, 1993).
1.12 FUNCTIONS OF THE UBIQUITIN PATHWAY:
Intracellular proteolysis does not just control the turnover of damaged or 
abnormal proteins. Ubiquitin-dependent proteolysis plays a key role in processes as 
diverse as embryonic development, receptor endocytosis and cell cycle control. This 
section attempts to review some functions which have not been previously discussed.
1.12.1 RECEPTOR MEDIATED ENDOCYTOSIS:
Many cell surface proteins are rapidly endocytosed, and recycled to the 
plasma membrane, or destroyed by vacuolar proteases in the vacuole or lysosomes. 
Plasma membrane proteins can be ubiquitinated, and this can serve as a tag for 
degradation (reviews: Hurtley, 1996; Hochstrasser, 1996).
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Most cases of cystic fibrosis (CF) are caused by mutations interferring with 
the folding of the cystic fibrosis transmembrane conductance regulator (CFTR) 
leading to rapid degradation of CFTR molecules that have not matured beyond the 
E.R.. CFTR is targetted for proteasomal degradation by ubiquitination (Ward et al.,
1995). The cell performs quality control of its secretory and membrane proteins in 
the E.R., and it is here that CFTR of CF patients is polyubiquitinated and degraded 
(Jensen etal, 1995).
Other intrinsic membrane proteins are presumably also substrates for 
ubiquitin-dependent degradation during their maturation within the E.R. However, 
Hicke and Riezman (1996) show ubiquitination of membrane proteins can also occur 
at the membrane, and marks the proteins for degradation in the vacuole, the yeast 
equivalent of the lysosome. Ligand-induced ubiquitination of a-factor receptor STE2 
protein, a yeast mating pheromone receptor, leads to receptor-ligand complex 
endocytosis followed by vacuolar degradation. Mutant yeast cells lacking some 
ubiquitin conjugating enzymes cannot internalize and degrade the receptor in 
response to added pheromone (Hicke and Riezman, 1996). A nine residue sequence 
within the cytoplasmic C-terminal tail of the STE2 protein is critical for 
internalisation. Cells expressing STE2 without this region bind pheromone, but are 
not ubiquitinated, internalized or degraded efficiently. In cells with protease- 
deficient vacuoles, ubiquitinated STE2 accumulates in vacuoles, but cannot be 
degraded. Cells with defective proteasomes have no effect on degradation of the 
ligand-bound, ubiquitinated and internalized receptor.
Ubiquitination is probably often used as a signal for endocytosis and 
vacuole/lysosome targetting of receptors. Yeast STE6, uracil permease, amino acid 
transporter GAP1 and multidrug transporter PDR5 all appear to follow a similar 
degradation pathway to STE2 (Rolling and Hollenberg, 1994; Egner and Kuchler,
1996). A number of mammalian membrane proteins are also multiubiquitinated at 
the cell surface and degraded in the lysosome (Ciechanover, 1994).
1.12.2 NEURODEGENERATIVE DISEASE:
Dramatic increases in ubiquitin and ubiquitin-protein conjugates are observed 
in a wide variety of neurodegenerative disorders (review: Muller and Schwartz, 
1995). These include Parkinson's disease (Manetto et al., 1988), Alzheimer's disease 
(Mori et «/., 1987), amyotrophic lateral sclerosis (motor neuron disease; Bergmann, 
1993), and Creutzfeldt-Jakob disease (Suenaga et al., 1990). The same increases are
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seen for animal models of the human dieases. One common feature found is the 
presence of filamentous inclusion bodies: abnormal cytoplasmic inclusions 
containing high levels of cytoskeletal proteins. Ubiquitin has been found covalently 
associated with some proteins in the inclusion bodies; ubiquitin is bound to the 
microtubule associated protein TAU of paired helical filaments in inclusion bodies 
in Alzheimers 1 brains (Mori et al , 1987).
It is not yet clear whether the accumulation of ubiquitin represents a role for 
the protein in the pathology of these diseases. Ubiquitin levels may be elevated in 
order to degrade damaged proteins arising from progression of the disease, or may 
be unrelated to the disorder, and just reflect random accumulation of small cellular 
proteins.
1.12.3 UBIQUITIN IN DEVELOPMENT:
Ubiquitin was first discovered as a protein capable of inducing the 
differentiation of T-cell and B-cell lymphocytes (Goldstein et al., 1975). The 
ubiquitin-dependent proteolytic pathway has other roles in differentiation of tissues 
and cell types in development. The tissue specificity of some ubiquitin pathway 
enzymes has previously been mentioned (see 1.6.3, 1.10). It is likely the degradation 
of certain sets of previously stable proteins, no longer necessary in a particular cell 
type, could lead to differentiation. Between different tissues, different sets of 
proteins will be expressed, so each cell type should have a ubiquitin system refined 
to recognise and degrade/control the half-lives of its particular expressed proteins.
1.12.3.1 Ubiquitin in plant development:
Ubiquitin with Lys48 mutated to Arg is an inhibitor of ubiquitin-dependent 
proteolysis. It was expressed in Nicotiana tabacum to assess the role of this pathway 
in plant development (Bachmair et al., 1990). Expression of mutant mono- or 
polyubiquitin gave vascular tissue abnormalities, probably because vascular tissue 
requires extensive degradation of intracellular proteins during differentiation. Plants 
were smaller due to decreased internode length (Bachmair et al., 1990), and 
overexpression of mutant polyubiquitin led to curled leaves with necrotic lesions. 
Perturbations of the ubiquitin system induced a programmed necrotic response. 
Pollen maturation appears to be the only part of plant development not requiring the
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ubiquitin system (Worrall and Twell, 1994). In maturing pollen, most proteins are 
produced for storage, and are not fully processed.
The substrate specificity of the ubiquitin pathway does appear to be different 
in different plant tissues, as different E2s are seen expressed differentially with 
respect to different organs of the plant (Genschik etal., 1994).
1.12.3.2 Ubiquitin in vertebrate development:
During erythroid differentiation some E2s increase in concentration, and 
some decrease (Haldeman etal., 1995; Wefes et al., 1995). This suggests a role for 
the ubiquitin pathway in eliminating previously stable proteins through the 
expression of new E2s. Erythroids lack nuclei, mitochondria and many cytoplasmic 
and cytoskeletal proteins. Induction of specific E2s may eliminate these proteins.
There is a role for ubiquitin-dependent proteolysis in the development of the 
testis. Certain Els appear to be specifically expressed in testis, and may be 
spermatogenic (see 1.6.3). A rat E2 is also expressed at high levels in testis (Wing 
and Jain, 1995), and a UCH in fish is involved in sex differentiation (Fujiwara et al., 
1994). Expression of the fish UCH begins during sex transition and continues during 
maturation of the testis. A C.elegans E2 has also been found with gonad specific 
activity during the period of gonad differentiation (Jones et al., 1995). This suggests 
the testis-determining role of the ubiquitin pathway is not restricted to vertebrates.
1.12.3.3 Ubiquitin in Drosophila development:
There are mutants of three Drosophila ubiquitin pathway genes: ben (see 
1.7.3.3), hyd (see 1.8.4) and faf (see 1.10.1.2). These mutants suggest developmental 
roles for ubiquitin-dependent proteolysis in nervous system development, imaginal 
disc growth, eye development and oogenesis (see chapter 6). When other mutants are 
discovered, they may be found to affect different developmental events.
1.12.4 PROGRAMMED CELL DEATH (P.C.D.):
The deliberate and orderly removal of cells by programmed cell death 
(P.C.D.) is a common phenomenon during animal development (review: Schwartz, 
1991). A cell's decision to die is equivalent to differentiation, as it requires the
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activation of specific sets of genes. One putative cell death gene has been identified 
as the product of the polyubiquitin gene (Schwartz et al., 1990). Ubiquitin 
presumably facilitates rapid removal of cellular proteins during degeneration.
The intersegmental muscles (ISMs) of the tobacco hawkmoth, Manduca 
sexta, form a model system for investigating P.C.D.. Intersegmental muscles are 
necessary for eclosion of adult moths from pupae on day 18 of the moth life cycle, 
and then die during the subsequent 30hr. The trigger for ISM death is a decline in 
insect hormone 20-hydroxy-ecdysone (20-HE). Polyubiquitin expression is 
upregulated during ISM programmed cell death (Schwartz et al., 1990), and an El, 
several E2s and an E3 are also induced in response to the fall in 20-HE (Haas et al., 
1995). Ubiquitin conjugates increase 10-fold at eclosion, when loss of muscle 
protein mass is maximum (Haas et al., 1995). Enzymes for ubiquitin conjugation 
may represent genes necessary for programmed cell death.
An increase in 26S protease activity accompanies P.C.D. of intersegmental 
muscles (Jones et al., 1995) and four new subunits are seen in the complex in 
response to the 20-HE trigger. Three of these subunits are related ATPases (Dawson 
et al., 1995). The large increase and extensive reprogramming of 26S proteasome 
activity may facilitate rapid muscular proteolysis.
Programmed cell death of nurse and follicle cells occurs in Drosophila 
oogenesis, and a large number of specific cells die during embryonic development 
(Abrams et al., 1993). The ubiquitin system may have a developmental role to play 
during these programmed cell deaths.
From the information presented in this chapter it is obvious protein 
ubiquitination is involved in many different processes. Control of protein levels by 
selective degradation is probably important for cell differentiation, programmed cell 
death and for correct spatial and temporal expression of proteins which are key 
developmental regulators. Enzymes of the ubiquitin pathway have been found to 
affect the development of the Drosophila eye, imaginal discs and parts of the C.N.S., 
so there are roles for ubiquitination in Drosophila development. Some specificity for 
substrate selection for ubiquitination resides in ubiquitin conjugating enzymes. 
Studies on the temporal and spatial expression of Drosophila E2s throughout 
development, and on the phenotypes of Drosophila mutant for E2 enzymes could be 








Luria Broth (L-broth): Difco Bacto tryptone, lOg; Difco Bacto yeast extract, 5g;
NaCl, 5g; per litre, adjusted to pH 7.2.
Luria Agar (L-agar): As Luria broth with 15g per litre Difco agar.
BBL-top Agar: Baltimore Biological Laboratories trypticase, lOg; NaCl, 5g; Difco
Agar, 6.5g; per litre.
Top agarose: Agarose, 0.6g; Luria broth, 100ml; 1M MgSO4, 1ml.
Ampicillin to a final concentration of 100|Lig/ml was added to media immediately 
prior to use when required.
2.1.2 DROSOPHILA MEDIA:
"French" fly food: Oxoid No.3 agar, 7.5g; polenta, 55g; dried flake yeast, 55g; 
nipagen (150mg/ml made up in 95% ethanol), lOmls; dH2O, lOOmls. 
Egg collection media: Difco Bacto Agar, 90g; dH2O, 31; apple juice, 11; nipagin, 
6g; sucrose, lOOg.
2.1.3 YEAST MEDIA:
YPDA: 1% (w/v) Yeast extract; 2% (w/v) Bacto-peptone; 2% (w/v) glucose;
0.003% (w/v) adenine.
YMG/CAS: 0.67% (w/v) Yeast Nitrogen Base without amino acids; 2% (w/v)
Casamino acids; 2% (w/v) glucose. For plates 2% (w/v) agar was added. Media was
supplemented with nutrients where required.
YMGal/CAS: 0.67% (w/v) Yeast Nitrogen Base without amino acids; 2% (w/v)
Casamino acids; 2% (w/v) galactose. For plates 2% (w/v) agar was added. Media
was supplemented with nutrients where required.
2.2 MATERIALS:
2.2.1 SOLUTIONS:
AP buffer: lOOmM NaCl; 50mM MgCl2; lOOmM Tris.HCl, pH9.5; ImM 
levamisol; 0.1% Tween 20.
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Boiling Mix: Stacking gel buffer, 1.0ml; 25% SDS, 0.8ml; p-mercaptoethanol,
0.5ml; 100% glycerol, 1.0ml; 0.05% BPB.
Denaturation buffer: 0.5MNaOH; LSMNaCl.
2x Freezing Mix: K2HPO4,3.78g; tri-Na citrate, 0.27g; MgSO4.7H 20,0.054g ;
(NH4) 2SO4, 0.54g; KH2PO4, l.OSg; glycerol, 26.4g; make up to 300ml with dH2O.
Gel buffer: Tris, 18.15g; SDS, 0.4g; pH to 8.9 with HC1; make up to 100ml with
dH2O.
Hybridisation solution: 0.5M NaP (1M Na2HPO4,72ml; 1M NaH 2PO4, 28ml); 7%
SDS; ImM EDTA pH 8.0.
Injection buffer: 5mM KC1; O.lmM NaPO4 , pH 6.8.
Loading buffer: 40ml 250mM EDTA, pH 8.0; BPB, O.lg; ficoll, 20g ; make up to
100ml with dH2O.
Lysis buffer: 300mM Tris.HCl, pH 9.0; lOOmM EDTA, pH 8.0; 0.625% SDS; 5%
sucrose.
lOx MOPS: 1M MOPS pH 7.0, 100ml; 3M CH 3COONa pH 7.0, 8.33ml; 0.5 M
EDTA, 10ml; make up to 500ml with dH2O.
lOx Nick Translation buffer: 500mM Tris-HCl, pH 7.2; lOOmM MgSO4 ; ImM
DTT.
5x OLB: 0.05M p-mercaptoethanol; 1M HEPES pH6.6; 0.03Upd(N) 6 ; 0.26M
MgCl2 ; O.lmM dATP, dTTP and dGTP.
lOx PBS: NaCl, 80g; KC1, 20g; Na2HPO4, 0.2g; KH2PO4, 20g; make up to 1 litre
with dH 2O.
40% PEG solution: 40% (w/v) PEG; T.E.; ImM LiAc pH 7.5.
Phage buffer: KH 2PO4, 3g; Na2HPO4, 7g; NaCl, 5g; 0.1M MgSO4 , 10ml; lOmM
CaCl 2, 10ml; 1% gelatin, 1ml; make up to 1 litre with dH2O.
Sample buffer: 20% glycerol; lOOmM EDTA; 0.1% BPB.
Stacking gel buffer: Tris, 5.1g; SDS, 0.4g; pH to 6.7 with HC1; make up to 100ml
with dH 2O.
STET: 8% sucrose; 0.5% Triton X-100; 50mM EDTA pH 8.0; 50mM TrisHCl pH
8.0; make up to 200ml with dH2O.
20x SSC: NaCl, 175g; tri-Na Citrate, 88g; make up to 11 with dH 2O.
T4 ligase buffer: 5mM ATP; 200mM Tris pH7.6; 50mM MgCl2 ; 50mM DTT;
500|ig/ml BSA.
20x TAE: Tris Base, 96.8g; Glacial acetic acid, 22.8ml; 0.5M EDTA pHS.O, 40ml;
make up to 11 with dH 2O.
20x TBE: Tris Base, 216g; Boric Acid, HOg; EDTA, 18.6g; make up to 11 with
dH 2O.
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T.E.: lOmM Tris; 50mM EDTA.
Tfbl: 1M CH3COOK pH 7.5, 30ml; RbCl, 12g; MnCl2.4H2O, 9.9g; CaCl 2.2H 2O,
!-5g; glycerol, 150g; pH to 5.8 with 0.2M acetic acid; make up to 11 with dH 2O.
Tfb2: 0.5M MOPS pH 6.8, 20ml; RbCl, 1.2g; CaCl 2.2H 2O, llg; glycerol, 150g; pH
to 6.8 with KOH; make up to 11 with dH2O.
10X TGS: Tris, 30.0g; Glycine, 144.0g; SDS, lO.Og; make up to 11 with dH2O.
Transfer buffer: Glycine, 47.5g; Tris, lOg; make up to 3.31 with dH 2O.
lOx Vogel buffer: 1M PIPES, pH 6.6; 50mM MgCl2 ; 0.6mM p-mercaptoethanol.
Wash solution: 40mM NaP (as for hybridisation solution); 1% SDS; ImM EDTA; 
make up to 11 with dH 2O.
2.2.2 ISOTOPES:
ot-32P-dCTP (3000 Ci/mM) 
oc-35S-dATP (400 Ci/mM)
2.2.3 SUPPLIERS:
Enzymes - Boehringer Mannheim.
Isotopes - Amersham International.
General laboratory chemicals - Sigma; Fisons; BDH; Boehringer Mannheim.
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Used for making 
competent cells for general 
cloning applications.___
Gough and Murray (1983)
NM646 P2 mcrA mcrE mrr+ hsdR Used to make plating cells 
for plating libraries.
Gift from Noreen Murray
Q358 supE Strain used for growth of 
all phage except for plating 
libraries.




For excision of phagemid 
from Lambda Zap n 
vector.
Stratagene Predigested 
Lambda Zap®H / EcoRI / 




supE44 recAl, lac [ F 
pro AB,
TnlO(tetr )]
Strain used for general 
transformations and 





XGEM11 Cloning vector. Arms derived from 
EMBL3.
Promega catalogue.
KZAP A, phage allowing rapid excision of the 
pBluescript® phagemid for 
characterisation in a plasmid system.
Stratagene Predigested 
Lambda Zap®II / EcoW I 
CIAP cloning kit Manual.
EXASSIST  
PHAGE
Contains an amber mutation 
preventing replication of the phage 
genome in a nonsuppressing E.coli 
strain.
Stratagene Predigested 
Lambda Zap®H / EcoRI I 
CIAP cloning kit 
Instruction Manual.
A,cI857 A, phage with temperature sensitive cl 
gene product. DNA digested with 
HindUl or Pstl and used as size 
markers.


















GAL1 promoter cloned into YCpSO. 
Yeast centromere plasmid for 
overexpression of genes under galactose 
control.
pTZ18R containing the Dhr6 cDNA on a 
2.1kb EcoRl fragment .
pNB40 containing ~4kb UbcDl cDNA.
pNB40 containing ~3.7kb UbcD2 cDNA.
pNB40 containing ~4.2kb UbcDS cDNA.
CDC34 cDNA cloned into pGEM-1.
Helper plasmid used in P-element 
transformation.
Helper plasmid for P-element 
transformation containing a P-element, 
lacking the germline specifically spliced 
intron, transcribed from the hsp70 
promoter.
Human CDC34 cDNA cloned into 
pBluescript KS+.
General yeast cloning vector, derived 
from 2\L plasmid.
Plasmid for P-element transformation to 
allow GAL4-dependent transcription of a 
gene of choice. The polylinker is 




Gift from M. Cooper.
Gift from M. Koken.
Gift from S. Jentsch.
Gift from S. Jentsch.
Gift from S. Jentsch.
Gift from M. Goebl. 
Goeble/tf/.,(1988).
Karess and Rubin (1984).
Gift from J-M Dura.
Gift from S. Plon. 
Plon era/., (1993).
Emr era/., (1986).



















Contains 17 internally 








Carries GAL4 transgene 
under control of a heat 
shock promoter on 
chromosome 3/TM3
Carries GAL4 transgene 




Be Elp/CyO', KifTM6 Ubx
Carries lacZ transgene 





Gift from K. Kaiser. 
Bingham etal. (1982).




Robertson et al, (1988).
Gift from C. O'Kane.
Gift from M. Akam.
Lindsley and Grell (1968).
Clark etal (1986)
Gift from A. Jarman.
Brand and Perrimon 
(1993).
Hazelriggeffl/. (1984).




16Y CCT TAA TCC TGA TCG 
TGC TCG G
"-" strand 3' oligonucleotide used in P 
element mutagenesis experiments to 
screen for insertions in uchD.
17Y GGA CGC CAC TTG AAT 
CT A ATC CCG
"+" strand 5' oligonucleotide used in P 
element mutagenesis experiments to 
screen for insertions in uckD.
23Y GGC GCA ACG CAG CTT 
TGT GTT TCG
"+" strand 5' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in UbcDl.
24Y CAC CTC CTT GAT AAG 
GGC TGT CCG
"-" strand 3' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in UbcDl.
25Y GGC TCT GCG TGG CCT 
CGT AAT TTG
"+" strand 5' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in UbcD2.
26Y CCT TCT GTA TGC GCT 
TGG CCG AGG
"-" strand 3' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in UbcD2 .
27Y CGC ACG TTA GTC ACA 
GCA ACG CAC
"+" strand 5' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in ben.
28Y AGG GCT GGA CTC CAG 
TTG TCC TTC
"-" strand 3' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in ben.
A26 TAA ACG CAA CGC ATT 
GCC CAG GCG
"+" strand 5' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in Dhr6.
A79 TGC CAT TCG CTC CTT 
GCC TTC CTG
"-" strand 3' oligonucleotide used in the P 
element mutagenesis experiment to screen 
for insertions in Dhr6.
D61 CGG AAT TCA CGC AAC 
GCA TTG CCC
"+" strand 5' oligonucleotide for PCR 
mutagenesis of the Dhr6 active site.
D62 GGT GGA ATA GCC TTG 
GAC ATA TTG C
"+" strand oligonucleotide for mutating 
DHR6 active site Cys to Ala.______
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D63 GCA ATA TGT CCA AGO 
CTA TTC CAC C
"-" strand oligonucleotide for mutating 
DHR6 active site Cys to Ala.
D64 GCC TCG AGC GAT CTA 
GGT AGC ATG
"-" strand 3' oligonucleotide for PCR 
mutagenesis of the Dhr6 active site.
D6S2 GGT GGA ATA AGC TTG 
GAC ATA TTG C
"+" strand oligonucleotide for mutating 
DHR6 active site Cys to Ser.
D6S3 GCA ATA TGT CCA AGC 
TTA TTC CAC C
"-" strand oligonucleotide for mutating 
DHR6 active site Cys to Ser.
D31 CGG AAT TCG CAA TAA 
CTT GGC GC
"+" strand 5' oligonucleotide for PCR 
mutagenesis of the ben active site.
D32 GGC CGC ATT GCC CTC 
GAC GTG C
"+" strand oligonucleotide for mutating 
BEN active site Cys to Ala.
D33 GCA CGT CGA GGG CAA 
TGC GGC C
"-" strand oligonucleotide for mutating 
BEN active site Cys to Ala.______
D34 GCC TCG AGT TCA TGT 
CAC GCA CCC
"-" strand 3' oligonucleotide for PCR 
mutagenesis of the ben active site.
D3S2 GGC CGC ATT AGC CTC 
GAC GTG C
"+" strand oligonucleotide for mutating 
BEN active site Cys to Ser._______
D3S3 GCA CGT CGA GGC TAA 
TGC GGC C
"-" strand oligonucleotide for mutating 
BEN active site Cys to Ser.______
E2 primer 1 ATC GCC GGT CCG CCT 
GAC CAG CCC
"+" strand oligonucleotide corresponding 
to postions 295 to 318 in UbcD4 cDNA.
E2 primer 2 GAT GGA ACA CTG GAC 
GATC
"-" strand oligonucleotide corresponding 
to postions 249 to 231 in UbcD4 cDNA.
E2 primer 3 GGT GCG ATT TGT CTG 
GAC
"+" strand oligonucleotide corresponding 
to postions 433 to 450 in UbcD4 cDNA.
E2 primer 4 TCT GTT CCT 
GGC
GCT TAC "+" strand oligonucleotide corresponding 
to postions 585 to 605 in UbcD4 cDNA.
E2 primer 5 TAG GCC ACC ACT GCG 
TCC
"-" strand oligonucleotide corresponding 
to postions 563 to 546 in UbcD4 cDNA.
E2 primer 6 TCA GCA TCA ATC CTT 
CAG
"+" strand oligonucleotide corresponding 
to postions 836 to 853 in UbcD4 cDNA.
E2 primer 7 CTC TCT CCC 
CTG
TGT TCC "-" strand oligonucleotide corresponding 
to postions 134 to 117 in UbcD4 cDNA.
E2 primer 8 GTT CAC CGT 
TTC
TCT CCT "-" strand oligonucleotide corresponding 
to postions 118 to 100 in UbcD4 cDNA.
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G58 CGG AAT TCC CAT CCA/C 
AAC/T GTA/G/T TAG
"+" strand degenerate oligonucleotide 
corresponding to HPNVY amino acids of 
CDC34.
G59 CGG GAT CCA/G GCG GC 
ATC C/GAC A/GTT A/GGC 
C/G/TGG C/G/TG A
"-" strand degenerate oligonucleotide 
corresponding to SPANDVAA amino 
acids of CDC34.
KS TCG AGG TCG ACG GTA 
TC
pBluescript sequencing oligonucleotide.
N54 CGG AAT TCC AA/GT 
ATA/G TCC AC/GA/G 
CAA/TAT
"+" strand degenerate oligonucleotide 
corresponding to ICLDIL amino acids of 
DHR6.
N55 CGGAATTCA/G GCA/C 
GGC/G/T GAG TG/TG ATT 
GGG
"+" strand degenerate oligoinucleotide 
corresponding to PNPNSPA amino acids 
of DHR6.
N56 CGGGATCCG AC/GT ATC 
CA/CT TC/TA AA/GC 
CA/CA AA/GG TG
"-" strand degenerate oligonucleotide 
corresponding to EYPNKPPTV amino 
acids of DHR6.
P31 CGA CGG GAC CAC CTT 
ATG TTA TTT CAT CAT G
Oligonucleotide corresponding to 31bp 
inverted repeats of the P element.___
rev GGA AAC AGC TAT GAC 
CATG
M13 reverse 19mer sequencing 
oligonucleotide.________
RK1 GTA TCC AAA CAA ACC 
GCC
"+" strand oligonucleotide for sequencing 
Dhr6 active site mutants.
RK2 TAT CCA ATG TCA GCG 
CCC
"+" strand oligonucleotide for sequencing 
ben active site mutants.
SK CGC TCT AGA ACT AGT 
GGATC
pBluescript sequencing oligonucleotide.
T7 GTA ATA CGA CTC ACT 
ATA GGG C
T7 promoter sequencing oligonucleotide.
All oligonucleotides are shown in 5' - 3' orientation. Extra nucleotides are shown in 
bold; restriction enzyme recognition sites are shown underlined - BamHl = 5' 
GGATCC 3'; EcoRI = 5' GAATTC 3'; Xhol = 5' CTCGAG 3'.
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2.3 METHODS:
2.3 .1 MANIPULATIONS OF BACTERIA AND PHAGE
2.3.1.1 Growth of E.coli Bacterial cultures:
Liquid culture of E.coli was performed in L-broth by inoculating with a 
single colony using a sterile metal loop. Cultures of lOmls or less were grown in 
2oz glass bottles, those greater than lOmls were grown in conical flasks with a total 
capacity 5-10x that of the culture volume. Cells were shaken at 37°C for an 
appropriate length of time.
2.3.1.2 Storage of E.coli bacterial cultures:
For long term storage, 1/2 ml of overnight culture, grown in L-broth, with 
antibiotic if necessary, was mixed with 1/2 ml of 2x Freezing Mix (autoclaved) in 
sterile vials. Vials were frozen in liquid N2, and stored at -70°C. To recover live 
cells, vials were thawed quickly at 37°C and the culture was streaked out on L-broth 
agar plates, with antibiotic when required.
Bacteria were stored as 5ml overnight cultures or on agar plates for short 
term storage (4-6 weeks).
2.3.1.3 Small scale preparation of plasmid DNA (boiling method
miniprep): ( Holmes and Quigley, 1981)
A single bacterial colony, containing a plasmid, was inoculated into 10ml of 
L-broth containing an antibiotic, if necessary. After overnight shaking at 37°C, 1.5ml 
of the culture was briefly spun down. The pellet was resuspended in 200 ul of STET 
and 20ul of lysozyme (lOmg/ml). The suspension was boiled at 100°C for 40sec, 
centrifuged for lOmin and the resulting flocculent pellet was removed with a sterile 
toothpick.
The plasmid DNA was precipitated by addition of 22 ul 3M NaAcetate and 
200ul isopropanol, and being placed at -70°C for 15min and spun down for lOmin. 
The pellet was rinsed with ether, dried under vacuum and resuspended in 50 ul of 
T.E..
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2.3.1.4 Large scale preparation of plasmid DMA (midi/maxi prep):
Large scale preparation of plasmid DNA was carried out by using QIAGEN 
Plasmid Midi/Maxi kits (QIAGEN GmbH and QIAGEN Inc.) according to the 
manufacturer's handbook instructions. This method is based on an alkaline lysis 
procedure, followed by binding to an anion-exchange resin under low salt and pH. 
Impurities such as RNA and protein are removed by a medium salt wash and 
plasmid DNA is eluted by high salt and concentrated by isopropanol precipitation.
2.3.1.5 Preparation of competent E.coli celis: (Hanahan, 1985)
E.coli cells were plated on to L-agar plates and grown overnight at 37°C. One 
colony was used to inoculate lOmls of L-broth and incubated at 37°C with agitation 
for approximately 2hr until cells reached an 0.0.550 of 0.3. A subculture of 5ml of 
cells in 95ml L-broth was incubated until an 0.0.550 of 0.35-0.6 was reached, then 
the culture was chilled on ice for 5min, aliquoted into corex tubes and chilled on ice 
for a further lOmin.
Cells were pelleted by centrifugation at 6,000rpm for 5min in a cold Sorvall 
centrifuge. The supernatant was discarded and the pellet was resuspended in 10ml of 
Tfbl. After a 15min incubation on ice, cells were recentrifuged at 6,000rpm for 
5min. Each pellet was resuspended in 1ml Tfb2 and the suspension was aliquoted 
into Eppendorf tubes, "snap" frozen in liquid nitrogen and stored at -70°C.
2.3.1.6 Transformation of plasmid DNA into competent cells:
Half a ligation reaction, or 0. l-10ng of plasmid DNA were added to 30-100(0,1 
of competent cells thawed slowly on ice.
After 30min on ice, cells were heat shocked in a 42°C water bath for 2min 
and chilled on ice for 2 min. Before placing the tubes at 37°C for 30-60min, 50- 
lOO^il of L-broth were added .
If blue/white selection was required, lOOul lOOmM IPTG and 20^,1 50mg/ml 
X-gal were added. Cells were plated on antibiotic containing medium to allow 
identification of plasmid containing colonies.
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2.3.1.7 Preparation of plating cells for phage infection:
Cells were grown overnight at 37°C on L-plates. A single colony was used to 
inoculate 10ml of L-broth, and this was grown overnight at 37°C with shaking. A 
subculture of 100^1 of the cells in 10ml of fresh L-broth with 0.2% maltose was 
grown for 4-6h, before being transferred to sterile plastic universals and spun for 
lOmin at 3,000 rpm in a bench centrifuge. Pelleted cells were resuspended in 5ml 
lOmM MgCl2 by vortexing. Plating cells could be kept at 4°C for several days.
Maltose improves the efficiency of bacteriophage adsorption as it induces the 
X receptor (lamB protein) and Mg2+ ions play an important part in the maintenance 
and integrity of A, phage particles (Maniatis et al 1982) and aid phage adsorption.
2.3.1.8 Plating and calculating litres of bacteriophage X:
Prepared packaged bacteriophage A, particles in phage buffer were kept at 
4°C. Serial dilutions of phage solution from 10~2 through to 10'8 were prepared in 
phage buffer. To infect cells, 10(il of each dilution were added to 100|il of plating 
cells and incubated at 37°C for 20min. The infected plating cells were then added to 
3ml of BBL top agar, supplemented with lOmM Mg2+ ions, at 65°C. This was 
poured onto L-agar plates, left to set and incubated at 37°C overnight. The titre of 
the phage was calculated by counting the number of plaques formed: each plaque 
corresponds to one infecting phage particle.
When plaque lifts were to be taken, such as when bacteriophage K libraries 
were plated, top agarose was used instead of BBL top agar.
2.3.1.9 Bacteriophage X DNA from minilysates:
Approximately 5xl0 7 cells (lOOjil) from a fresh overnight culture of an 
appropriate strain of E.coli, and IxlO8 phage particles were added to 4ml L-broth 
and 40|il 1M MgSC>4 in a bijou bottle. Bottles were shaken at 37°C until lysis had 
occured (3-5hr) and any bacteria not lysed by K were lysed by the addition of lOOul 
chloroform and vortexing. Debris was pelleted by centifugation for lOmin in a bench 
centrifuge. To remove bacterial nucleic acid, 5(il lOmg/ml RNase and DNase were 
added, and the supernatant was transferred to a clean bijou. After shaking at 37°C for 
30min, the phage solution was added to 4ml 20% PEG/NaCl in phage buffer in 
corex tubes. Tubes were left at 4°C overnight.
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After centrifugation at 10,000rpm for 20min at 4°C, the supernatant was 
removed, and the phage pellet was resuspended in 0.5ml phage buffer. To ensure no 
bacteria remained present, 0.5ml chloroform was added, tubes were vortexed, and 
the phage solution was transferred to Eppendorf tubes and microfuged for 3min. 
Progressive phenol extraction, phenol/chloroform extraction, chloroform extraction, 
and ethanol precipitation were performed on the supernatant, before resuspension of 
the phage DNA in lOOul of T.E.
2.3.1.10 Preparation of large scale bacteriophage X DNA:
Bacteriophage were harvested by scraping the top agarose from L-plates into 
glass universals. More phage were harvested by adding 4ml of L-broth to the scraped 
plate and transferring this to the universal. The universals were vortexed and spun in 
a cold bench centrifuge for lOmin. The supernatant was pipetted into a glass bijou, 
3-4 drops of chloroform were added, and the phage stock so formed could be kept at 
4°C for several weeks.
Phage were titred (as described above) and 4xl0 10 phage particles were 
added to 200ml L-broth, 2ml MgCl2 and 10ml of an overnight culture of Q358 cells 
at an 0.0.550 of 0.5. Flasks of the culture were shaken vigorously for 3-4hr at 37°C 
before lysis began (O.D.gso reaches a plateau) and for a further 2-4hr until lysis was 
complete (O.D.650 of 0.5-1). To lyse any remaining cells, 0.5ml of chloroform were 
added, and shaking was continued for lOmin.
Flasks were left to stand at room temperature for Ihr after addition of 8g 
NaCl and 20|il lOmg/ml DNase and RNase. Cultures were spun in a Sorvall 
centrifuge at 10,000rpm for lOmin, then the supernatant was poured back into flasks 
containing 20g PEG and left overnight at 4°C to precipitate the phage.
After spinning down the phage at 10,000rpm for lOmin and removal of the 
supernatant, 5ml of phage buffer were added to each sample, and the bottles were 
laid flat in a basin of ice and washed by the buffer for 2hr. Resuspended phage were 
spun down again at 5,000rpm for 5min.
The phage suspension was layered on top of CsCl step gradients, set up by 
aliquoting 2.5ml of CsCl (1.3g/ml) into Beckman Ultra-Clear tubes, and 
successively under-layering this with 2ml CsCl (1.5g/ml) and 1.5ml CsCl (1.7g/ml) 
using a pasteur pipette. These were spun for 40min at 18°C in a Sorvall
70
ultracentrifuge, and the phage band was removed by puncturing the tube with a 
needle on a syringe, and drawing off the band in about 0.8ml of liquid.
The concentrated phage suspension was dialysed against 1-21 phage buffer 
for l-2hr at 4°C, then layered on a second CsCl step gradient and spun as before. The 
collected phage was dialysed against 21 T.E. at 4°C for Ihr, followed by 3 phenol 
extractions in Eppendorf tubes, and overnight dialysis against T.E., again at 4°C. 
Bacteriophage A, DNA was then ethanol precipitated and resuspended in 200|il T.E..
2.3.2 DNA MANIPULATION AND DETECTION
2.3.2.1 Phenol extraction of proteins from DNA:
Distilled phenol was equilibriated to pH 8, by mixing phenol with an equal 
volume of 1M Tris.HCl pH 8. Phases were allowed to separate, and the aqueous 
phase was discarded. This was repeated until phenol reached pH 8, then the Tris 
layer was replaced by T.E.. DNA to be extracted was mixed thoroughly with 0.4-Ix 
the volume of phenol then spun for 2-5min. The upper aqueous phase was removed 
into a fresh tube, taking care not to transfer protein from the interface, and 
reextracted with phenol if necessary.
2.3.2.2 Ethanol precipitation of DNA:
DNA was precipitated from solution by addition of 0.1 volumes of 3M Na 
Acetate pH 5 and 2-2.5 volumes of absolute ethanol at room temperature. The 
solution was mixed thoroughly and left at -20°C overnight or -70°C for 15min. DNA 
was pelleted by centrifugation for 15min, the supernatant was discarded and the 
pellet washed with 70% ethanol and spun again for 2min. After removal of the 
supernatant, the pellet was dried under vacuum for 4-10min and the DNA was 
dissolved in T.E..
2.3.2.3 Digestion of DNA with restriction endonucleases:
All DNA restrictions were performed using Boehringer Mannheim enzymes 
and buffers. For all enzymes except Smal, which digests at 26°C, 0.1-lOu.g of DNA 
were cut in 20-200p,l of Ix the appropriate buffer for l-12hr in a 37°C waterbath .
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2.3.2.4 Agarose gel electrophoresis:
DNA was separated in 0.5-1.4% (w/v) Flowgen SEA KEM LE agarose with 
O.S^ig/ml ethidium bromide in IxTBE buffer (for routine gels) or IxTAE buffer 
(when cutting out bands from gels). Prior to loading, DNA samples were mixed with 
0.1 volume sample buffer, and bacteriophage XcI857 DNA, cut with HindUI or Pstl 
was used as size markers. Electrophoresis was carried out horizontally across a p.d. 
of l-10v/cm. DNA was visualised by UV trans-illumination.
2.3.2.5 Recovery of DNA from agarose gels:
After agarose gel electrophoresis in IxTAE, the desired DNA fragment was 
cut out and extracted using Geneclean  (Bio 101). This involves binding of the 
DNA to a silica matrix formed by "glassmilk" and Nal. Supplier's instructions were 
followed. Fragments less than 200b.p.were extracted using Mermaid  (Bio 101) in 
which DNA binds to "glassfog". Again manufacturer's directions were followed.
Recovery of DNA using Geneclean and Mermaid was usually around 80%.
2.3.2.6 Ligation of cohesive termini:
Plasmid and foreign DNA to be ligated, were first digested with restriction 
endonucleases to yield complementary overhanging ends. Equimolar amounts of 
vector (0.1 (ig) and foreign DNA were mixed and dt^O was added up to 7.5|il. The 
solution was warmed to 45°C for 5min to melt cohesive termini that had reannealed. 
Samples were then cooled to 0°C, and 1 ul lOx T4 ligase buffer, and 1 Weiss unit T4 
ligase (Boehringer Mannheim) were added. Samples were incubated at 22°C for 1 - 
3hr, or overnight at 16°C.
2.3.2.7 Southern blotting: (Southern 1975)
After DNA fragments had been separated by gel electrophoresis, Southern 
blotting was used to transfer bands onto a nitrocellulose membrane. For genomic 
Southerns, l-10(ig of DNA was used per lane. To cleave fragments larger than 5kb., 
the gel was immersed in 0.2M HC1 for 20min. The gel was then soaked in 
O.SMNaOH, 1.5M NaCl for 30min to denature the DNA, and neutralised in 
1.5MNaCl, 1M Tris pH 7.5 for Ihr.
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The gel was placed on a support, on a wick of blotting paper which had both 
ends in a tray of 20x SSC. A nitrocellulose membrane (Hybond N, Amersham Intl.) 
the same size as the gel was placed on top, followed by 3 sheets of 2x SSC-soaked 
blotting paper, some dry pieces of blotting paper, a stack of paper towels and a 
weight, usually a heavy bottle.
The transfer was allowed to proceed for 8-14hr, before the membrane was 
rinsed in 2x SSC and either baked at SOT for 2hr, or UV cross-linked for 2min to 
bind the DNA to the membrane.
2.3.2.8 Random primed radioactive labelling of DNA:
About 50ng-l(ig of linear purified DNA was heat denatured by boiling and 
snap cooling on ice. The DNA was then either mixed with 30^Ci (X 32P-dCTP 
(3000mCi/mmol), 10|Lig BSA, lOuJ 5x OLE and l|nl E.coli DNA polymerase I 
Klenow fragment, or an "oligo-labelling kit" (Pharmacia) was used following the 
manufacturer's instructions. Labelling reactions were left at 37°C for 2-12hr.
Radiolabelled DNA was separated from unincorporated nucleotides by 
Nuctrap  push columns (Stratagene).
2.3.2.9 Hybridisation:
Nylon membranes, with bound nucleic acid, were placed in Techne 
hybridisation cylinders and 10-20ml of hybridisation solution, prewarmed to the 
temperature of the hybridisation, were added. The cylinders were put in Techne 
hybridisation ovens at the desired temperature (usually 65 °C for Southerns) for a Ihr 
prehybridisation.
The 32P-labelled heat denatured probe was added to the cylinders and 
hybridisation was carried out, at the same temperature as prehybridisation, for 4hr- 
overnight. Filters were washed 3 times in wash solution for 30min, usually at 5°C 
lower than the hybridisation temperature, before being wrapped in Saran wrap and 
placed in autoradiographic cassettes.
The radioactive signal was detected on X-ray film laid over the filters. 
Cassettes were stored at -70°C for an appropriate length of time, before developing 
the film in an automatic X-ray film processor.
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Probes could be kept in hybridisation solution at room temperature and then 
reused, by boiling for 20min, and using this to replace the prehybridisation solution.
Nylon membranes could be stripped of probe DNA by boiling for 3min in 
0.1% SDS. Filters could then be reprobed.
2.3.2.10 Colony hybridisation: (Benton and Davis, 1977)
To identify bacteria harbouring recombinant plasmids, colonies were 
transferred to 9cm nitrocellulose discs by placing filters onto the agar plates for 
2min. Cells were lysed and DNA was denatured by soaking the discs in denaturation 
buffer for 2min. Discs were then neutralised on 0.5M Tris/1.5M NaCl, pH7 for 
2min, washed in 2x SSC + 0.1% SDS for 2min, and finally washed twice, for 2min, 
in 2x SSC.
Filters were baked at 80°C for 2hr, before hybridisation was carried out, as 
described above.
2.3.2.11 Bacteriophage X library screens:
Phage libraries were titred as described in 2.3.1.8. An appropriate volume of 
library (see Clark and Carbon, 1976) was then plated out onto large plates, using the 
required strain of plating cells and top agarose, and incubated overnight at 37°C.
The resulting plaques were screened directly by plaque hybridisation, 
whereby plaque DNA is transferred to nitrocellulose filters. First plates were chilled 
at 4°C to harden the top agarose, then circular Hybond N (Amersham) filters were 
placed on the plates for 2min, whilst a pattern of needle pricks were marked on the 
discs and plates by piercing through the agar. Filters were then placed in denaturing 
solution for 2min and neutralising solution for 2min, as for colony hybridisation. 
After 2min in 2x SSC, filters were baked at SOT for 2hr.
Filters were hybridised and washed as described before, and Glogos 
autoradiogram stickers (Stratagene) were used to mark their positions in the cassette. 
Autoradiographs could therefore be aligned with the positions of plaques on the 
plates, and positives could be identified and picked.
The wide end of a pasteur pipette was used to pull out an agar plug 
surrounding the positive plaque. The agar was suspended in 500(il of phage buffer, a 
drop of chloroform was added, and phage were resuspended by vortexing. After 1 -
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2hr, dilutions were prepared and plated out on small agar plates. These were 
incubated overnight at 37°C.
Second screens were carried out by taking lifts from plates with low densities 
of plaques, in order to be able to pick single positives after hybridisation. Single 
positives were picked with the narrow end of a pasteur pipette and phage were 
resuspended in 200 ul of phage buffer with one drop of chloroform.
DNA was made from positive plaques, as described above (2.3.1.9 and 10). 
When the cDNA X ZAP library was being used, in vivo excision of the phagemid 
was performed as described in the Stratagene lambda ZapH/EcoRI/CIAP cloning kit 
manual.
2.3.2.12 Polymerase chain reaction (PCR):
All reactions were carried out using a Hybaid OmniGene programmable PCR 
machine. Primers were usually 18-24b.p. (see 2.2.8 for sequences) and provided by 
the Oswel DNA Service. For a 100|u,l reaction volume, lOOpg template DNA was 
mixed with 20nmoles dNTPs, lOOpmoles each primer, 2.5U TaqI polymerase (Gibco 
BRL), lO^il lOx PCR buffer, supplied by the manufacturers, (200mM Tris.HCl 
pH8.4; 500mM KC1), 5^1 1% W-l and 3ul 50mM MgCl2- Reactions were overlaid 
with 75|xl mineral oil (Sigma).
A usual PCR run consisted of one cycle of denaturation at 94°C for 2min, 
annealing at 50°C for Imin and polymerisation at 72°C for 3min, followed by 25 
cycles of Imin at 94°C, Imin at 50°C, and 3min at 72°C. The final cycle was usually 
Imin at 94°C, 3min at 50°C, lOmin at 72°C. Conditions were changed depending on 
the Tm of specific primers and the type of PCR being performed.
Products from PCR amplifications were checked by agarose gel 
electophoresis. They were cloned, if necessary, by extracting the bands from gels, 
and, if primers had restriction endonuclease sites at their ends, by digesting and 
ligating as usual, or by making use of the fact TaqI polymerase adds a 3' terminal 
adenine to both strands. In this case pGEM-T Vector Systems (Promega) were used, 
following manufacturer's directions, to "TA clone" the products.
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2.3.2.13 Sequencing double-stranded DMA: (Sanger etal., 1977)
DNA sequencing was carried out using Sequenase-2 supplied by USB 
(United States Biochemicals), with a-35S-dATP (Amersham 400Ci/mM). Boiling 
method miniprep DNA (3-5u.g) was denatured in 0.2M EDTA, 0.2M NaOH for 
30min at 37°C, and used for double-stranded sequencing. Standard annealing and 
termination reactions, as described by USB, were modified by the addition of 
DMSO. Annealing reactions were performed at 37°C for 30min, before chilling on 
ice. Labelling reactions were performed at room temperature for 5min, and 
termination reactions were left for lOmin at 37°C.
Samples were loaded on a 6% polyacrylamide denaturing gel and run at 
approximately 40W, to maintain a gel temperature of 50-55°C. The gels were fixed 
in 10% methanol (v/v), 10% acetic acid (v/v) for 15min, then dried under vacuum 
for Ihr at 80°C and autoradiographed at room temperature overnight.
2.3.3 RNA PREPARATION AND ANALYSIS.
2.3.3.1 Collection of Drosophila developmental stages:
Embryos were collected on egg collection medium in petri dishes placed on 
the bottom of fly cages. Plates were spread with yeast to provide food for the flies. 
After allowing females to lay eggs for the appropriate length of time, plates were 
collected and embryos were washed off onto nylon mesh with distilled water. 
Embryos were then thoroughly washed with distilled water, and collected in 
Eppendorf tubes.
To collect larvae, apple juice agar plates from fly cages were left in big 
plastic containers, with lots of yeast, for 2-3 days until some third instar larvae could 
be seen. Larvae were washed off the plates and sides of the container with distilled 
water, and thoroughly rinsed.
Egg laying flies were placed in fresh food bottles for 4hr, then removed. 
Bottles were incubated for 5-10 days, and pupae (early and late) could then be 
collected by picking them off the sides with a paint brush.
Adult flies were anaesthetised (with carbon dioxide or diethyl ether), sexed, 
and collected in Eppendorf tubes.
All stages were "snap" frozen in liquid nitrogen and stored at -70°C until 
RNA was extracted.
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2.3.3.2 Preparation of total RNA : (Chomczynski and Sacchi, 1987)
An RNAzol stock solution was made from 1 volume of stock solution A 
(23.64g guanidium thiocyanate; 1.25ml 1M NaCitrate, pH 7.0; 0.5g sodium lauryl 
sarcosine; made up to 50ml with DEPC-treated water, with 0.36ml of p- 
mercaptoethanol/50ml added before use), 0.1 volumes of 2M NaAcetate, pH 4.0, and 
1 volume of water saturated phenol. For every lOOmg tissue, 2ml of RNAzol stock 
were used.
Different developmental stages were homogenised in RNAzol at room 
temperature, to ensure solubilisation of RNA. Chloroform was added (100|nl per 1ml 
of homogenate) and the tube was vigorously shaken for 15sec, then put on ice for 
15min. After centrifugation at 10,000g for 15min at 4°C, the aqueous phase was 
transferred to a fresh tube and RNA was precipitated with an equal volume of 
isopropanol for 45min at -20°C.
The RNA pellet, from centrifugation at 10,000g for 15min at 4°C, was 
washed twice with 75% ethanol, dried under vacuum and dissolved in DEPC-treated 
0.5% SDS at 65°C for lOmin. This RNA was stored at -70°C and used for Northern 
blot analysis.
2.3.3.3 Preparation of ovary RNA:
Ovaries were dissected in 1 part 2x buffer mix (0.7M NaCl; 0.2M Tris.HCl, 
pHS.O; 0.02M EDTA; 4% SDS), 1 part 14M urea, and frozen in liquid nitrogen. 
Ovaries could then be stored at -70° C, or homogenized directly in more buffer.
Several phenol/chloroform extractions were performed, then the nucleic acid 
was ethanol precipitated with NaAcetate at -70°C for Ihr. After centrifugation, the 
RNA and DNA pellet was washed in 70% ethanol, dried and resuspended in 30-50|iil 
DEPC-treated water.
RNA was precipitated overnight at 4°C,with 3 volumes of 3M LiCl, then 
spun down, washed with 70% ethanol, dried and resuspended in lOjil DEPC-treated 
water.
2.3.3.4 Northern blotting:
Approximately I0|ig of total RNA samples were added to sample preparation 
buffer (62.5fil deionised foramide; 12.5ul lOx MOPS buffer; 20.0|Lil formaldehyde;
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5.0|j,l 0.5mg/ml ethidium bromide per 10 samples) and heated to 65 °C for 5min, 
before cooling on ice and addition of 2.5uJ loading buffer. These samples were 
loaded on a denaturing gel (1.4g agarose; 87ml dH 2O; 10ml lOx MOPS: 2.98ml 
formaldehyde) and run in Ix MOPS, 2.2% formaldehyde at 25V overnight.
Gels were blotted for 8hr in 20x SSC, in the same way as Southern blots, but 
using a positively charged nylon membrane (Boehringer Mannheim). DNA probes 
were labelled as described in 2.3.2.8. Prehybridisation and hybridisation were carried 
out as described in 2.3.2.9, but at 55°C and with 10% dextran sulphate and 50u\g/ml 
ssDNA in the hybridisation solution. Washes were performed at 50°C, followed by 
autoradiography.
2.3.4 IN SITU DETECTION OF DNA AND RNA.
2.3.4.1 Preparation of DIG-labelled DNA probes:
Probes labelled with DIG were synthesised by random primer labelling of 
DNA, either using the Boehringer Mannheim DIG DNA Labelling and Detection 
Kit, following instructions exactly, or by the method described below.
Approximately lOOng of DNA was mixed with lOfil of lOmg/ml pd(N)6, and 
DEPC-treated water up to 15ul After boiling for 5min and quick chilling on ice, 2jil 
lOx Vogel buffer, 2|u,l dNTP mix (Boehringer Mannheim DIG DNA labelling kit), 
and lu,l Klenow DNA polymerase (Boehringer Mannheim) were added. This was 
incubated overnight at 15°C, then lu,l more Klenow was added and the reaction was 
continued for 4hr at room temperature. To stop the reaction, 2|il 0.5M EDTA were 
added, and the tube was heated to 65°C for lOmin. To precipitate the DNA, 80u,l 
DEPC-treated water, 5jil lOmg/ml tRNA, 8u,l 5M LiCl and 300^1 ethanol were 
added. Tubes were left on ice for 30min, centrifuged for 20min, and the resultant 
DNA pellet was washed with 70% ethanol, and dried.
DIG-labelled DNA probes were resuspended in the appropriate hybridisation 
solution, and stored at -20°C.
The concentration of labelled DNA was determined by comparison to control 
DNA in the Boehringer kit, using the method described in the instruction leaflet. 
This method was also used when detecting DNA on Southern blots using DIG- 
labelled probes.
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2.3.4.2 Preparation of Biotin-labelled DMA probes:
Double stranded purified linear DNA was labelled with biotin by nick 
translation. In this process, free 3' hydroxyl ends (nicks) are created by DNase I, then 
DNA polymerase I catalyzes the addition of a labelled nucleotide to the 3'-hydroxyl 
terminus of the nick. At the same time 5'-3' exonuclease activity of this enzyme 
removes the nucleotide from the 5' phosphoryl terminus of the nick, so the nick is 
shifted along one nucleotide at a time in a 3* direction.
The following components were mixed on ice:- 300|LiM dATP, 3.3 jil; 300|iM 
dCTP, 3.3U.1; 300jiM dGTP, 3.3u.l; 3.3nmoles Biotin-16-dUTP (Boehringer 
Mannheim); lOx Nick Translation Buffer, 5(11; DNA polymerase I/DNase I mix 
(Promega), 5|Lil; l-2|Hg DNA; dH2O up to 50^,1. Nick translation took place at 15°C 
for l-2hr, before 5^il of 1.25M EDTA, pH 8.0 was added to stop the reaction.
After nick translation, the DNA solution was spun in Sephadex G50 columns 
to remove unincorporated nucleotides.
2.3.4.3 RNA in situs of whole mount embryos: (Tautz and Pfeifle, 1989) 
Embryo fixation
Embryos were collected as in 2.3.3.1 and dechorionated in 50% household 
bleach (containing less than 5% sodium hypochlorite) for 3min. Dechorionated 
embryos were fixed by vigorous shaking for 15min in 1 volume 4% formaldehyde in 
Ix PBS, 1 volume heptane, in a scintillation vial. As much of the lower aqueous 
phase as possible was removed, and 8ml of methanol were added. To remove the 
vitelline membrane, embryos were shaken and vortexed vigorously for lOsec and, 
after they had settled, were collected into an Eppendorf tube and washed 2-3 times 
with methanol to remove any remaining heptane. Methanol was replaced with 
ethanol, and the fixed embryos were stored at -20°C for several weeks.
Hybridisation
Fixed embryos were rinsed in 50% ethanol, 50% xylene, then soaked in 
100% xylene for several hours. After rinsing again in 50% ethanol, 50% xylene and 
several rinses in 100% ethanol, embryos were sequentially washed in methanol, and 
50% PBT (Ix PBS; 0.1% Tween 20) plus 5% formaldehyde. Postfixation was 
carried out for 20min in PBT plus 5% formaldehyde. Embryos were then rinsed 3 
times in PBT, and incubated for 3-5min with 50|ng/ml proteinase K in PBT at 37°C. 
Rinsing twice with 2mg/ml glycine in PBT stopped the proteinase digesting further,
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and this was followed by 2 rinses in PBT, another post fixation step of 20min in PBT 
plus 5% formaldehyde, and 5 rinses in PBT.
Washes in 50% hybridisation solution (50% deionised formamide; 5x SSC; 
lOO^ig/ml boiled ssDNA; 100u.g/ml tRNA; 50M,g/ml heparin; 0.1% Tween 20), 50% 
PBT, then 100% hybridisation solution, preceded prehybridisation in hybridisation 
solution at 48°C for l-2hr. Hybridisation was carried out overnight at 48°C in 100|il 
of solution containing O.lng/ml heat denatured DIG-labelled probe. The tube was 
mixed thoroughly several times during the reaction, and spun briefly the next 
morning to remove probe from the sides.
To remove background hybridisation of the probe, 20min washes in 1ml of 
the following solutions were carried out at 48°C:- hybridisation solution, 50% 
hybridisation solution plus 50% PBT, 5 washes of PBT.
An anti-DIG AP antibody (Boehringer Mannheim DIG-labelling and 
detection kit) was diluted 1:5 in PBT and preabsorbed over at least an equal volume 
of fixed embryos at 4°C for several hours. Preabsorbed antibody was diluted to a 
final concentration of 1:2000 in PBT, and probed embryos were incubated in this 
solution, on a rotating wheel for l-2hr, before being washed four times in PBT (here 
Ix PBS, 0.1% BSA, 0.2% triton).
The next two washes were in AP buffer. The substrates for alkaline 
phosphatase (4.5 ul NBT, 3.5(0,1 X-phosphate (Boehringer Mannheim)) were added to 
the second wash to form the colour reaction. This was continued in the dark for 5min 
to several hours as the colour developed. The reaction was stopped by rinsing several 
times in PBT.
To dehydrate the embryos, PBT was serially exchanged with 70% , 95% and 
100% ethanol. Several washes of 100% ethanol were carried out, including a final 
wash of 20min. Embryos were then stored at 4°C under ethanol before placing them 
in a watch glass, and replacing the ethanol with xylene. The xylene was changed 3-4 
times, before embryos were mounted on slides in DPX mountant (BDH).
2.3.4.4 In situ hybridisation to polytene chromosomes:
Chromosome squashes
In order to get big larvae, 8-10 female flies were allowed to lay embryos in a 
bottle of fly food supplemented with dry yeast. Only larvae close to pupal formation 
were used.
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Larvae were dissected in lOOul fix (1:2:3 lactic acid: water: glacial acetic 
acid) on a concave slide. The mouth hooks and rear were held with forceps, the head 
was pulled off, and salivary glands were separated from the carcass. Lateral fat was 
dissected off the glands, and they were sucked up in 7(il fix and put on a clean slide. 
A siliconized coverslip was placed on top.
To squash the glands, the slides were tapped with forceps. Chromosomes 
were viewed under lOx phase contrast to check they had been adequately spread out. 
Chromosomes were flattened by pressing hard with my thumb. Slides were left 
overnight at room temperature to fix the chromosomes, then plunged into liquid 
nitrogen. After breathing on the slides, coverslips were flipped off with a razor 
blade. Slides were then immersed in dry-ice-cold 95% ethanol for 5min, transferred 
to room temperature 100% ethanol for 5min, then air dried.
Hybridisation
Slides were incubated at 65 °C for 30min in 2x SSC, transferred to 70% 
ethanol at room temperature for 2x lOmin, then further dehydrated in 95% ethanol 
for lOmin. After air drying, slides were boiled in Tris base/MgCl2 (L02g MgCl2; 
1.58g Tris Base; made up to 11 with dH2O) for 3min to denature DNA. Slides were 
washed three times in 2x SSC for 5min then soaked in 70% ethanol for 2x 5min, 
95% ethanol for 5min and air dried.
A 20pJ drop of hybridisation solution (2x SSC; 10% Dextran sulphate; 50% 
deionised formamide; 2u,g/ml denatured salmon sperm DNA) containing 20ng heat- 
denatured Biotin-labelled DNA probe was added to each slide, on top of the area of 
the squashes. Cover slips were laid on top, and hybridisation was carried out 
overnight at 37"C in a sealed box containing moist benchcoat.
After hybridisation, slides were washed as follows:- 2x lOmin in 2x SSC at 
37°C, 2x lOmin in room temperature 2xSSC, 5min in PBS. Biotin can be detected by 
avidin which binds essentially irreversibly to up to four molecules of biotin at a time. 
Avidin was first allowed to bind to POD-linked biotin (Vector Laboratories) for 
5min at room temperature in 4% nuclease free BSA and 500mM Tris, pH 7.6, before 
addition of 20u.l of this solution to the slides. Binding of avidin to the biotinylated 
probes took place at 37°C in a sealed box containing moist benchcoat, for Ihr 30min.
The POD-linked biotin:avidin complex was detected using the DAB substrate 
(Vector Laboratories, made up as described in the manufacturer's instructions) which 
yields a red-brown stain in the presence of peroxidase. Before addition of 20|il of 
DAB to each slide, slides were washed 3x in room temperature PBS. The DAB
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colour reaction was left to develop overnight at 37°C in a sealed box containing 
moist benchcoat. Slides were washed for 5min in PBS, then counterstained for 5min 
in Giesma staining solution (5% Giemsa in 50mM Na2HPO4/NaH 2PO4, pH 7.2), and 
washed again in distilled water for 5min.
Slides were washed in xylene to make them permanent, and squashes were 
mounted in DPX mountant (BDH). Chromosomes were examined and scored under 
high power bright field and phase contrast microscopy.
2.3.5 PROTEIN EXTRACTION AND DETECTION.
All protein work was performed by Dr P. zur Lage.
2.3.5.1 Extraction of proteins from Drosophila and SDS PAGE:
To extract protein, flies were homogenised in boiling mix. Samples were 
boiled for lOmin over a 100°C water bath before loading on an acrylamide gel made 
from 10% acrylamide in gel buffer for the resolving gel, and 3.75% acrylamide in 
stacking gel buffer for the stacking gel. Approximately 110(ig of protein were loaded 
per well for Western blot analysis. Gels were run at 200V in IX TGS.
2.3.5.2 Preparation of anti-DHR6 antibodies:
In order to raise antibodies to DHR6, a soluble GST fusion protein was 
injected into New Zealand rabbits. After a pre-immune sample had been taken, 0.2ml 
of a solution containing 100|ig of DHR6 fusion protein, in a 1:1 ratio with Freund's 
complete adjuvant, was injected at each of 4 sites. After 10-14 days a 5ml test bleed 
was taken. A second series of injections was performed 4-6 weeks after the first 
injections using a 1:1 ratio of protein to Freund's incomplete adjuvant. A test bleed 
was taken after 10-14 days. This process was repeated for a third set of injections. 
Blood samples were centrifuged and serum was removed and allowed to clot. 
Supernatant was frozen in aliquots at -70°C, and this was diluted 1/1,000 in block for 
use as the primary antibody in Western blots.
2.3.5.3 Western Blotting:
Western blots were performed in a tank of transfer buffer using PVDF 
membrane (Millipore) according to the manufacturer's directions. Protein was
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detected using antibodies and the Boehringer Mannheim Chemiluminescence 
Blotting Substrate (POD), again according to the manufacturer's instructions. The 
primary antibody binds to protein and is detected by a POD-linked secondary 
antibody. This reacts with the substrate luminol (Boehringer Mannheim), in the 
presence of H262, to produce light which is detected on X-ray film.
2.3.6 DROSOPHILA METHODS.





















Table 1. Amount of solutions used for making DNA from different numbers of flies.
1-50 flies were put in an Eppendorf tube at -70°C for 5min, then 
homogenised in solution A (0.1M Tris.HCl, pH9.0; 0.1M EDTA, pH8.0; 1% SDS; 
see Table 1. for amount added per fly). After incubation at 70°C for 30min, solution 
B (8M KAcetate) was added and tubes were left on ice for 30min.
To obtain a clear supernatant, samples were centrifuged twice at 4°C for 
15min. Isopropanol was added, and DNA left to precipitate for lOmin at -70°C. After 
a 5min centrifugation, the pellet was washed in 70% ethanol, dried under vacuum 
and resuspended in T.E..
2.3.6.2 DNA extraction from single flies: (Ashburner, 1989)
Single flies were homogenised in Eppendorf tubes in 50ul of homogenisation 
buffer (lOmM Tris.HCl, pH 7.4; 60mM NaCl; lOmM EDTA, pH 8.0; 0.15mM 
Spermine/Spermidine; 5% sucrose). To lyse cells, 50|Lil of lysis buffer were added, 
and tubes were incubated at 70°C for 15min. After addition of 15pi 8M KAcetate 
and 30min incubation on ice, the homogenate was centrifuged at 4°C for lOmin and 
the supernatant was removed to a fresh tube.
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The supernatant was phenol/chloroform extracted, ethanol precipitated, and 
resultant DNA pellets were dissolved in 20ul I.E. plus 50ug/ml RNase A.
2.3.6.3 DNA extraction from embryos:
Embryos were collected as in 2.3.3.1., then placed in 50-100^,1 of 
homogenisation buffer (lOmM Tris.HCl, pH 7.4; 60mM NaCl; lOmM EDTA; 
0.15mM Spermine/Spermidine; 0.5% Triton) in an Eppendorf tube. After 
homogenisation, the volume of buffer was made up to 500|il and 1% w/v SDS was 
added. Tubes were incubated for 2-3h at 37°C after the addition of 200ug/ml 
proteinase K. Two phenol/chloroform extractions, and one chloroform extraction 
were performed, and the DNA was ethanol precipitated and resuspended in 200|il of 
T.E..
2.3.6.4 Establishment of transgenic lines by P element transformation:
(Rubin and Spradling, 1982)
DNA for transformation was prepared as described in 2.3.1.4, but DNA was 
resuspended in deionised water, not T.E. as this may kill embryos. Injection buffer 
containing 300ng/p,l test plasmid and 100ng/^il helper plasmid (phsp70A2-3wc) was 
backloaded into the injection needle. Embryos from w 1118 flies were collected over 
30min intervals, dechorionated in 50% bleach, and washed onto a gridded filter. 
After lining up embryos in the same orientation alongside a grid line, they were 
transferred to a coverslip with glue solution (from dissolving sticky tape glue in 
heptane) along one edge, and dessicated in a petri dish containing silica gel for 
approximately 6min.
Embryos were covered with halocarbon oil, and DNA was injected into the 
posterior pole of preblastoderm embryos, whilst older embryos were killed by 
running the needle gently through them. After incubation at 18°C for 36-60hr, larvae 
were collected as they emerged and were left to develop at 25°C in vials of fly food. 
Adults were mated with w 1118 flies, and their progeny was examined for coloured 
eyed flies.
Transformants were crossed to w 1118 flies to produce males and females with 
the same insertion. Homozygous lines were then establised by sibling matings.
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2.3.6.5 Staining embryos for p-galactosidase activity:
Embryos were collected from crossing GAL4 lines to UAS/acZ flies. They 
were washed with PBT, then dechorionated in 50% bleach. After a further wash for 
2-5min in PBT, embryos were blotted dry and fixed for 7min in n-heptane saturated 
with PBS/2.5% glutaraldehyde. Embryos were washed with PBT for approximately 
2hr until they sank to the bottom of the vial, and were washed for another 2hr, with 
several changes of PBT, to remove all traces of heptane.
The staining solution (lOmM PO4 buffer, pH7.2; 150mM NaCl; ImM 
MgCl2 ; 3mM K4[Fen(CN) 6]3H 2O; 3mM K3 [Feffl(CN) 6]; 0.3% triton) was heated to 
65°C until it went cloudy, and 1/50 volume of 10% X-gal in DMSO was added. 
Embryos were placed in staining solution and stained at 37°C in a moist chamber 
overnight.
After washing with PBT, embryos were mounted in 50% PBS/50% glycerol, 
and viewed under a microsope.
2.3.7 YEAST METHODS.
2.3.7.1 Yeast transformation:
This method was performed by Dr M. Cooper. The yeast strain to be 
transformed was used to inoculate 5ml of YPDA, and the culture was grown 
overnight to l-2x!07 cells/ml. Cells were then diluted in fresh YPDA to 2xl06 
cells/ml, and regrown to 1x10^ cells/ml. After centrifugation at 3000rpm for 5min 
cells were resuspended in 1ml dH2O, recentrifuged and washed once more in dH2O, 
once in lOOmM LiAc pH 7.5 in T.E., and finally resuspended in lOOmM LiAc pH7.5 
inT.E.
Aliquots of 50|il of the yeast cell suspension were mixed with 1 jig of DNA, 
50|ig denatured salmon sperm DNA, and 300|il of 40% PEG solution. The mixture 
was vortexed gently and incubated at 30°C for 30min on a rotating wheel. After heat 
shocking at 42°C for 15min, cells were pelleted by brief centrifugation, and 
resuspended in 500 |il of T.E. Cells were diluted appropriately and plated onto 




Individual colonies were picked from plates of transformants, and diluted in 
120|Lil dH2O in microtitre plate wells. After resuspension, a sterile nail block was 
used to plate a drop of each yeast colony suspension on appropriate medium. This 
was repeated for up to 20 plates.
2.3.8 COMPUTER PROGRAMS:
2.3.8.1 GCG programs:
Various programs from the Wisconsin Package GCG version 8.1 were used 
to analyse DNA and protein sequences, and to compare them to homologous 
sequences present in DNA and protein databases.
2.3.8.2 Phosphoimager software:
Scans from phosphoimager cassettes were analysed using Molecular 
Dynamics Image Quant  software. The Volume Integration program was used to 
compare the relative intensity of bands on radioactive filters after exposure to a 
phosphoimager cassette.
2.3.8.3 Dendrogram construction and analysis:
The CLUSTALW program (Thompson et al, 1994) was used to carry out an 
automatic multiple alignment of all E2 sequences present in the SWISSPROT 
protein sequence database and the UBCD4 sequence. This was then analysed using 
programs in the PHYLIP phylogeny inference package (Kuhner and Felsenstein, 
1994).
Phylogenetic inference consists of two steps: (1.) obtaining an estimate of the 
best tree, and (2.) checking the accuracy of the tree obtained.
Distance-based methods of phylogenetic inference can make use of PAM 
(accepted point mutation) matrices (Dayhoff, 1978). These quantify the relative 
chance of an amino acid replacement for each of the possible changes. The Weighted 
Least-squares method (Fitch and Margoliash, 1967) was used for this dataset, in 
preference to the Neighbour-Joining method because of recent simulations showing 
slightly higher accuracy (see citations in Swofford et al., 1996). The PROTDIST
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program was used to calculate PAM-based pairwise distances from the multiple 
alignment. These were then fed into the FITCH program to estimate the tree.
The accuracy of the tree was tested using a statistical technique called 
bootstrapping. This method provides the level of "bootstrap support" for each cluster 
in the tree. If a cluster has high "bootstrap support" (above 90%) one can be 
confident it is distinct from the rest of the tree (see Swofford et aL, 1996 for further 
discussion).
2.3.8.4 Statistical analysis:
The StatView® Student data analysis package (Abacus Concepts) was used 
to perform statistical analysis on the results of crossing UASDhr6 lines to C22C and 
heat shock GAL4 lines (see chapter 5 and Appendices).
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CHAPTER 3
THE SEARCH FOR NEW




There is a family of E2 enzymes in every eukaryotic organism so far 
investigated; as yet 10 have been found in Saccharomyces cerevisiae, and 16 in 
Arabidopsis thaliana. At the start of the project only four E2s had been discovered in 
Drosophila, so more were likely to be present, some perhaps with interesting 
patterns of expression and functions in development. This chapter deals with the 
search for more E2 enzymes in Drosophila, and the characterisation of the new gene 
discovered.
3.2 RESULTS:
3.2.1 THE SEARCH FOR THE DROSOPHILA CDC34 HOMOLOGUE a 
brief summary):
3.2.1.1 Introduction:
A likely candidate for a Drosophila E2 with a role in development, is the 
CDC34 (Goebl et al, 1988) homologue, with probable roles in normal cell cycles 
and the rapid cell cycles characteristic of early embryonic development. As this is an 
essential gene in yeast (Goebl et al., 1988), and the human homologue has been 
found, and is also essential (Plon et al., 1993), this gene should be present in 
Drosophila .
3.2.1.2 Screening Libraries Using Dhr6:
CDC34 is most similar to RAD6 (Goebl et al, 1988) of all other yeast E2s, 
and domains of each protein can functionally substitute for one another (Kolman et 
al, 1992; Silver et al, 1992). RAD6 is 50% identical to Dhr6 at the DNA level, so it 
is likely Dhr6 is similar to the Drosophila CDC34 homologue. Therefore a 471bp 
PvuWEcoKL fragment (figure 3.1) of Dhr6 cDNA (Koken et al, 199la.), covering 
the regions of greatest homology between RAD6 and CDC34, was ^^P-labelled and 
used to probe genomic Southerns of OregonR (OrR) DNA (figure 3. IB) and to 
screen an OrR embryo K GEM 11 genomic library. In each digest, this probe 
hybridised strongly to fragments corresponding in size to those expected for Dhr6 
and weakly to other fragments, which could not be from Dhr6 but could be from the 































































































































































































































































































Table 3.1 Size of bands expected for Dhr6, compared to size of 
















Fig. 3.2 Genomic Southern of OrR fly DNA, probed with 
471bp EcoRl/PvuE Dhr6 fragment (Dr P. zur Lage). 
Approximately 4jig DNA were loaded per lane. 
Bacteriophage lambda DNA digested with Pstl was used as a size marker
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digests as some were smaller than the bands corresponding to Dhr6. The five 
positive plaques obtained from the library screen were, however, all found to be 
clones of Dhr6.
3.2.1.3 PCR with Degenerate Primers:
One sequence of five consecutive amino acids, and another of 7/8 in CDC34 
are identical to the corresponding residues in RAD6 (figure 3.3) and are similar to 
those in the RAD6 homologues of Schizosaccharomyces pombe (rhp6\ Drosophila 
melanogaster (Dhr6) and humans (HHR6A and HHR6B; Koken et al, 1991b), but 
are different to those in other yeast E2s. These sequences were used to design 
degenerate primers G58 and G59 (Materials and Methods), taking Drosophila codon 
usage into consideration. Products of the expected size, about 180bp, were produced 
by PCR amplification with these primers, but after sequencing they were not found 
to come from a Drosophila CDC34 homologue.
3.2.1.4 Searching for the CDC34 homologue by homologous probing:
Clones of CDC34 and its human homologue were received from Dr M. Goebl 
and Dr S. Plon respectively. These were used to probe genomic Southerns, as the 
human gene had been found to hybridise weakly to Drosophila DNA (Plon et al., 
1993). No hybridisation was seen with CDC34, despite using varying levels of 
stringency for the hybridisations, whereas multiple bands were seen for the human 
homologue probe (results not shown). An OrR embryo X Gem 11 genomic library 
was screened with the human gene, but no positive plaques were obtained.
3.2.1.5 Discussion:
The Drosophila homologue of CDC34 was not found by any of the methods 
described above. As it performs an essential function in the cell cycle, and human 
CDC34 hybridises to Drosophila genomic DNA, this enzyme should be present in 
Drosophila. It seems unlikely the Drosophila gene would have evolved so much as 
to be undetectable by these searches, which rely on homology, as human and yeast 
CDC34 homologues still show 64% similarity, 36% identity at the amino acid level. 
Designing degenerate PCR primers to other regions of similarity between these two 
proteins may enable the Drosophila homologue to be found.
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DHR6 ...MSTPARR RLMRDFKRLQ EDPPTGVS..
HHR6B ...MSTPARR RLMRDFKRLQ EDPPVGVS..
RHP6 ...MSTTARR RLMRDFKRMQ QDPPAGVS..
UBC2 ...MSTPARR RLMRDFKRMK EDAPPGVS..












UBC4 .....MSSSK RIAKELSDLE RDPPTSCS.. .AGPVGDDLY HWQ.ASIMGP
51 
DHR6 HDTPFEDGTF KLTIEFTEEY
HHR6B EGTPFEDGTF KLVIEFSEEY 



















UBC4 ADSPYAGGVF FLSIHFPTDY PFKPPKISFT TKIYhpninA NGNICLDILK
	101 150 
DHR6 NR. ....... ... .WSPRYD VSAILTSIQS LLSDPNPNsp anstaaOLYK
HHR6B NR. ....... ... .WSPTYD VSSILTSIQS LLDEPNPNsp anscraaOLYO
RHP6 NR. ....... ....WSPTYD VAAILTSIQR LLNDPNNAsp anaeaaOLHR
UBC2 NR. ....... ... .WTPTYD VASILTSIQS LFNDPNPAsp anveaaTLFK
CDC34 QSGDPMTDEP DAETWSPVQT VESVLISIVS LLEDPNINsp anvdaaVDYR








Fig. 3.3 Alignment of the CDC34 
amino acid sequence to that of RAD6 
(UBC2) and its homologues, to show 
regions (lower case and underlined) 
used to design degenerate primers G58 
and G59. UBC4 sequence is shown for 
comparison at these regions. 
(DHR6 = a Drosophila RAD6 homologue; 
HHR6B = a human RAD6 homologue; RHP6 = 
an S.pombe RAD6 homologue).
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3.2.2 THE CLONING OF UBCD4:
3.2.2.1 Introduction:
As the Drosophila CDC34 homologue had not been found by any of the 
methods described above, I carried out a broader search for any E2s. All E2s show at 
least 35% homology within their UBC domains (Jentsch, 1992) so primers designed 
to regions of homology common to all E2s would be expected to amplify PCR 
products from many genes.
3.2.2.2 Degenerate primer PCRs gave products from putative new E2s:
A comparison of all known Drosophila E2 amino acid sequences (figure 3.4) 
showed regions of identity, which were then compared at the DNA level. Degenerate 
oligonucleotides were designed for regions containing stretches of amino acid 
identity (figure 3.4), taking into account Drosophila codon usage and that of each 
E2. The oligonucleotides were designed with an EcoRI site (coding strand primers) 
or a BamHl site (non-coding strand primer) at their 5' ends, so that products derived 
from polymerase chain reaction amplifications using these as primers, could be 
cloned in a particular orientation. Two nucleotides (CG) were added at the start of 
each oligonucleotide, as restriction enzymes do not cut well if the recognition site is 
right at the end of the DNA fragment. The extra nucleotides result in restoration of 
>90% cleavage (New England Biolabs catalogue, 1990-91 p. 132). The primers were 
called N54, N55 and N56 (see Materials and Methods for sequences) and correspond 
to ICLDIL, PNPNSPA and EYPNKPPTV amino acid regions ofDhrf respectively.
Polymerase chain reaction amplifications were set up using N54 and N56 
primers, and N55 and N56 primers, with usual temperature cycles (Materials and 
Methods) and OrR adult DNA as the template. If no introns were present in the 
genomic sequence to which the primers bind, then the fragments amplified by N54 
and N56, and N55 and N56 would be expected to be about 92bp and 180bp 
respectively. Figure 3.5 shows the results of these PCR amplifications. All bands are 
larger than expected, but the same bands were produced when changes were made in 
the PCR temperature cycles, or to the concentrations of components in the reactions. 
As degenerate primers were used, multiple bands were expected, but only one band 
of approximately 340bp was produced from the N54, N56 PCR (figure 3.5). An 
intron is present in Dhr6 within the region that both sets of primers were expected to 
amplify, but the sites of introns in UbcDl , UbcD2 and bendless are unknown as
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51 100
UBCD1 .......... .......... .......... ..... MALKR INKELQDLGR
UBCD2 RGSNGNGGAS GRNAGGGDEP RKEAKTTPRI SRALGTSAKR IQKELAEITL
BEN .......... .......... .......... . . .MSSLPRR IIKETQRLMQ
DHR6 .......... .......... .......... . . MSTPARRR LMRDFKRLQE
101 150
UBCD1 DPPAQCSAGP VGDDLFHWQA TIMGPPDSPY QGGVFFLTIH FPTdvpfkpp
UBCD2 DPPPNCSAGP KGDNLYEWVS TILGPPGSVY EGGVFFLDIH FSPevpfkpp
BEN EPVPGINAIP DENNARYFHV IVTGPNDSPF EGGVFKLELF LPEdvpmsap
DHR6 DPPTGVSGAP TDNNIMIWNA VIFGPHDTPF EDGTFKLTIE FTEevpnkpp
151 200
)Q£AFTTRIYH PNINSNGSic IdilRSOWSP ALTISKVLLS ICSLLCDenp_
JSYTFRTRIYH CNINSOGVic IdilKDNWSP ALTISKVLLS ICSLLTDssp.
JSYRFITKIYH PNIDRLGRic IdvlKDKWSP ALQIRTILLS IQALLSApnp





201 234  
UBCD1 ddp_lVPEIAR IYKTDREKYN ELAREWTRKY AM. .
UBCD2 a^p_lVGSIAT QYLQNREEHD RIARLWTKRY AT . .
BEN <2d£lANDVAE LWKVNEAEAI RNAREWTQKY AVED
DHR6 nspaNSTAAO LYKENRREYE KRVKACVEQS FID.
Fig. 3.4 Alignment of Drosophila E2 enzymes to show regions used to design 
degenerate primers (lower case and underlined). The active site Cys residues are 
shown in bold italics. 
(N54 corresponds to the icldi/v region, N55 to p/cnpd/a/nd/spl/a, and N56 to d/eyp^m/nk/sp/apk/tv).
MARKER N55 +
123
Fig.3.5 Agarose gel of degenerate primer PCR on 
OregonR genomic DNA. Sizes are in bp.
96
only cDNA has been sequenced. It is possible all Drosophila E2 genes have an 
intron at the same site as Dhr6, which would mean the size of bands amplified 
should have been larger than previously expected.
The 340bp N54, N56 PCR band was extracted from a gel, digested with 
EcoRl and BamHI, ethanol precipitated and ligated into EcoR^BamHl digested 
pBluescriptll KS+ (Stratagene). The five smallest fragments from the N55, N56 
PCR were similarly cloned, except where the fragments did not digest well, and the 
strategy of "TA" cloning was employed. Taql polymerase adds a 3' terminal adenine 
to both strands and using pGEM-T Vector Systems (Promega), the PCR products 
were cloned into a vector with 3'-thymidine overhangs. Fragments were then cut out 
of this plasmid using Sphl and Sail sites present in the vector, and directionally 
cloned into pBluescriptn KS+. Double-stranded sequencing was performed on DNA 
prepared by the boiling method using SK, KS, reverse (rev.) and T7 primers which 
anneal to pBluescript.
3.2.2.3 Sequencing showed part of a new E2 had been cloned:
Sequencing was carried out from both ends of each of the six PCR products 
cloned. At least two clones for each PCR product were sequenced. The band from 
the N55, N56 PCR of approximately 260bp in length (figure 3.5) was found to be 
part of UbcDl (Treier et al., 1992). It consisted of the expected 182bp of coding 
sequence, the restriction sites on the primers, and a 64bp intron (figure 3.6) found 
between nucleotides 304 and 305 of the coding region of the gene. Three other bands 
from this PCR were found to be artifacts due to the same primer annealing to each 
end, and the fifth product cloned was found not to be an E2 enzyme due to the lack 
of a cysteine codon within the sequence, necessary in this region as the active site 
residue.
The 340bp fragment from the other PCR was seen to have the necessary 
coding capacity for an E2 in this region (figure 3.7), interrupted by an intron. This 
fragment was purified, and used as a probe on Southern blots of OrR adult genomic 
DNA, and to screen genomic and cDNA libraries. The Southern blots showed one or 
two bands hybridising for each enzyme used (results not shown), showing this 
fragment does come from the Drosophila genome.
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PCR BAND 1 gactatcccttcaaaccccccaaggtgGCTTTTACAACGCGCATATACCA 49
IMMIMIII Mill Mill MMMMMMIMMMMMIM
UbcDl 370 gactatccctttaaaccacccaaagtgGCTTTTACAACGCGCATATACCA 419 
PCR BAND 50 TCCAAACATCAACAGCAATGGATCGATTTGTCTCGATATATTAAGATCTC 99
IMIM MIIIIIIIIIIMMIIIIIIIMIIIIMIII Ml MM
UbcDl 420 TCCAAACATCAACAGCAATGGATCGATTTGTCTCGATATATTAAGATCTC 469 
PCR BAND 100 AGTGGTCGCCAGCATTAACTATTTCAAAAGGTGAGTTCATCTAAGTTCTA 149
MMIiMIIMilllllll,,;,'!""
UbcDl 470 AGTGGTCGCCAGCATTAACTATTTCAAAAG.................... 497
• « » • •
PCR BAND 150 CATCGAAAATGATACTAACATGTGTTTCCATATTCTCTTTCAGTTTTATT 199
MMIM
UbcDl 498 ...........................................TTTTATT 506
PCR BAND 200 ATCAATTTGCTCTCTACTCTGTGATcccaatccaaactcccctgct
IMMIIMIIMMMIIIIMMMMIMM II Ml I
UbcDl 507 ATCAATTTGCTCTCTACTCTGTGATcccaatccagacgatcctctt
Fig. 3.6 The 245bp N55, N56 PCR product aligned with the UbcDl cDNA sequence 
to show the site of the 64bp intron. Sequences differ only at the sites of the primers, 
shown in lower case. Intron splice sites are shown in bold, and the putative splice 
branch-point of the intron is underlined.
EYP FKPP K 
1 gagtatccct ttaagccgcc aaaaataCGT AATAGCCATG TCAGACTTTG
51 TGCAGCCTAT ACATATGCTA GCTTAGAAAT AAACAACTCT TACATGAGTA
101 CACCTCATCT TTCAAAAATC GTATCTTATG ACTTCACTTC GTAGAAGTGA
151 CACTTCTATG AATCCACAAT GTTAACTTGA ATTCTGAAAG GCGCAATAAG
201 AACCTGTAAC TTGTAATTGA AACCTAAATA AATTGCAAAC TTCTTCGCAG
VRF ITRI WHP NIS SVTG 
251 GTACGCTTCA TAACGCGCAT CTGGCATCCG AATATATCGT CGGTTACGGG
A I C L D I L 
301 TGCGatttgt ctggacatac tg
Fig. 3.7 DNA sequence of 322bp PCR product from N54, N56 PCR. Primer regions 
are shown in lower case, and the putative intron region is underlined. Appropriate 
splice sites are found 5' and 3' of the intron, and the predicted protein translation 
shown above the DNA, is similar to other E2 enzymes for this region.
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3.2.2.4 Genomic and cDNA sequences corresponding to the PCR 
product were cloned from libraries:
An OrR X GEM11 genomic library (provided by Kim Kaiser), and an embryo 
CantonS cDNA library in A, ZAP (Stratagene) were titred. The 32P-labelled N54, 
N56 PCR product, used as a probe, gave five positive plaques from the primary 
screen of the genomic library, and five from the cDNA library. After secondary 
screens this was reduced to three positives from the genomic library, and one from 
the cDNA library.
Phage DNA was made from minilysates of the genomic positives, and this 
was digested with Xhol, BamHl and Xhol/BamHl. These enzymes cut inserts out 
from the lambda arms (figure 4.7). These digests showed two positives were clones 
of the same genomic region as they gave the same size bands (results not shown). 
The third positive also gave the same bands for the BamHl digest, but more smaller 
bands for the Xhol digest and the double digests, implying it also contained the same 
genomic region, but covered a slightly larger area. Southern blots were performed 
and showed an Xhol fragment of approximately 13kb, and a BamHl fragment of 
approximately 11kb hybridised to the probe used for the library screens.
In order to have enough DNA to be able to clone appropriate genomic 
fragments, large scale A, DNA preparations of the two different positives were made. 
Autoradiographs of Southern blots of restriction enzyme digests showed Sail 
digested the genomic region hybridising to the probe to a fragment of approximately 
6kb in size (results not shown), which was the same for both positive clones. This 
fragment was subcloned into pBluescriptn KS+ (Stratagene). The 6kb Sail fragment 
was cut by EcoRl into fragments of 2.2kb and 4kb, both of which hybridised to the 
probe. These fragments were in turn cloned into pBluescriptll KS+ and sequenced.
No subcloning was necessary from the cDNA library, as the X ZAPn® vector 
can be used in conjunction with ExAssist™ phage, to allow excision of the 
pBluescript SK~ phagemid containing the cDNA clone. "Packaged" pBluescript 
DNA is then mixed with fresh E. coli cells and spread on L-ampicillin plates to 
produce colonies. This procedure was carried out for phagemids from the cDNA 
positive plaque, and minipreparations of pBluescript DNA were made. EcoRl digests 


















































































3.2.2.5 Genomic and cDNA Sequences of a new Drosophila E2 enzyme 
had been cloned:
The cDNA clone was sequenced completely on both strands using SK, KS, 
T7, and rev primers which anneal to the plasmid, and the degenerate primers N54 
and N56 and E2 primers 1, 2, 4 and 5, which anneal within the insert. The E2 
primers 1-7, N54, N56, T7 and SK primers were used to sequence the genomic 
clones. The genomic sequence was not determined completely on both strands: 
approximately 75% of each strand was sequenced.
The sequences of the cDNA and genomic clones align with each other, and 
with the PCR product of N54 and N56 primers (figure 3.9), showing that the 
equivalent cDNA and genomic regions have been cloned. The expected features of a 
gene are found in the cDNA and genomic sequences (figures 3.10 and 3.11 
respectively). The 945bp cDNA has an ORF of 597bp, which is interrupted by 2 
introns (figure 3.12), and codes for a protein of approximately 21.9kDa (figure 3.10). 
The protein was seen to be a novel Drosophila E2 enzyme by amino acid sequence 
comparison with other known E2s. It is structurally a class 2 E2 (Jentsch et al., 
1990), having a C-terminal extension to its UBC domain, and has a putative active 
site cysteine residue (by sequence comparison) at amino acid position 92.
The gene was named UbcD4, for Drosophila ubiquitin conjugating enzyme 
number four. The name reflects the order of identification of Drosophila E2 
enzymes, and does not relate to homologues in other species.
The UbcD4 cDNA sequence has been deposited in the EMBL/GenBank 
nucleotide sequence database, accession number X92838.
3.2.2.6 Mapping the genomic region around UbcD4:
OrR adult DNA was digested overnight with various restriction enzymes, a 
Southern blot was performed, and the filter was probed with 32p'-labelled £/&cD4 
cDNA. The autoradiograph (figure 3.13) was used to make a partial restriction 
enzyme map of the genomic region surrounding the UbcD4 gene (figure 3.14).
The fragments detected in the genomic Southern corresponded to those 
identified previously using the N54, N56 PCR product as a probe (data not shown). 
Other weaker bands could be seen in each track of the genomic Southern (figure 
3.13). These bands are not due to partial digestion of DNA, and may correspond to a 
related gene.
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PCR band 1 ........ .GAGTATCCCTTTAAGCCGCCAAAGGTGcgtaatagccatgt 41
IMMIII II II MINIM Ml Illlllllll
Genomic 751 gtgcccgagACATATCCCTTCAATCCACCAAAGGTAcgtaatagccatgt 800
MMMMMMMMMMMMMMMMI
cDNA 343 gtgcccgagACATATCCCTTCAATCCACCAAAG. ................
PCR band 42 cagactttgtgcagcctatacatatgctagcttagaaataaacaactctt 91
IMMIMMIMMMMMMMMMMIIIIMIMM IMIIM
Genomic 801 cagactttgtgcagcctatacatatgctagcttagaaataaacaactctt 850 
cDNA ..................................................
PCR band 92 acatgagtacacctcatctttcaaaaatcgtatcttatgacttcacttcg 141
IMIMMMMIIIIIIMMIIMM I I I IMIMMIIIIMI
Genomic 851 acatgagtacacctcatctttcaaaaatcgtatcttatgacttcacttcg 900 
cDNA ..................................................
PCR band 142 tagaagtgacacttctatgaatccacaatgttaacttgaattctgaaagg 191
IMIMMMIIIMMMMMMIIMMIMMMIIMMMIMI
Genomic 901 tagaagtgacacttctatgaatccacaatgttaacttgaattctgaaagg 950 
CDNA ..................................................
PCR band 192 cgcaataagaacctgtaacttgtaattgaaacctaaataaattgcaaact 241
IMMIMMIMMMMIIMIMMMMIIIIIIIIMMMIMI
Genomic 951 cgcaataagaacctgtaacttgtaattgaaacctaaataaattgcaaact 1000 
cDNA ..................................................
PCR band 242 tcttcgcaggtacgcttcataacgcgcatctggcatccgaatatatcgtc 291
MIIIMIIIIMMMMIIIIIIIMMIIIIIIIIIIIIIMIMII
Genomic 1001 tcttcgcaggtacgcttcataacgcgcatctggcatccgaatatatcgtc 1050
I Illlll IMIIM I Illllllllllllllllllll
cDNA ........ .gcacgctttataacgcgcatctggcatccgaatatatcgtc 417
PCR band 292 ggttacgggtgcgATTTGTCTGGACATACTG. .................. 322
IMIMIIMMIIIMI Mlllll I
Genomic 1051 ggttacgggtgcgATTTGCTTGGACATCTTAaaggacaactgggctgcag 1100
Illlllllllll MMMMMMMIMIMMMMMMMIMM
cDNA 418 ggttacgggtgcgATTTGCTTGGACATCTTAaaggacaactgggctgcag 467
Fig. 3.9 Comparison of sequences of cDNA, and genomic clones to the N54, N56
PCR amplification product sequence.
Genomic and cDNA sequences differ in two positions, probably because they were
cloned from different Drosophila melanogaster strains.
The PCR product differs from the genomic and cDNA sequences only in the regions
where the primers anneal (shown in capitals).
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1 caaaatccaa aattgcacgg gggggcaaca ataaaaacag aggcagaaca 
51 gaacacagca agaagagcgt ggtgaagagg agcggcggag aaaggagaac
101 ggtgaacagg gaacagggag agagcagaaa ggagagtccg agaaacggag
M ANM AVS RIKR EFK 
151 gaaacatcat ggcgaacatg gcagtgtcgc ggatcaagcg ggagttcaag
EVM RSEE IVQ CSI KIEL 
201 gaggtgatgc gcagcgagga gatcgtccag tgttccatca aaatcgaact
VND SWTE LRG EIA GPP 
251 ggtcaatgac agttggacgg agctgcgcgg cgagatcgcc ggtccgcctg
DTPY EGG KFV LEIK VPE 
301 acacgcccta cgagggcggc aagttcgtcc tggagatcaa ggtgcccgag
TYP FNPP KAR FIT RIWH 
351 acatatccct tcaatccacc aaaggcacgc tttataacgc gcatctggca
PNI SSV TGAI CLD ILK 
401 tccgaatata tcgtcggtta cgggtgcgat ttgcttggac atcttaaagg
DNWA AAM TLR TVLL SLQ 
451 acaactgggc tgcagcgatg acactgcgca ccgtactgct gtcgctgcag
ALL AAAE PDD PQD AVVA 
501 gcgctcctgg ccgccgcaga gccggacgat ccacaggacg cagtggtggc
YQF KDK YDLF LLT AKH 
551 ctatcagttt aaggacaagt acgatctgtt cctgcttacg gccaagcact
WTNA YAG GPH TFPD CDS 
601 ggaccaacgc gtatgcgggc ggaccgcaca cctttcccga ttgtgattca
KIQ RLRD MGI DEH EARA 
651 aagatccaac gtctcaggga catgggcatc gacgagcatg aggcgcgcgc
VLS KEN WNLE KAT EGL 
701 cgtgctctcc aaggagaatt ggaatttgga aaaggccacc gagggcctgt
F S * 
751 tcagttagct tgtcccagcc gaactagcat cagtaccatt cgcggcggtg
801 gcagcaccaa gaacaccggc caacttcagc atcaatcctt cagaacggca
851 atcacgctaa atgtacactc acgcaccaat atattttcgt aaatcttatc
901 cacgaaatta cattgccctg tagttataat aaaaaaaaaa aaaaa
Fig. 3.10 UbcD4 cDNA nucleotide sequence with amino acid sequence of 
the encoded protein. The putative active site cysteine residue is shown in 
bold and underlined. 
cDNA was sequenced on both strands.
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-202 ggaaaaacaa aaaagaaata gcgctggcaa aatagacgtg ctgagcgctg
-152 taaaaagtca gattcgtgtt gaaattggaa tattaagttt tttattttcc
-102 gtgcgctggt cgagctcgtt acttcaacaa ttcaaaaaac gatcgtaagg
-52 agcaaccttg taggccaaca gccagacata atttacacaa cgcacaacac
-2 tcacaaaatc caaaattgca cgggggggca acaataaaaa caggggcaga
48 acagaacaca gcaagaagag cgtggtgaag aggagcggcg gagaaaggag
98 aacggtgaac agggaacagg gagagagcag aaaggagagt ccgagaaacg
148 gaggaaacat cATGGCQAAC ATGGCAGTGT CGCGGATCAA GCGGGAOTTC
198 AAGGAGGTGA TGCGCAGCOA QGAGgtgagt cccgagcacc aaggccgaag
248 gacactcaaa cggcacctcg gcaatgccag ctgcaccacc gcccctggtc
298 atggtgcagg ggggatcggg ggagggtgtc ggcgaacgtt ggtggcgttt
348 ttggcgegct tatgggctcc gttttgtttg tgaaatgtaa acagtggcc.p
398 as£ga£tgta ttgctgtaat ccctgaacag ATCGTCCAGT GTTCCATCAA
448 AATCGAACTG GTCAATGACA GTTGGACGGA GCTGCGCGGC GAGATCGCCG
498 GTCCGCCTGA CACGCCCTAC GAGGGCGGCA AGTTCGTCCT GGAGATCAAG
548 GTGCCCGAGA CATATCCCTT CAATCCACCA AAGgtacgta atagccatgt
598 cagactttgt gcagcctata catatgctag cttagaaata aacaactctt
648 acatgagtac acctcatctt tcaaaaatcg tatcttatga cttcacttcg
698 tagaagtgac acttctatga atccacaatg ttaacttgaa ttctgaaagg
748 cgcaataaga acctgtaac£..tgtaattgaa acctaaataa attgcaaact
798 tcttcgcagG TCACGCTTCTAT AACGCGCATC TGGCATCCGA ATATATCGTC
848 GGTTACGGGT GC6ATTTGCT TGGACATCTT AAAGGACAAC TGGGCTGCAG
898 CGATGACACT GCGCACCGTA CTGCTGTCQC TGCAGGCQCT CCTGGCCGCC
948 GCAGAGCCGG ACGATCCACA GGACGCAGTG GTGGCCTATC AGTTTAAGGA
998 CAAGTACGAT CTGTTCCTGC TTACGGCCAA GCACTGGACC AACGCGTATG
1048 CGGGCGGACC GCACACCTTT CCCGATTGTO ATTCAAAGAT CCAACGTCTC
1098 AGGGACATGG GCATCGACGA GCATGAGGCG CGCGCCGTGC TCTCCAAGGA
1148 GAATTGGAAT TTGGAAAAGG CCACCGAGGG CCTGTTCAGT tagcttgtcc
1198 cagccgaact agcatcagta ccattcgcgg cggtggcagc accaagaaca
1248 ccggccaact tcagcatcaa tccttcagaa cggcaatcac gctaaatctt
1298 gtacactcac gcaccaatat attttcgtaa atcttatcca cgaaattaca
1348 ttgccctgta gttataataa ttctctgatc tgttctataa ttttattatg
1398 attaatgtgc acatctttgc cgctgggtgg gtcaccagaa ggttgagcca
1448 aaggccatgc cgcgcgcccc attaagcatg tggtgttatg taattgaacc
1498 caggttctgt ttcattaatt tacgtgcagt cgcatttact tgcaggctct
1548 tcttaaacag tactgttgtt ttccatttca agcttaaact aaaacacaaa
1598 caaaaatgat ttacaaaaca aaataaatgt gaaggcgagg atgtgataac
1648 aaatcg
Fig. 3.11 UbcD4 genomic nucleotide sequence.
Transcribed sequences, according to the cDNA clone, are shown in bold, and
translated regions in upper case.
-Assuming the 5' end of the cDNA is the transcriptional start site, then the 
underlined sequences could be the putative TAT A box and CAAT box. 
The consensus for a TATA box is TATAAAA (7bp of A.T base pairs), 
surrounded by GC-rich DNA, situated approximately 25bp upstream of the 
transcription start. Here the putative TATA box starts at -24bp, is surrounded 
by GC base pairs, and consists of TAATTTA. CAAT boxes are usually 
found 75bp upstream of the transcription start, and have the consensus 
sequence GGCCAATCT, in either orientation. The putative CAAT box 
has the sequence CGAGAATTC and is at -78.
-Putative splice branch-point sequences are indicated by dotted lines. 
They match the consensus sequence of PyNPyPyPuAPy, and are positioned 
18-40 nucleotides upstream of the 3' splice site, CAG.
-The presumed polyadenylation signal is doubly underlined. 
Polyadenylation signals are usually 1 l-30bp upstream of the polyadenylation 
site, and are highly conserved with a consensus sequence of AAUAAA. This 
site was chosen due to closely matching the polyadenylation signal, and 
being at the correct position with respect to the polyA regions found in the 
cDNA clone. However, mRNA studies (see chapter 4) show ~ 1.8kb mRNA 
for UbcD4, not ~ 1kb as expected from the cDNA clone. This implies a 
polyadenylation site matching the consensus may be present further 
downstream from the genomic sequence shown here.
-Superscripts show the position of base differences between cDNA and 
genomic sequences. The one at position 815 does not result in an amino acid 
change, whereas the base change at position 808 results in a Val residue 
being present in the genomic translation, and an Ala in the cDNA protein 
sequence. Both base changes are probably due to different strains of 
Drosophila melanogaster being used; genomic DNA was sequenced from 


































































































































Fig. 3.13 Genomic Southern of OrR adult DNA, probed with 
UbcD4 cDNA.
Approximately 4u.g DNA were loaded per lane.
Bacteriophage lambda DNA digested with PstI was used as a size marker.
01234
Scale (kb): | | | | |
X P EH S EPHX P S
6.2 kb X clone
Fig. 3.14 Partial restriction enzyme map of genomic region around UbcD4. 
Boxed region shows the position of the UbcD4 gene. 
E = EcoRI; H = HindlU; P = PstI; S = Sail; X = Xhol
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3.2.2.7 The UbcD4 gene is located at position 67C5-C11 on 
chromosome 3L:
In situ hybridisation to polytene chromosomes, using biotinylated£/6cD4 
cDNA as a probe, was used to determine the location of UbcD4 in the genome. The 
probe hybridises to position 67C5-C11 (figure 3.15) on chromosome 3L (Lefevre, 
1976).
In the same way the Dubal gene (DNA provided by Dr P. zur Lage) was 
seen to localise to position 46A (figure 3.16) on chromosome 2R.
3.2.3 THE RELATIONSHIP OF UBCD4 TO OTHER E2 ENZYMES:
3.2.3.1 Introduction:
Sequence comparisons had shown UbcD4 was an E2 enzyme. Database 
searches were used to find the enzyme most related to UbcD4, in order to determine 
something about its possible roles in Drosophila. E2 enzymes tend to be named with 
respect to order of identification within a particular organism, as a result it is not 
obvious which enzymes are likely to be functional homologues. This question has 
been addressed by using sequence comparison programs to establish the 
phylogenetic relationships between all E2 sequences in the SwissProt database.
3.2.3.2 UBCD4 is an E2 enzyme related to Bovine E22sK-'
The protein most similar to UBCD4 is E225K (Chen et al , 1991), a bovine E2 
enzyme (Figure 3.17). Chen et al. (1991) have shown E225K is similar to UBC1 and 
UBC4/5 of Saccharomyces cerevisiae (Seufert et al., 1990; Seufert and Jentsch, 
1990) and UBCD4 shows approximately the same similarity to these enzymes (table 
3.2). UBC1, 4 and 5 are essential yeast genes which together make a functionally 
overlapping E2 subfamily, each being able to at least partially complement 
mutations in the other two. This family appears to be responsible for degrading most 
abnormal and short-lived proteins (Johnson et al, 1992; Seufert and Jentsch, 1990; 
Seufert et al., 1990). Homologues of these genes are encoded by a multigene family 
in Arabidopsis thaliana (Girod et al., 1993) and it seems probable both UbcD4 and 
the E225K §ene are P^ °f respective multigene families in Drosophila melanogaster 
and Bos taurus .
108
Fig. 3.15 Hybridisation of UbcD4 cDNA to polytene chromosomes from OrR larval 
salivary glands.




UBCD4 MANmAVsRIK REFKEVmrSE EivqcsIKie LVndswTELR GEIAGPPDTP 
E225K MANiAVqRIK REFKEVlkSE EttknqlKvd LVdenfTELR GEIAGPPDTP
51 100
UBCD4 YEGGkfvLEI KvPETYPFNP PKaRFITrlW HPNISSVTGA ICLDILKDnW
E2 25K YEGGryqLEI KiPETYPFNP PKvRFITklW HPNISSVTGA ICLDILKDqW
101 150 
UBCD4 AAAMTLRTVL LSLQALLAAA EPDDPQDAW AyQfKdkydl FllTAkhWtn 
E225K AAAMTLRTVL LSLQALLAAA EPDDPQDAW AnQyKqnpem FkqTArlWah
151 200
UBCD4 aYAGgPhtfP dcdsKIqrLr dMGiDehear avLSkenWnl EkATEgLfS.
E2 25K vYAGaPvssP eytkKIenLc aMGfDrnavi vaLSsksWdv EtATElLlSn
Fig. 3.17 Comparison of amino acid sequences of UBCD4 and E225K, identical
residues in upper case.
Overall, proteins show 81% similarity, 68% identity (to the nearest %). Their UBC



















































Table 3.2 Comparison of UBCD4 and E225K proteins to UBC1,4, 5, the 
yeast E2 enzymes for bulk degradation of proteins via the ubiquitin pathway. 
Values shown are to the nearest percent.
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3.2.3.3 E2 enzymes can be divided into subgroups, in which UBCD4 
and E225K belong to the same group as UBC1:
In order to see the relationship between UBCD4 and all other E2 enzymes in 
the SwissProt database, their complete amino acid sequences, and those of their 
UBC domains were used to construct dendrograms (see Materials and Methods). The 
UBC domain tree is shown in figure 3.18. The dendrogram of total E2 proteins 
showed the same groupings, and is not shown. UBCD4, E225K and UBC1 are 
grouped together in the dendrogram, implying that they are homologues. All three 
are class n E2s, having C-terminal extensions to the UBC domain, and all differ 
more in their C-termini than across the UBC domains (table 3.2).
A yeast specific function may be determined by the C-terminal domain of 
UBC1, for example UBC1 is involved in early stages of growth after spore 
germination (Seufert et al, 1990). Other C-terminal extensions of yeast E2s have 
been shown to provide yeast specific functions; Dhr6, a class IE2, can complement 
all of the rad6 mutant phenotypes bar the sporulation defect (Koken et al. , 199la.) 
which requires the function of the C-terminal domain (Morrison et al , 1988).
Analysis of figure 3.18 also reveals other groups into which E2 enzymes 
could be divided, and may help define other functionally overlapping E2 
subfamilies. This could allow for better nomenclature; instead of enzymes being 
named with respect to order of discovery, they could be named by organism and E2 
subgroup to which they belong.
As a lot is known about S. cerevisiae E2 enzymes, it would be appropriate for 
subgroups to refer to the yeast E2s they contain. Obvious subgroups from figure 3.14 
are those containing UBC3/7, UBC9, UBC2, UBC8, UBC1 and UBC4/UBC5. A 
particular E2 could be named using the initials from the species name, e.g. Dm for 
Drosophila melanogaster, UBC for ubiquitin conjugating enzyme, and a number 
referring to the yeast E2 present in the subgroup of E2s to which the enzyme 
belongs. As an example, UBCD4 would be renamed DmUBCl. However, this could 
become complicated when two or more E2s from the same organism fall into the 
same group (they could be given a letter e.g. the Arabidopsis UBC9 could be known 
as AtUBC4a) and when species have the same initials. It would be useful to know 
which E2 genes are homologues from their names, and the proposed scheme for 
nomenclature would be possible for the E2s in figure 3.18, but genes for more E2s 
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Fig. 3.18 Dendrogram of UBC domains of all E2 enzymes present in the SwissProt database.
Branchpoint values show the percentage likelihood of being correct.
The scale is in substitutions pei position .Yeast UBC6 does not appear in the tree as it was too
distant from other E2s to be included.
At = Arabidopsis thaliana; ASFV = African swine fever virus; Bt = Bos taurus; Ca =Candida albicans ; Ce =
Caenorhabditis elegans; Dm = Drosophila melanogaster; Hs = Homo sapiens; Le = Lycopersicon esculentum; Ms
= Medicago saliva; Sc = Saccharomyces cerevisiae; Sp = Schizosaccharomyces pombe; Ta = Triticum aestivum
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3.2.3.4 UBCD4 may be unable to functionally substitute for UBC1:
UBCD4 had been identified as an E2 enzyme only by sequence analysis. One 
functional assay for E2 activity would be to see if it could substitute for another E2 
enzyme. Some Drosophila E2s can complement mutations in their yeast 
homologues:UBCDl can functionally substitute for UBC4 (Treier etal, 1992), and 
DHR6 can complement a rad6 mutant for all functions except those of the RAD6 C- 
terminal tail (Koken etal, 199la.). The dendrograms described above imply UbcD4 
is the Drosophila homologue of UBC1 . If UbcD4 can complement mutations in any 
yeast E2 gene, it is likely to be UBC1.
The ubcl mutant phenotype is moderately slow growth, and markedly slow 
growth after germination (Seufert et al., 1990). Complementation of this mutant 
phenotype would be difficult to determine. S.cerevisiae with mutations in both 
UBC4 and UBC5 cannot grow at 37°C, and this phenotype can be complemented by 
overexpressing UBC1 carried on a 2\i derived plasmid (Seufert et al., 1990). This 
suggested an alternative method for testing the functions of UbcD4.
UbcD4 cDNA was cloned into two different plasmids, both containing a 
URA3 selectable marker, under the control of the GAL1 promoter (figure 3.19). One 
vector used was a 2\i -derived plasmid, the other was a low copy number centromere 
plasmid, with overexpression due to induction by galactose. Dr M. Cooper 
transformed YW023 (ubc4, ubc5, wra3-52) yeast cells with Ijxg of DNA from each 
construct, and with pBM125 and pSEYS plasmids as controls. After transformation 
Dr M. Cooper grew cells on YMG/CAS medium minus uracil to select for the URA3 
containing plasmids, and at 23°C due to the temperature sensitivity of the strain.
Twelve colonies of each type of transformant were replica plated on 
YMG/CAS, YMGalRaff/CAS and YMGal/CAS, all minus uracil, at 18°C, 23°C, 
30°C, 34°C, 36°C and 37°C. YMGalRaff/CAS plates were used as the strain is very 
slow growing, and here could use Raffinose as an additional carbon source to 
Galactose.
All transformants grew on all media at 18°C, 23°C, 30°C, and 34°C. At 36°C, 
the yeast were all slow growing on all media, and at 37°C no growth was seen for 
any transformant on any medium. This could be for a number of reasons, as it is not 



































Fig. 3.19 Construction of plasmids for overexpression of UBCD4 
in yeast strain YWQ23ubc4ubc5.
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3.3 DISCUSSION;
A new Drosophila E2 gene named UbcD4 was cloned and sequenced. It is 
surprising that only one band was seen using N54 and N56 as primers, but perhaps 
the primers bound well to UbcD4, and less strongly to other E2 enzyme sequences. 
The other set of degenerate primers produced multiple bands, only one of which was 
part of an E2 enzyme. These primers were designed to anneal to regions from all 
E2s, but only amplify fragments from a subset of E2s. If different regions of E2 
enzymes were used to design primers to anneal to all E2s, perhaps a different subset 
of E2 enzymes would be cloned.
UBCD4 is the Drosophila homologue of bovine E225K- When multiple 
alignments of the UBC domains of all E2 enzymes in the SwissProt database were 
made, the resulting dendrogram showed that both proteins are related to UBC1. 
UbcD4 may not be able to substitute for UBC1 in rescuing the ubc4ubc5 yeast strain 
YW023, but this was not proved, as no experiments were performed to show 
UBCD4 protein was expressed. Other Drosophila E2s that are able to rescue yeast 
mutants are more closely related to each other than UBCD4 is to UBC1. UbcDl can 
fully restore growth of ubc4ubc5 mutants at 37°C (Treier et al., 1992), UbcD2 only 
partially complements the growth defects, and UbcD3lben cannot restore growth 
(Matuschewski et al., 1996). It seems likely UbcD4 would at best be able to partially 
restore growth of YW023 yeast cells at 37°C, as it is less related to UBC4 and UBC5 
than UbcD2 (figure 3.18).
The dendrogram of figure 3.18 could be used to determine sub-groups of E2 
enzymes. UbcDl lies within the yeast UBC4/UBC5 cluster, as expected, and Dhr6 is 
found with other UBC2 homologues. UbcD2 appears to be a distant relative to the 
UBC4/UBC5 subgroup, and ben may be related to UBC 1-like E2s.
Genomic Southerns show UbcD4 is a unique gene, but bands not from 
UbcD4 are seen to hybridise weakly to the probe. It is possible that they correspond 
to a related gene, as UBC1, 4 and 5 homologues have been found to be encoded by 
multigene families in other organisms, such as Arabidopsis (Girod et al., 1993).
Knowing the position of the UbcD4 gene within the genome could be useful 
when trying to create mutants of this gene. Many stocks are available with P 
elements residing in different positions within the Drosophila genome, and a P 
element lying near UbcD4 could be mobilised to create insertional mutations. Also 
deletions covering this region could reveal the mutant phenotype of the gene in 
conjunction with another mutant allele for UbcD4, such as a P element insertion.
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CHAPTER 4




Ubiquitin-dependent proteolysis may play an important role during early 
Drosophila development, as nurse cells and follicle cells undergo programmed cell 
death in oogenesis, and in the embryo certain regulatory proteins need to be 
transiently expressed and then rapidly degraded, such as those establishing the 
embryonic axes. Ubiquitin is involved in degrading cyclins and controlling the cell 
cycle (see Chapter 1). The first 10 mitotic divisions in the Drosophila embryo 
require different control to later divisions, as they occur in a syncitium and are very 
rapid. Programmed cell death also occurs during metamorphosis in the pupa, when 
larval tissues are destroyed, and the adult forms from imaginal discs.
There are many E2 enzymes present in an organism, as one means of 
providing substrate specificity for the ubiquitin system (see chapter 1). It is likely 
some ubiquitin conjugating enzymes have specific roles in development. In order to 
investigate temporal and spatial control of expression of Drosophila E2s during 
development, RNA studies were performed.
4.2 RESULTS:
4.2.1 NORTHERN ANALYSIS:
The first step in investigating developmental roles for cloned Drosophila E2 
enzymes was to perform developmental Northerns. These were used to determine the 
size and abundance of transcripts, and to show how levels of mRNA vary during 
development. If a large amount of transcript from an E2 is present at a certain stage 
of development, this could imply the enzyme has a specific developmental function 
at this stage.
4.2.1.1 UbcD1, UbcD2, ben, UbcD4 and Dhr6 are all expressed in adult 
Drosophila:
In order to confirm the size and number of transcripts of UbcDl, UbcD2, ben 
and Dhr6 (published in Treier etal., 1992, Matuschewski et al.., 1996, Muralidhar 
and Thomas, 1993, and Koken et al., 1991a. respectively), and to see the size and 
number of UbcD4 mRNAs, Northerns were performed on total adult OregonR (OrR) 
RNA (10|LLg per sample). Ubiquitin conjugating enzyme cDNAs were 32p_iabelled 
and used as probes.
All E2s were expressed in adult RNA. UbcDl , UbcD2 and UbcD4 were seen
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to have transcripts of 1.5, 1.6 and 1.8kb respectively (figure 4.1). Dhr6 and ben 
each have two transcripts present in adult RNA. As published, ben mRNAs are 1.2 
and 2.0kb, and those of Dhr6 are 1.3 and 2.1kb (figure 4.1).
4.2.1.2 Developmental Northerns:
Different developmental stages of wild-type OrR Drosophila melanogaster 
were collected as described in 2.3.3.1, and total RNA preparations were made. 
Approximately 10|ig total RNA were loaded per lane on each gel, and Northern blots 
were performed, again using 32p_iabelled E2 cDNAs as probes. After exposure to 
film, each radioactive filter was exposed to a phosphoimager cassette, then stripped 
and reprobed with a-tubulin. This was used as a loading control, as it has been 
shown to be expressed at a constant level throughout development (Kalfayan and 
Wensink, 1982), although expression levels in different adult tissues are unknown, 
so this was not a good standard for comparing ovarian E2 mRNA levels to those of 
different developmental stages. Again filters were exposed first to film, then in a 
phosphoimager cassette. This enabled quantitative measurements to be made on the 
way levels of E2 enzyme mRNAs vary during development.
All E2 transcripts seen in adult RNA were detected throughout development 
(figures 4.2-4.6). For all E2 enzymes, transcript levels in ovaries appeared low. This 
could be due to many a-tubulin transcripts being present in this tissue. UbcDl and 
UbcD4 seemed to show a higher level of expression than the other E2s in general, 
though this could only be confirmed by using probes with the same specific activity 
and performing Northern blots under identical experimental conditions. UbcD4 
hybridises to more than one band in the developmental Northern (figure 4.5). It is 
possible the extra bands correspond to transcripts from other similar E2 enzymes, as 
UBC1,4 and 5 homologues have been found to be encoded by multigene families in 
other organisms (see 1.7.1.1). The smaller 1.2kb ben transcript was usually present 
at higher levels than the larger 2.0kb transcript, while both Dhr6 mRNAs were 
present at approximately equal levels.
Quantitative analysis revealed levels of transcripts varied up to 26 fold 
between stages for certain E2s (table 4.1 and figure 4.7). In order to determine the 
significance of the observed differences, these experiments would have to be 
repeated and statistical analysis performed on the sets of data. UbcD4 transcript 
levels were more or less constant, allowing for some degree of experimental error in 
these values. The highest levels for each of the other E2s tested were found in larvae, 































































































































































































— 1.5kb UbcDl transcript
0.24 _
— 1.8kb ot-tubulin loading control
Fig. 4.2 UbcDl developmental Northern of total RNA from different stages, 
a-tubulin was used as a loading control.
Sizes are shown in kb. Boehringer Mannheim RNA ladder was used as size markers. 
Approximately lOfXg total RNA were loaded per lane.
(O = ovaries; EO-2 = embryos 0-2h; E2-4 = embryos 2-4hr; E4-6 = embryos 4-6h; E6-24 = 
embryos 6-24hr; L = larvae; P = pupae; AD-F = adult females; AD-M = adult males).
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— 1.6kb UbcD2 transcript
1.8kb a-tubulin loading control
Fig. 4.3 UbcD2 developmental Northern of total RNA from different stages.
a-tubulin was used as a loading control.
Sizes are shown in kb. Boehringer Mannheim RNA ladder was used as size markers. 
Approximately 10(0,g total RNA were loaded per lane.
(O = ovaries; EO-2 = embryos 0-2hr; E2-4 = embryos 2-4hr; E4-6 = embryos 4-6hr; E6-24 = 
embryos 6-24hr; L = larvae; P = pupae; AD-F = adult females; AD-M = adult males).
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2.0kb UbcDS /ben transcript
1.2kb UbcDS /ben transcript
— 1.8kb a-tubulin loading contro
Fig. 4.4 UbcDS/ben developmental Northern of total RNA from different stages.
a-tubulin was used as a loading control.
Sizes are shown in kb. Boehringer Mannheim RNA ladder was used as size markers. 
Approximately 10(ig total RNA were loaded per lane.
(O = ovaries; EO-2 = embryos 0-2hr; E2-4 = embryos 2-4hr; E4-6 = embryos 4-6hr; E6-24 = 
embryos 6-24hr; L = larvae; P = pupae; AD-F = adult females; AD-M = adult males).
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— 1.8kb UbcD4 transcript
— 1.8kb a-tubulin loading control
Fig. 4.5 UbcD4 developmental Northern of total RNA from different stages.
a-tubulin was used as a loading control. 
Approximately 10(ig total RNA were loaded per lane.
Sizes are shown in kb. Boehringer Mannheim RNA ladder was used as size markers. 
(O = ovaries; EO-2 = embryos 0-2hr; E2-4 = embryos 2-4hr; E4-6 = embryos 4-6hr; E6-24 = 
embryos 6-24hr; L = larvae; P = pupae; AD-F = adult females; AD-M = adult males).
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\— 2.1kb Dhr6 transcript
1.3kb Dhr6 transcript
— 1.8kb a-tubulin loading control
Fig. 4.6 Dhr6 developmental Northern of total RNA from different stages.
a-tubulin was used as a loading control. 
Approximately 10|ig total RNA were loaded per lane.
Sizes are shown in kb. Boehringer Mannheim RNA ladder was used as size markers. 
(O = ovaries; EO-2 = embryos 0-2hr; E2-4 = embryos 2-4hr; E4-6 = embryos 4-6hr; E6-24 = 























































































Table 4.1 Results of quantitative analysis on the amount of E2 mRNA present at 
different stages ofDrosophila development.
Values were calculated using the Volume Integration programme on Molecular Dynamics ImageQuant 
software. This calculates the number of pixels in an area. Background values were deducted, and ratios 
between a-tubulin and E2 bands were calculated for each stage.
In order to directly compare ratios between different stages within a particular developmental Northern, 
ovary E2 band:oc-tubulin ratios were taken to be 1.0. However, a-tubulin is not a good loading control for 
comparing ovary expression to that of different developmental stages, as the level of expression between 
different tissues is not known. It appears the level of expression of E2 mRNA is low in ovaries, but this 
is probably not the case.
Values cannot be compared between different E2 enzymes.
O = ovaries; EO-2 = embryos 0-2hr; E2-4 = embryos 2-4hr; E4-6 = embryos 4-6hr; E6-24 = embryos 6- 
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Dhr6 1.3kb transcript 
Dhr6 2.1kb transcript
Fig.4.7 Graphs to show variation in levels of 
E2 enzyme transcripts across development. 
Data from table 4.1.
The amount of E2 mRNA in ovaries may appear low due to 
large amounts of a-tubulin transcripts being present. 
O = ovaries; EO-2 = embryos 0-2hr; E2-4 - embryos 2-4hr; 
E4-6 = embryos 4-6hr; E6-24 = embryos 6-24hr; L = larvae; 
P = pupae; AD-F = adult females; AD-M = adult males.
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in adult females, and elevated expression in 0-2hr embryos. These were the two 
other stages where increased levels of UbcD2 mRNA were detected. Both ben 
transcripts showed similar patterns of expression, except in 0-2hr embryos where the 
1.2kb mRNA showed an increase in abundance. Dhr6 mRNAs increase in number 
for both transcripts at the 0-2hr embryo stage as well as in larval stages. Again both 
transcripts show similar variations except at the 4-6hr embryo stage where the 2.1kb 
transcript increases in number greater, with respect to other stages, than the 1.3kb 
mRNA.
4.2.1.3 Discussion:
All E2 transcripts investigated are present in adult RNA. The size and 
number of UbcDl, ben and Dhr6 transcripts were confirmed. UbcD2 was seen to 
have one transcript of approximately 1.6kb, although Matushchewski el al. (1996) 
report an approximately 1.5kb transcript. The exact size is probably between these 
two values. UbcD4 has a 1.8kb transcript. This is different from the expected size of 
950bp from the cDNA clone, perhaps due to the cDNA clone not being complete. 
There is no sequence matching the polyadenylation signal consensus in the genomic 
sequence at the site corresponding to the 3' end of the cDNA, while sequences at the 
5' end matching the TATA box, CAAT box and transcription start site are present 
(see chapter 3). This suggests the 3' end of the cDNA clone is not complete.
UbcDl and UbcD4 mRNAs appear to be present at higher levels across 
development than other E2s tested, although this has not been confirmed. They may 
be required at constantly high levels due to their putative roles as enzymes for bulk 
degradation of abnormal and short-lived proteins (Treier etal., 1992; chapter 3). A 
fairly constant level of UbcD4 mRNA is seen at all stages, again possibly due to the 
enzyme functioning in a wide variety of ubiquitin conjugation reactions. UbcD4 
cDNA hybridised to more than one band in developmental Northerns. The higher 
band of approximately 4kb also hybridised weakly in adult Northerns (figure 4.1), 
and may correspond to a transcript from a similar E2 enzyme, such as the putative 
E2 which hybridises weakly to UbcD4 cDNA in genomic Southerns (figure 3.13). 
Smaller bands may be due to degradation of RNA.
The highest levels of mRNA for E2s, other than UbcD4, were found at the 
larval stage of development. This implies an increase in activity of the ubiquitin 
pathway at this stage. In larvae, most larval tissue cells grow bigger without 
dividing, and the majority of cells determined to give adult tissue are segregated and
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organised into imaginal discs. The cell cycle is therefore altered, and transcription 
patterns within cells will be altered, but it is not obvious why an increase in protein 
degradation via the ubiquitin pathway would be necessary. Development of the giant 
fibre and retinal innervation of optic lobes occurs at late third larval and early pupal 
stages, so ben must be active, and this could be why high levels of ben mRNA are 
observed in larvae.
A lot of protein degradation takes place in the pupa, when larval tissues are 
destroyed and the adult forms from imaginal discs. Levels of mRNA from E2 
enzymes were seen to fall at the pupal stage, implying less activity of the ubiquitin 
system. This may be a function of the difficulty in obtaining good pupal RNA. Often 
pupal RNA was found to be degraded, possibly due to the amount of degradation 
occuring naturally in the pupa. However, were this to be the case, a-tubulin RNA 
would be likewise affected.
High levels of mRNA for UbcDl, UbcD2, ben 1.2kb transcript, and Dhr6 
transcripts were seen in 0-2hr embryos. This probably reflects maternal mRNA, as 
embryonic transcription would not have been expected to have taken place. The 
embryo may inherit mRNA for ubiquitin conjugating enzymes, in order to be able to 
rapidly degrade proteins, such as bicoid, which are necessary only transiently to 
establish embryonic axes. Dhr6 is the homologue of yeast RAD6. This protein has 
been seen to have a cell cycle component (Silver et al , 1992) so the Dhr6 transcripts 
^ay have a role in the early rapid nuclear divisions of embryogenesis.
Where adult females show high values for amounts of E2 mRNA, and where 
they are higher than adult males, this may reflect the amount of E2 transcripts in 
ovarian tissue. Follicle cells and nurse cells undergo programmed cell death 
(Mahowald and Kambysellis, 1980) so ubiquitin conjugating activity may be 
important here.
Matuschewski etal (1996) also found UbcDl and ben transcripts throughout 
development (results not shown). In contrast to my results, they found UbcD2 
appeared to be expressed exclusively at post-larval stages (results not shown). Both 
my results and those of Muralidhar and Thomas (1993) showed ben to have two 
transcripts of 1.2kb and 2.0kb. Euk Oh et al. (1994) found a 1.9kb transcript 
expressing throughout development with heightened expression at the pupal stage. 
However, they did not have a control to show equal loading of lanes on the gel.
Values for levels of mRNA do not necessarily reflect levels of enzyme 
activity, but mRNA levels from several E2 enzymes do vary across development. In
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particular, stages at which the ubiquitin system may be playing important roles are in 
larvae, 0-2hr embryos, and adult females, probably in the ovaries. For the variations 
in transcript levels to be determined as significant, these experiments must be 
repeated.
4.2.2 IN SITU HYBRIDISATION TO EMBRYO RNA:
E2 enzymes could have distinct developmental roles due to differential 
expression in different tissues. High levels of ben mRNA are restricted to the CNS, 
where it is known to be required, during development (Muralidhar and Thomas, 
1993). RNA i/i situ hybridisation to wholemount embryos was used to show where 
other E2 mRNAs were located throughout embryonic development.
4.2.2.1 UbcD1, UbcD2, ben and Dhr6 mRNAs become restricted to the 
central nervous system (CNS) during embryonic development:
Each E2 cDNA was labelled with DIG (see 2.3.4.1), and used as a probe to 
detect mRNA in situ, in fixed wholemount OrR embryos collected over 24hr. DIG is 
detected by anti-DIG antibodies which are conjugated to alkaline phosphatase. Sites 
of cDNA hybridisation were detected as a purple colour after developing with X- 
phosphate and NET. To confirm that signals were due to hybridisation of the probes, 
control in situ hybridisations were performed. When no probe was used, no staining 
was seen (figure 4.8). The positive control used wasfushi tarazu (DNA provided by 
Dr L. Brown), and this gave the expected 7 stripes (Carroll and Scott, 1985) of 
hybridisation (figure 4.9).
UbcDl mRNA was present throughout the embryo at pre-blastoderm and 
blastoderm stages (figure 4.10). This includes the 0-2hr embryo stage when UbcDl 
mRNA levels are seen to be high (figure 4.7). From gastrulation through to 
stomodeal invagination, mRNA is restricted to the presumptive mesoderm (figure 
4.10) and areas which will develop into the nervous system (3-6hr embryo). High 
levels of mRNA are restricted to the developing CNS at later stages (figure 4.10).
This is the pattern of expression seen for ben (Muralidhar and Thomas, 
1993), and the same pattern was observed when UbcD2 (figure 4.11), ben (figure 
4.12) and Dhr6 (figure 4.13) were used as probes.
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Fig. 4.8 OrR embryo taken through the RNA in situ process with no probe. 
Stage 7: midgut invagination.
Fig. 4.9 RNA expression pattern offtz. 
Stage 5: cell formation.














A= anterior; P= posterior; D= dorsal; V= ventral.
Fig. 4.10 UhcDI RNA in situ hybridisation to wholemount
OrR embryos.















A= anterior; P= posterior; D= dorsal; V= ventral.
Fig. 4.11 UbcD2 RNA in situ hybridisation to wholemount
OrR embryos.

















A= anterior; P= posterior; D= dorsal; V= ventral.
Fig. 4.12 ben RNA /// situ hybridisation to wholemount 
OrR embryos.















A= anterior; v= posterior; L>= dorsal; V= ventral.
Fig. 4.13 Dhr6 RNA in situ hybridisation to wholcmount
OrR embryos.
Stages from Wieschaus and Nusslein-Volhard, 1 ()S6.
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4.2.2.2 UbcD4 transcript can be detected all over wholemount embryos:
The UbcD4 transcript appears to follow the pattern of expression seen for 
other E2s, but at later stages the concentration within the CNS is not so strong; RNA 
can still be detected weakly all over the embryo (figure 4.14).
4.2.2.3 Discussion:
Transcripts from Drosophila E2 genes so far cloned all appear to undergo 
gradual restriction to the CNS during embryonic development, although this is less 
severe for UbcD4. This implies that the ubiquitin pathway has a role in nervous 
system development. The ben gene product may regulate nervous system 
development by axon growth cone guidance (Euk Oh et al, 1994), and appears to be 
specific for certain neurons. Perhaps each of these E2 enzymes is responsible for a 
different set of neurons. UbcD4 transcript can be detected throughout the embryo, 
reflecting its putative role as an E2 for bulk degradation of abnormal and short-lived 
proteins.
This study has only been carried out on five Drosophila E2 enzymes. There 


















A= anterior; P= posterior; D= dorsal; V= ventral.
Fig. 4.14 UhcD4 RNA /// situ hybridisation to wholemount
OrR embryos.






The full biological significance of protein ubiquitination can only be revealed 
by a molecular genetic analysis in a multicellular organism. In order to directly 
determine the role of the ubiquitin pathway, and E2 enzymes in particular, in the 
Drosophila life-cycle, it is necessary to determine mutant phenotypes for each gene. 
This chapter dicusses methods employed to create mutants.
5.2 P ELEMENT MEDIATED MUTAGENESIS (a brief summary):
P transposable elements can create mutations when inserted within a gene 
(for review see Engels, 1989). Mobilization of P elements already present in the 
genome can result in novel P element insertions. This formed the basis of the first 
two methods used in the attempt to create mutant E2 enzymes.
5.2.1 "SITE SELECTED" P ELEMENT MUTAGENESIS:
This experiment was performed in collaboration with Dr P. Emery in Dr K. 
Kaiser's laboratory at Glasgow University. The method employed is used to try to 
create mutants where genes have been cloned, but associated phenotypes are 
unknown, and is based on Kaiser and Goodwin (1990). Flies were screened for 
insertions in Dhr6, UbcDl, UbcD2, ben and uch-D .
If a transposon lies within or close to any genetic locus this can be detected 
by PCR amplification between a primer specific for the transposon and one specific 
for the gene of interest. As PCR amplification is very sensitive, one fly with such a 
configuration can be detected in a large excess of flies.
The crosses shown in figure 5.1 were performed, and 10,000 mutagenized 
flies with possible new insertions were produced. By PCR on DNA from progeny 
embryos, a fly with a required insertion was sought by subdivision of cages of 100 
flies and further rounds of PCR. Insertions both 5' and 3' to the genes were 
detectable due to using two primers for each gene (primers 16-28Y, A26 and A79), 
and the P element 31-mer terminal inverted repeat, present at both ends, as the P 
primer (P31). As many spurious bands were seen, gels were blotted and probed with 
a digoxygenin labelled probe from the gene of choice. Eventually single females, 
from cages of 10 identified to have possible required P insertions, were allowed to 


















SCREEN EMBRYOS FOR INSERTIONS
Fig. 5.1 Crosses for P element site selected mutagenesis. 
Birmingham 2 (Birm.2) flies have 17 defective P elements on chromosome 2, non-mobile 
due to internal deletions. They still have intact terminal inverted repeats, and so can be 
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SCREEN EMBRYOS FOR INSERTIONS
Fig. 5.2 Crosses for local jumping of the D19 P element into uch-D.
* = possible new insertions.
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Transposition rates of P elements (Engels, 1989), showed 10,000 flies should 
have been enough for a P element to be inserted on average every 1kb along the 
Drosophila genome. However, despite several possible P insertions being followed 
to the single fly stage, no insertions for the genes screened were detected in the 
mutagenized flies. The singed gene has a site where P elements frequently insert, and 
this had originally been used by Dr P. Emery to show P elements were transposing. 
However, this was found to be due to the singed primer used giving "false positive" 
bands in PCR amplifications with the P31 primer. P elements were not transposing at 
expected levels. This was shown by a radioactive P element DNA probe hybridising 
to the same size bands for Birm.2 and "mutagenized" flies in genomic Southerns, 
and experiments performed by Dr. P. Emery, with a new primer, detecting only 
1/5000 insertions in the singed gene.
5.2.2 LOCAL P ELEMENT JUMPING:
The efficiency of insertional mutagenesis can be significantly enhanced by 
using a P element located near the target of interest (Golic, 1994; Tower et al., 1993; 
Zhang and Spradling, 1993). From figures in these publications for rates of insertion, 
it was calculated 80 new P element insertions, 2-128kb from the original P element, 
should be created in a population of 2,000 flies in a local jumping experiment. 
Experiments were designed to try to jump P elements into the genes of interest using 
elements known to reside nearby.
The first local jumping experiment performed used the single P element in 
D19 flies, known to be 10-15kb away from the uch-D gene (Zhang, 1992; Zhang et 
al., 1993). The crosses used to jump this P element are shown in figure 5.2. 
Approximately 6,000 flies were screened for insertions in uch-D in the same way as 
for the "site selected" mutagenesis experiment. No insertions in uch-D were found, 
although control PCR amplifications showed the primers could amplify the correct 
regions of DNA, and genomic Southerns of single fly DNA extracts probed with 
32p_iabelled P element DNA, showed P elements were transposing.
As no insertions were produced for uch-D, and many of the P element 
insertions near to other ubiquitin pathway genes resided up to 300kb away, beyond 
the zone of enhanced transposition, no further local jumping experiments were 
carried out.
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5.3 MUTAGENESIS USING THE GAL4 ENHANCER TRAP SYSTEM:
5.3.1. INTRODUCTION:
P element mutageneses yielded no mutants, so another experiment was 
designed as a first step to determining the function of E2s in Drosophila. This 
involved altering the active site cysteine residue, and using the GAL4 enhancer trap 
system (Brand and Perrimon, 1993) as a means of expressing mutant E2s in a 
specific manner, to generate dominant phenotypes.
Expression of a dominant negative protein must be regulated as it may be 
lethal. The ability to restrict expression of the protein would be a useful means of 
analyzing its role in development, as if expressing the mutant protein everywhere 
was lethal, it might be more informative to view the effects of temporal or tissue 
specific expression. Driving expression of a gene from a heat shock promoter allows 
it to be turned on at a specific point in development by heat shocking the animal, but 
expression is ubiquitous. Also basal levels of expression are observed from heat 
shock promoters, and heat shock itself can induce phenocopies (Parkhurst and Ish- 
Horowitz, 1991). The use of tissue-specific promoters allows transcription to be 
restricted to a defined subset of cells, but this is limited by the availability of cloned 
and characterised promoters.
One way of avoiding the problems associated with heat shock or tissue 
specific promoters is to put the gene of interest under the control of a transcriptional 
activator in a different line of flies to those expressing the activator. Only when the 
lines are crossed is the target gene turned on in the progeny. Different lines can be 
made expressing the transcriptional activator in numerous specific patterns. Brand 
and Perrimon (1993) used the yeast GAL4 transcriptional activator in such a system, 
as GAL4 had been shown to be able to promote transcription in Drosophila (Fischer 
et al, 1988), and bound an optimized binding site with high affinity (Webster et al., 
1988).
O'Kane and Gehring (1987) fused the E.coli lacZ gene to the weak P 
transposase promoter, and showed this reporter gene could respond to neighbouring 
transcriptional regulatory elements. This was developed as an "enhancer trap" 
system, to identify transcriptional regulatory elements in the Drosophila genome. 
Fusing the GAL4 coding sequence to the P transposase promoter in a transformation 
vector, enabled Brand and Perrimon (1993) to create "enhancer trap" lines. These 
direct expression of GAL4 in a wide range of patterns, depending on the genomic 
site of integration of the vector. By cloning the gene of interest behind a promoter
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with five optimized GAL4 binding sites (the upstream activation sequence or UAS) 
on a P element transformation vector, and creating flies homozygous for this 
construct, lines are made where the gene can be expressed in a number of different 
patterns by crossing them to specific GAL4 enhancer trap lines (figure 5.3). To view 
the expression pattern of a particular GAL4 line, progeny from crossing it to a 
UASlacZ line are stained for (3-galactosidase expression.
The following section describes using GAL4 lines to overexpress mutant E2 
enzymes.
5.3.2. RESULTS:
Dhr6 is the Drosophila RAD6 homologue, and can functionally substitute for 
RAD6 in its DNA repair and U.V. mutagenesis functions (Koken et ai, 199la.). 
This implies it has the same functions in Drosophila, and may have an informative 
mutant phenotype. The ben mutant phenotype is known: the axon of the giant fibre 
neuron fails to form its terminal bend in the thoracic ganglion, and thus fails to 
connect normally to the tergal depressor of the trochanter motorneuron and ben~ flies 
are unable to make the jump response (Thomas and Wyman, 1984). Mutating ben in 
the same manner as Dhr6 therefore acts as a control for the whole process, as it can 
be seen if the giant fibre neuron is affected.
Changing the active site cysteine (Cys) residue of RAD6 to alanine or valine 
produced the same mutant phenotype as seen with rad6 null alleles (Sung et #/., 
1990), proving the active site cysteine residue of an E2 enzyme is essential. It was 
decided to mutate the active sites of Dhr6 and ben to alanine (Ala) and serine (Ser). 
Alanine is the same as the cysteine residue minus the side chain, and serine is 
approximately the same size as cysteine, but with a hydroxyl group instead of a 
sulphydryl group. Sullivan and Vierstra (1993) showed a stable adduct was formed 
between ubiquitin and the ubiquitin-conjugating enzyme ATUBC1+ when its active 
site was mutated to Ser. Ubiquitin became attached to the E2, but could not be 
removed for conjugation to target proteins.
Overexpression of both mutant proteins should result in a mutant phenotype 
as the alanine mutant should recognise and bind to target proteins, but might be 
unable to conjugate to ubiquitin. Serine mutant proteins should bind to both 
ubiquitin and the target proteins, but ubiquitin might be bound irreversibly, and so 
might not be transferred.
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Tissue-specific expression of GAL4 Transcriptional activation of Gene X
Fig. 5.3 The GAL4 enhancer trap system (after Brand and Perrimon, 1993).
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5.3.2.1. Site directed mutagenesis of Dhr6 and ben active site cysteine 
residues:
Oligonucleotides were designed for PCR amplification of the coding regions 
ofDhr6 and ben cDNAs, and to alter their active sites to alanine and serine. Outer 
primers were designed with 5' restriction enzyme sites (£o?RI on the 5' primer, Xhol 
on the 3' primer), so they could be cloned easily, and two nucleotides upstream of 
the restriction enzyme site, so enzymes cut efficiently. One outer primer for each 
gene was located upstream of the translation start sequence and downstream of the 
transcription start, and the other was just upstream of the polyadenylation site. The 
middle two primers were complementary to each other, and contained the mutated 
codon. The active site cysteine residues of Dhr6 and ben both have the codon TGC. 
The middle primers were designed to change this to GCC for alanine, the most 
common codon used in Drosophila for alanine, and AGC for serine.
Dr P. zur Lage carried out PCRs, as described in figure 5.4, with 25 cycles of 
25sec at 94°C, 35sec at 50°C, 2.5min at 68°C. Primary PCRs were performed with 
template DNA of plasmid containing the cDNA for each gene, and secondary PCR 
amplification used 0.5(il of both primary PCRs per lOOfil reaction. The wild-type 
coding regions of both genes were also amplified.
After PCR amplifications, Helena Thomaides, a Summer student in the 
laboratory, gel purified the fragments, digested them with Xhol and EcoRl and 
cloned them into pUAST (figure 5.5). This is the P element transformation vector, 
designed by Brand and Perrimon (1993), to direct GAL4-dependent transcription of 
a gene of choice. The coding sequence of the gene is subcloned into the polylinker, 
downstream of five, tandemly arranged, optimised GAL4 binding sites (figure 5.6). 
The plasmid also has P element ends, containing the inverted repeats where the 
transposase binds, which enable the piece of DNA between these ends to be moved 
into the Drosophila genome when P transposase is present. Genes cloned in this 
plasmid are transcribed from hspTO promoter regions upstream of the polylinker, and 
are polyadenylated due to the presence of the SV40 polyadenylation site. The mini 
white gene is present to enable transformed flies, carrying an insertion of this 
construct, to be identified by eye colours which range from pale yellow through to 
wild-type brick red in a white' background.
The six constructs created (both ben and Dhr6 with alanine, cysteine, or 
serine at the active site) had to be sequenced to show the active sites had been 




Fig. 5.4 PCR mutagenesis of the active site cysteine residue, shown in bold, of Dhr6lben. 
Dhr6 primers: 1 = D61; Ala2 = D62; Ala3 = D63; Ser2 = D6S2; Ser3 = D6S3; 4 = D64. 
ben primers: 1 = D31; Ala2 = D32; Ala3 = D33; Ser2 = D3S2; Ser3 = D3S3; 4 = D34. 
See Materials and Methods for oligonucleotide sequences.
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Fig. 5.5 Plasmid map of pUAST.
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PCR amplifications. The four primers used, for each gene, in the PCR amplifications 
were used for sequencing the constructs. The wild-type ben construct was found to 
have a mutation, so it was remade and sequenced. Oligonucleotides RK1 and RK2 
were used to sequence the active site regions of Dhr6 and ben respectively. The 
active sites were seen to be mutated as expected (figure 5.6) and no other mutations 
were found in the final pUAST constructs.
5.3.2.2 The creation of transformed lines:
P element mediated transformations were performed for all six constructs. 
The helper plasmid used was phs70A2-3wc, and in total, approximately 3,000 w * 1 18 
embryos were injected. Lines of the transformants produced were screened for P 
element insertions in Southern transfer experiments using 32p.iabelled 400bp Sail 
and 838bp HindIR gel purified fragments from pn;25.7wc, to hybridise to EcoPl 
digested genomic DNA. As expected, two bands hybridised to the probe in each case 
(see figure 5.10 for genomic Southerns of the Dhr6 transformed lines utilised in 
further experiments) as EcoRI should cut once within the insertion (see figure 5.8). 
Different lines are necessary for each construct, in order to show any effects are due 
to the construct, not the position of insertion. The number of different homozygous 
transformed lines produced is shown in table 5.1.
Only one line was obtained that had been transformed with Dhr6 Cys. This 
insertion was seen to be on the Y chromosome as no coloured eyed females were 
produced after sibling crosses. The eye colour of these male flies was pale yellow 
implying that the white gene was not being efficiently expressed, and this was 
presumably also true of Dhr6 . As it is necessary to have lines overexpressing wild- 
type DHR6 protein, in order to show that any phenotypes from overexpression of a 
mutant protein are due to the mutation itself, not just to overexpression of the protein 
perse, more Dhr6 Cys lines were necessary. An experiment was designed to jump 
the P element present on the Y chromosome in Dhr6 Cys linel, to different sites in 
the genome by exposing it to P element transposase as shown in figure 5.7. New 
insertions could be easily detected, as coloured-eyed females must carry new 
insertions.
The crossing scheme of figure 5.7 was designed so as to give secondary 
insertions in the same genetic background as primary transformants, so there could 
be no effects due to constructs being overexpressed in different genetic backgrounds. 








































































































































Table 5.1 Number of transformed lines with different 
insertions from injection of pUAST constructs.
Dhr6lben Cys = lines transformed with wild type constructs 
Dhr6lben Ala = lines transformed with Ala active site constructs 
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Males and females with new insertions 
SIB CROSS
HOMOZYGOUS LINES
Figure 5.7 Crosses performed to mobilize the Dhr6 Cys linel insertion from the Y chromosome. 
* = insertion, or possible new insertions; +(w) implies w-t chromosome, but from wl 118 flies. 
OrR= OregonR; Dr= drop; Bc= black cells; EIp= ellipse; Ki= kinked; Ubx= ultra bithorax; CyO= curly osier.
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construct provided transposase for jumping the Dhr6 Cys insertion. Females from 
cross 6b. could have had new insertions; 386 were screened, but all had white eyes. 
Transposition was shown to have been occuring, by probing a single fly genomic 
Southern of extracts from males from cross 6a. with a P element probe. New 
insertions were observed (results not shown).
As transposition had been taking place, more females with possible new 
insertions were created by crosses 5b. and 6b.. Six females with coloured eyes were 
produced from these crosses. Two coloured eyed females and one red eyed male 
were also seen in the progeny of cross 5b., implying that they had new insertions. 
This should be impossible for the females, as the A2-3 and Y chromosome P 
insertion had never been present in the same fly. However, the male could have A2-3 
and the Y insertion, and his red eyes could be produced by somatic transposition of 
the P element. Alternatively all three flies could have been produced by a single non- 
disjunction event creating a female with both the Y chromosome or part of the Y 
chromosome, and therefore the P insertion, and the A2-3 element.
To show the nine lines created had new insertions, genomic Southerns were 
probed with the same P element probe as before. Genomic DNA was digested with 
EcoRI which cuts once in the insertion (figure 5.8), so again two bands were 
produced for each insertion, corresponding to each P element end. Each insertion 
gives bands of different lengths according to the position of the flanking EcoRI sites. 
From the Southern it appeared Dhr6Cys line 2 has three insertions, Dhr6Cys lines 3, 
5, 6, 7 and 10 have two insertions, and Dhr6Cys lines 4 and 9 have one (figure 5.9). 
However, one weak band is present in six of the lines and corresponds in length to 
the smaller band produced from the Dhr6Cys line 1 Y chromosome insertion (figure 
5.10). Each lane of the genomic Southern contains DNA extracted from five males 
and five females, so the weak band could correspond to the Y chromosome P 
element in male flies, which has not been excised during transposition. The larger 
band for this insertion may be obscured by bands present in males and females 
which are more prevalent, so appear to hybridise more strongly to the probe. If this 
is true then Dhr6Cys lines 2, 5, and 6 may have two new insertions, and 3, 4, 7, 8, 9, 
and 10 may have one new insertion. This could have been tested by comparing male 
and female fly DNA hybridisation patterns to the P-element probe.
It was necessary to prove these P element bands did come from the Dhr6 
construct insertions, so the filter was stripped and reprobed with 32p_iabeneci Ohr6 
cDNA. Dhr6 is expected to hybridise to one band per insertion (figure 5.8), and also 
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Fig. 5.9 Genomic Southern to show P element insertions of lines 
produced by transposition of Dhr6Cys line 1 (Y) P element. 
Bacteriophage lambda DNA digested with Pstl was used as a size marker.
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Fig. 5.10 Genomic Southern to show P element 
insertions of Dhr6 lines produced by transformation. 
Bacteriophage lambda DNA digested with Hincl\\\ was used as a 
si/.c marker.
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within the gene. One band per insertion was seen to match when the autoradiographs 
were compared (results not shown), implying all lines do contain the Dhr6 Cys 
construct in different copy numbers and positions.
Figure 5.10 shows combined autoradiographs of Southerns probed with 
radioactive P element DNA for all the Dhr6 lines kept from transformation 
experiments. The Southerns from ben transformed lines are not shown. No ben Ala 
lines were created by transformation experiments, but as there were many Ser lines 
(table 5.1) to act as controls for the Dhr6 experiment, these were not considered 
absolutely essential.
5.3.2.3 Expression patterns of utilised GAL4 lines:
The pattern of expression of GAL4 in enhancer trap lines can be detected by 
crossing each GAL4 line to a strain containing the E.coli lacZ gene under the control 
of the GAL4 upstream activating sequence (UAS/acZ flies) and staining the progeny 
for (3-galactosidase expression. This was carried out, for embryonic stages, for all 
GAL4 lines used in later experiments:- heat shock (h.s.) GAL4 line, C22C and 
Kriippel (Kr) 5Y. Before staining, h.s.GAL4 x UAS/acZ embryos were collected on 
apple juice agar plates, and heat shocked at 39°C on a heating block for 30min. 
UAS/ocZ embryos were also stained as a control.
No P-galactosidase expression was detected in UAS/acZ embryos (figure 
5.11 A.), implying that there is no basal level of lacZ transcription in these flies. The 
positive control of Kr 5Y x UASlacZ embryos showed P-galactosidase expression in 
a broad band across early embryos (figure 5.1 IB.) as expected (Hoshizaki, 1994). 
The Kr gene product is expressed in a narrower band, and presumably this is how the 
GAL4 protein is expressed, but the p-galactosidase band is larger due to activation 
of lacZ expression by the GAL4 protein, and sequential diffusion of both GAL4 and 
P-galactosidase proteins.
Embryos from the h.s. GAL4 x UAS/acZ cross stain for p-galactosidase in all 
tissues throughout embryonic development when embryos are heat shocked (figure 
5.12A.). This implies that GAL4 is expressed everywhere. A similar pattern of P- 
galactosidase staining is seen in progeny embryos of the C22C x UAS/acZ cross; P- 
galactosidase and therefore also GAL4 are expressed throughout embryogenesis in 




Fig. 5.11 Expression patterns of GAL4 lines.
Embryos were stained for p-galactosidase after crossing to UASlacZ. 
A. UAS lacZ control (stage 7: midgut invagination). 
B. Kr 5Y (stage 3: pole cell formation. 




Embryos were stained for p-galactosidase activity 
after crossing to UAS/wZ. 
A. h.s. GAL4 (top= stage 3: pole cell formation; 
bottom= stage 16: condensation of C.N.S.). 
B. C22C (top= stage 9: stomodeal plate formation; 
bottom= stage 16: condensation of C.N.S.).
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5.3.2.4 Transformed Dhr6 lines overexpress DHR6 protein:
To determine whether protein was overexpressed from the transgenes in 
transformed lines, proteins were induced and levels of DHR6 protein were followed 
using a polyclonal DHR6 antibody raised against a GST fusion protein.
To induce Dhr6 expression, all the Dhr6 lines were crossed to the h.s. GAL4 
line at 18°C to minimise basal expression from the heat shock promoter, and adult 
progeny were heat shocked at 39°C for 30 mins. In order to allow time for 
expression of both the GAL4 transcriptional activator, and the DHR6 protein under 
GAL4 control, flies were left to recover at room temperature for 3 hours. The h.s. 
GAL4 insertion is on the third chromomsome and is balanced by TM3 with Stubble 
(Sb) as the dominant marker. Both Sb+ and Sb~ flies were kept frozen at -70°C, until 
protein extracts were made by Dr P. zur Lage.
Dr P. zur Lage ran total protein extracts on SDS PAGE gels with 
approximately 110|ig protein loaded per lane, and DHR6 was detected on Western 
blots by a polyclonal DHR6 antibody (at a dilution of 1/1000), made in rabbits. The 
results of detection of the primary antibody by a secondary antibody and 
chemiluminescence (Dr P. zur Lage; see Materials and Methods) are shown in 
figures 5.13 and 5.14. Overexpressed bands of the correct size of 16.6kDa can be 
seen for all lines except the Dhr6 Cys Y insertion (linel), and Dhr6 Ala line 2. 
Comparing Sb+ flies where GAL4 is being expressed, and Sb~ flies where there is no 
GAL4, shows there is overexpression of the protein in the presence of GALA In Sb~ 
flies a much weaker band is visible from expression of the genomic copy of Dhr6.
The DHR6 antibody binds to two proteins with different molecular weights in 
Ser lines. The lower band is the same size as the band for the Ala lines, and 
presumably corresponds to the overexpressed mutant DHR6 protein. When an E2 
enzyme has Ser at the active site, ubiquitin can become irreversibly bound (Sullivan 
and Vierstra, 1993), so the higher molecular weight band could be the E2 bound to 
ubiquitin. In order to test this hypothesis, Dr P. zur Lage ran the same samples on 
two gels and performed Westerns using the DHR6 antibody for one gel, and a 
polyclonal ubiquitin antibody (Novocastra Laboratories Ltd., at a 1/500 dilution) to 
detect ubiquitinated proteins on the other gel. The results are shown in figure 5.15. 
The DHR6 antibody bound to the same overexpressed bands for the Ala and Ser 
lines as before, but only the higher molecular weight overexpressed band in Ser lines 
was bound by the ubiquitin antibody. It therefore appears DHR6 with Ser at the 
active site does bind to ubiquitin for a long period of time, and the interaction may 
be irreversible.
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Fig. 5.13 Reaction of anti-DHR6 antiserum with extracts of 
transformed flies from Dhr6Cys lines in the presence or absence 
of GAL4.
Approximately 110|ig protein were loaded per lane. The anti-DHR6 antibody
was used at a 1/1000 dilution.
C = 6his DHR6 control (DHR6 protein expressed with a 6 his tag to allow
purification on a nickel column).
Higher molecular weight bands present in the lower picture were also detected
by preimmune serum.
Cl -CIO = Dhr6Cys lines 1-10.
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6hisDHR6 
DHR6
Fig. 5.14 Reaction of anti-DHR6 antiserum with extracts 
of transformed flies in the presence or absence of GALA 
A. Dhr6Ala lines. 
B. Dhr6Ser lines.
Approximately 1 lOjug protein were loaded per lane. The anti-DHR6 
antibody was used at a 1/1000 dilution.
C = 6his DHR6 control (DHR6 protein expressed with a 6 his tag to 
allow purification on a nickel column). 
Al-A4 = D/zr6Alalines 1-4. 
Sl-S5 = D/zr6Ser lines 1-5.
































































































































































































































































































































































































































5.3.2.5 BEN protein was not overexpressed in the transformed lines:
To detect overexpression of BEN protein, all ben transformed lines were 
crossed to the h.s. GAL4 line, and treated as described above for detection of DHR6 
protein in Dhr6 lines. Dr P. zur Lage performed Western blots of protein extracts 
from these flies, but was unable to detect overexpression of the protein (results not 
shown).
It is not known why the ben lines did not overexpress BEN protein, but 
experiments with them were discontinued.
5.3.2.6 Overexpressing mutant DHR6 in the pattern of GAL4 line C22C, 
is lethal:
In order to investigate the effects of overexpressing mutant DHR6, lines 
expressing GAL4 in different patterns were used. The C22C GAL4 line expresses in 
all tissues throughout embryonic develoment (figure 5.12B.). The expression 
patterns after embryogenesis are unknown, but this line was used to show the effect 
of high level expression of DHR6 active site mutants throughout the embryo.
The P element GAL4 insertion in C22C is on the second chromosome, and is 
balanced by the SM5 chromosome which carries the dominant marker curly (Cy\ 
When transformed Dhr6 lines were crossed to C22C, a 1:1 ratio of Cy~ to Cy+ flies 
was expected if overexpression of mutant DHR6 was not lethal (figure 5.16). Any 
Cy+ flies produced could be examined for phenotypes due to overexpression of 
mutant DHR6 protein. The results are shown in table 5.2, and the method for 
statistical analysis on this data is described in Appendix n.
When w 1H8 was crossed to C22C, there was no significant difference in the 
ratio of Cy~ to Cy+ progeny between males and females, or from the expected 1:1 
ratio of total numbers of Cy~:Cy + flies. The same was true for the cross to Dhr6A\a 
line 2 where there was no overexpression of mutant protein. There was no significant 
difference between the ratio of Cy to Cy+ progeny from crosses to wl 1 18 and the 
two transformed lines not overexpressing DHR6 protein (Dhr6A\a line 2 and 
Dhr6Cys line 1), although the progeny of the Dhr6Cys linel cross contained 
significantly more Cy+ than Cy flies. This was also true when the results for all 
three lines were pooled. The Cy flies from C22C crosses where there is no 
overexpression of DHR6 may be less viable than the Cy+ flies, simply due to the 

















































































































































Table 5.2 Results of C22C crosses to Dhr6 transformed lines.
161
There was no significant difference between the ratios of Cy~:Cy + progeny 
from crosses of C22C to the two Dhr6Cys lines with insertions on the X 
chromosome. The ratio of Cy~:Cy + progeny from these crosses was not significantly 
different between sexes, or from 1:1. Overexpressing wild-type DHR6 in the pattern 
of C22C in crosses to Dhr6Cys lines with autosomal insertions (lines 3-9) did not 
result in a significant difference from the expected 1:1 ratio of Cy~:Cy + flies, except 
for the females from Dhr6Cys lines 3 and 9. In crosses to these lines, there were few 
or no Cy+ females produced. As this was seen for just two lines out of nine, and only 
females are affected, it seems unlikely the affect is due to overexpression of wild- 
type DHR6 protein, and could be due to the position of insertion of the construct in 
the genome. Lines overexpressing wild-type DHR6 protein when crossed to C22C 
did not result in progeny with a significantly different ratio of Cy~:Cy + flies from 
control lines with no overexpression. Again more Cy+ than Cy~ flies were seen 
overall, and Cy+ progeny had no mutant phenotype. This implies that overexpressing 
wild-type DHR6 protein throughout all tissues in embryogenesis has no effect on 
development of flies.
No difference was detected between the progeny from crosses to Dhr6 Ala 
and Ser lines, where no Cy+ progeny were observed when either type of mutant 
DHR6 protein was overexpressed (table 5.2). As males from the transformed lines 
were crossed to C22C virgin females, X chromosome insertions could not be 
inherited by male progeny. The ratio of Cy~ to Cy+ males in progeny from Dhr6Ala 
line 4 and Dhr6Ser lines 2 and 3 is therefore not significantly different from 1:1, or 
from the results for lines not overexpressing, or overexpressing wild-type, DHR6 
protein.
The phenotype for overexpression of Ala or Ser active site mutants of DHR6 
protein, in the pattern of the C22C GAL4 line, is lethality.
5.3.2.7 Lethality of overexpression of mutant DHR6 protein may act at 
the pupal stage:
In order to investigate when overexpression of mutant DHR6 protein was 
lethal, all transformed lines were crossed to a h.s.GAL4 line and heat shocked for 
different lengths of time at different stages of development. Flies were kept at 18°C 
and tipped into fresh vials every other day. Three sets of seven vials for each cross, 
representing progeny from particular stages, were collected, and one set of each was 
heat-shocked in a 39°C water bath for 15min, 30min or 45min.
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The h.s.GAL4 insertion is on the third chromosome and is balanced by TM3, 
which carries the dominant marker stubble (Sb). Any Sb+ progeny from these 
crosses should be overexpressing mutant protein. The full results of this experiment 
can be seen in Appendix I, and the method for statistical analysis on the data is 
presented in Appendix II. The expected ratio of Sb~ to Sb+ flies is 1:1 if there is no 
lethality (figure 5.17). Statistical analysis was performed in order to see whether data 
for different lines and different variables could be pooled. This was found to be the 
case for some lines and variables, and pooled results for this experiment are 
presented in table 5.3. I also tested for significant differences in Sb~:Sb+ ratios 
between male and female progeny, and to see whether the variables of length of time 
for heat shock, and developmental stage at which progeny were heat shocked, 
affected the ratio of Sb~:Sb+ flies produced. Finally, Sb~:Sb+ ratios were compared to 
the expected 1:1 ratio. Overexpression of mutant DHR6 protein was again seen to 
affect the viability of flies, although some Sb+ flies were seen, so lethality was not 
absolute (table 5.3).
The ratio of Sb~:Sb+ progeny was not significantly different between sexes 
for all crosses except those to Dhr6A\a and Dhr6Ser transformed lines with X 
chromosome insertions. In Sb+ male progeny from crosses to these lines, mutant 
DHR6 protein is not overexpressed, so significantly more Sb+ males than females 
are produced. No significant difference was seen between Sb+ males and females 
from crosses to Dhr6Cys lines with insertions on the X chromosome; overexpression 
of wild-type DHR6 protein did not affect viability. Overexpression of mutant DHR6 
protein had the same effect in male and female flies.
Control crosses showed heat shocking progeny from crossing the h.s. GAL4 
line to a line with no transgene or to lines with wild-type Dhr6 transgenes under 
control of the UAS, did not result in a 1:1 ratio of Sb~:Sb+ flies. Overall for both 
types of cross, a significant excess of Sb+ flies were produced probably due to a 
reduction in fitness of flies carrying the Sb~ mutation. The results for Dhr6Cys lines 
were significantly different from those for w 111 ^, but there appeared to be no 
lethality due to overexpression of the wild-type DHR6 protein.
There was lethality when either type of mutant DHR6 protein was 
overexpressed, and no matter at what stage progeny were heat shocked, even at late 
pupal stages, an effect on Sb~:Sb+ flies was seen. Some Sb+ flies were produced, 
probably because the heat shock did not result in uniform levels of expression of 









Figure 5.17 h.s.GAL4 crosses to UAS Dhr6 transformed lines.
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Table 5.3 Results of h.s GAL4 crosses to Dhr6 transformed lines. 
Data for each sex, and for some Dhr6 Ala, Cys and Ser lines have been pooled (see 
Appendix II).
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been high enough to kill them. The Sb+ flies surviving did not show any obvious 
mutant phenotype.
The ratio of Sb~:Sb+ progeny from crosses to Dhr6Ala. and Dhr6Ser lines 
differed significantly from that from progeny of crosses to Dhr6Cys lines, and from 
a 1:1 ratio, as very few Sb+ flies were produced. Significantly more Sb+ flies were 
present in the progeny from crosses to Dhr6Ser lines than from crosses to Dhr6Ala 
lines. This implies that overexpressing a mutant DHR6 protein with Ser at the active 
site is less severe in its effects on the fly than overexpressing an Ala active site 
mutant.
Varying the length of time progeny from crosses to Dhr6Ala and Dhr6Ser 
lines were heat shocked produced significant differences in the ratio of Sb~:Sb+ flies, 
as significantly more Sb+ flies were produced from a 15min heat shock than from 
heat shocking for 30 or 45 min. This is probably due to more mutant protein being 
produced when flies are heat shocked for longer periods of time.
Although the stage at which progeny from crosses to Dhr6Ala and Dhr6Ser 
lines were heat shocked produced significant differences in the ratio of Sb~:Sb+ flies, 
there appeared to be no pattern to this effect, and this could have been due to the 
same factors that also made the stage at which progeny were heat shocked a 
significant variable for control crosses. As significantly less Sb+ flies were produced 
even when progeny were heat shocked at late pupal stages, lethality of 
overexpression of mutant DHR6 protein appeared to act very late in development.
Uneclosed pupal cases were observed in vials from h.s. GAM crosses to 
Dhr6Ala and Dhr6Ser lines, from heat shocking progeny at each stage. When these 
were dissected, fully formed white adults were found inside. It appeared that the flies 
were unable to eclose. A study on the percentage of flies eclosing after heat shocking 
for 30min at 39°C at each stage, was performed on crosses to Dhr6A\a line 1, 
Dhr6Al& line 3, and w^^. The full results of this experiment and method of 
statistical analysis performed on the data are presented in Appendix II. The stage at 
which progeny were heat shocked did not significantly alter the percentage of flies 
eclosing, so numbers for each stage were pooled (table 5.4). The percentage of 
eclosion was not significantly different between the progeny from crosses to the 
Dhr6Ala lines, but was significantly different between the progeny of these two 
crosses, and those from the cross to w* 11$ This shows a burst of overexpression of 
mutant DHR6 protein at different stages of development results in death of 
Drosophila at the late pupal stage, but does not exclude the possibility of lethality 


























Table 5.4 Percentage of flies eclosing, after heat-shocking progeny from 


















Table 5.5 Sb~ and Sb+ flies produced when progeny from Dhr6 lines 
crossed to h.s.GAL4 was not heat shocked.
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the C22C experiment, but here eclosion was always greater than 83%, so in these 
crosses Drosophila overexpressing mutant DHR6 protein are dying at an earlier 
stage.
In order to show the effects on the Sb~:Sb+ ratio were due to heat shock 
induced overexpression of DHR6, progeny from crosses of Dhr6 transformed lines 
to the h.s. GAL4 strain were scored without having been heat shocked. Appendix n 
contains the method used for statistical analysis on the data and full results of this 
experiment. The results are also presented in table 5.5. Significant differences in the 
ratio of Sb~:Sb+ flies between the two sexes were only seen for progeny from the 
cross to Dhr6Ma line 4 which has an X chromosome insertion. The results from this 
experiment showed that there was a significant reduction in Sb+ flies which had the 
ability to overexpress mutant DHR6 protein under heat shock conditions. In the 
progeny from the cross to w^^ there were again significantly more Sb+ than Sb~ 
flies. Many Sb+ flies were present in the progeny from crosses to the transformed 
lines (table 5.5), but the heat shock promoter probably allows basal levels of 
expression of mutant DHR6 protein, and this significantly reduced the number of 
Sb+ flies, though not to levels seen when progeny were heat shocked. One reason 
why Drosophila were seen to die at the late pupal stage, no matter at what 
developmental stage they were heat shocked, could be due to the basal levels of 
expression of mutant DHR6 protein.
5.3.2.8 Lethality of overexpression of DHR6 in the pattern of C22C may 
act at many stages:
As overexpression of mutant DHR6 protein in the pattern of the C22C GAL4 
line resulted in death of all Drosophila, approximately 50 embryos from crosses of 
C22C to selected Dhr6 transformed lines and w 1 1 18 were lined up and scored for 
survival through development to identify the stage at which they died. 
Approximately half of the embryos, from crosses to Dhr6A\a and Dhr6Ser 
transformed lines with autosomal insertions, were expected to not be overexpressing 
mutant DHR6 protein, as the C22C insertion is balanced by SM5. Embryos which 
carried the SM5 chromosome were expected to survive to become Cv" flies. 
Embryos were collected from cages and lined up on coverslips in the same manner 
as for creating transgenic lines, but without dechorionation. In order to view
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development of embryos, they were covered with halocarbon oil which makes the 
chorion transparent. Any larvae hatching were put into vials of 10-20 per vial. 
Embryos which did not hatch were scored for their degree of development using the 
presence of certain morphological structures as evidence for development to a 
particular stage. The presence of a midgut showed some development had taken 
place, and embryos which did not have a midgut were grouped as blastoderm stages. 
Development of the posterior end was scored by the presence of Malphigian tubules, 
and the presence of mouthparts showed normal development had occured at the 
anterior end of the embryo. Some embryos appeared to develop into wild-type larvae 
which were not able to hatch, and these were scored as fully formed larvae. The 
development of the hatched larvae was scored at the pupal stage, and any adults 
produced were scored as Cy~ or Cv+ . The results of this experiment are shown in 
tables 5.6 and 5.7.
Some lethality was seen at each stage tested (table 5.8). The Dhr6 gene 
product is probably involved in DNA repair, so when a mutant DHR6 protein is 
present, the death of Drosophila may be due to the accumulation of mutations. This 
could explain why Drosophila die at different stages of development. A lot of death 
occured at embryonic stages, but the same effects were also seen for crosses to 
yylllS This was not due to the process of lining up the embryos, as when 50 
homozygous w^ ̂  embryos were put through this process they all hatched. This 
implied that the SM5 chromosome was causing embryonic lethality. Heterozygote 
viability of Drosophila carrying the SM5 chromosome is not as good as that of flies 
carrying the SM1 chromosome 2 balancer (Roberts, 1986). Even though no flies 
were produced when mutant DHR6 protein was overexpressed as expected, no 
statistical analysis was performed on the data from this experiment, as many 






















































































































































Table 5.7 Degree of embryonic development seen in the progeny, from C22C 














































Table 5.8 Percentages of the total progeny from crosses of C22C to transformed 
lines dying at each stage of development (to the nearest percent).
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5.3.2.9 A ben transformed line had mosaic eyes due an insertion near 
heterochromatin:
One ben Cys line showed mosaicism for eye colour when the insertion was 
homozygous (figure 5.18). Heterozygotes showed a uniform pale yellow eye colour 
implying that the miniwhite gene was in a position in the genome where it was 
unable to be fully expressed. The mosaicism could have been due to position effect, 
as if the insertion was in a heterochromatic region, in some cells 
heterochromatinisation could proceed through the insertion, resulting in poor 
expression of the w gene.
In order to test this hypothesis, polytene chromosome squashes were made 
from salivary glands of larvae from this line, and a biotinylated ben cDNA probe 
was hybridised to them. The ben locus has been mapped to 12D1-2 (Thomas and 
Wyman, 1984; Matuschewski etal, 1996) on the X chromosome. In figure 5.19 ben 
cDNA can be seen to hybridise to 12D1-2 on the X, and also to 83B-C1 (Lefevre, 
1976) on chromosome 3R, in the benCys line (figure 5.19). This shows the position 
of the insertion is near to heterochromatin at the chromocentre. A breakpoint in 
heterochromatin can affect expression of distant euchromatic genes, and when 
chomosome rearrangements were used to study the range of influence of 
heterochromatin, it was seen to vary between rearrangements (for review see Weiler 
and Wakimoto, 1995). Position effect variegation has been seen to act in an extreme 
case nearly 2Mb away from the breakpoint. The insertion in the benCys transformed 
line is approximately 66 polytene chromosome bands away from heterochromatin, 




Fig. 5.18 Photographs of benCys line 2 flies heads mounted in Ringers solution 
(taken by William Sauer, a Summer student in the lab.). 
A. Heterozygous for the insertion; uniform pale yellow eyes. 








Fig. 5.19 Hybridisation of ben cDNA to benCys Iine2 larval salivary gland polytene 
chromosomes.
A. Position of w-t ben gene, and P insertion are visible. 
B. Centromeric regions to show P insertion. 
Chromosomes were photographed under bright field optics.
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5.3.3 DISCUSSION:
Dhr6 is the RAD6 homologue, so probably has roles in DNA repair 
mechanisms. If the DHR6 protein is mutant this implies that Drosophila may die at a 
stage when the lack of repair to damaged DNA becomes lethal. Overexpressing 
mutant DHR6 protein gives a lethal phenotype. It seems likely there is a threshold 
level of mutant protein expression, above which Drosophila will die. In the C22C 
crosses, there should be a constant high level of overexpression of mutant protein at 
least throughout embryogenesis. Probably all Drosophila die due to this level of 
overexpression being over the threshold level.
Some flies survive the overexpression of mutant DHR6 in the h.s.GAL4 
experiment because there is only a pulse of high level expression, which may not be 
above the threshold level in all flies. There is also low level expression of mutant 
DHR6 protein due to the h.s promoter being leaky. Overexpression of mutant DHR6 
protein in the h.s.GAL4 experiment resulted in death of Drosophila at the late pupal 
stage, which could also be the stage when the lethality of having a mutant Dhr6 gene 
acts. Dhr6 is expressed in the C.N.S. of developing embryos (chapter 4), as is ben, 
and ben~ flies also have an increased likelihood of failing to eclose (Edgecomb et al, 
1993): 60% of mutant pupae cannot eclose and often die during emergence (Euk Oh 
et al., 1994). Perhaps it is defects in the central nervous system, not the lack of DNA 
repair functions, that leads to flies expressing mutant DHR6 protein being unable to 
eclose.
These experiments show the DHR6 protein probably performs essential 
functions, as overexpression of mutant DHR6 protein is lethal. Lethal effects could 
be due to the overexpressed protein binding to and depleting other factors within 
each cell, rather than to failure to mediate degradation of particular substrate 
proteins, but both types of mutant protein had similar effects, and when the wild- 
type protein is overexpressed it has little or no affect on Drosophila development, so 
this seems unlikely. The active site Cys is necessary for these proposed vital 
functions, as this is the only part of the protein that was altered and this implies that 
DHR6 functions are mediated by it acting as an E2 ubiquitin conjugating enzyme. It 
appears no other residue in DHR6 can act as a site for ubiquitin attachment and 
exchange, and ubiquitin probably binds irreversibly to Ser when this residue is 
present at the active site. Overexpressing a mutant DHR6 protein with Ser at the 
active site was less severe in its effects on Drosophila than Overexpressing an Ala 
active site mutant in the crosses to the h.s. GAL4 line. One possible explanation for 
this observation is that if ubiquitin is bound irreversibly to the Ser active site in most
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of the overexpressed mutant DHR6 protein, pools of free ubiquitin in cells may be 
depleted, which in turn could result in overexpression of ubiquitin from ubiquitin- 
encoding genes. If there was a ubiquitin deficiency, the Ser mutant would have been 
expected to have a more severe phenotype than the Ala mutant. If overexpression of 
ubiquitin does occur, it may be able to slightly suppress the lethality of 






The role of E2 enzymes in the life cycle of yeast has been partially 
determined for most known ubiquitin conjugating enzymes (see 1.7), and shows 
areas of yeast development and metabolism in which ubiquitination is important. 
The full significance of protein ubiquitination in a multicellular organism is not 
known, and work presented in this thesis attempted to address this problem by 
investigating the ubiquitin conjugating enzymes of Drosophila melanogaster.
A new E2, the Drosophila homologue of bovine E225K and possibly also 
UBC1 of S.cerevisiae, has been discovered. All known E2s were found to express 
mainly in the developing C.N.S. in embryos, suggesting a role for ubiquitin - 
dependent proteolysis in development of the nervous system. High levels of mRNA 
were found for most of these E2s in adult females, probably due to ovarian 
expression, early embryos and larvae. The ubiquitin system may be particularly 
important at these stages of development (see below).
At the start of the project, E2s were thought to be the major enzymes of the 
ubiquitin system for substrate selection, so it was likely any specific developmental 
role would involve a specific E2. Multiple ubiquitin conjugating enzymes had been 
discovered in each organism investigated, and yeast E2s were seen to have different 
functions. E2s are involved in recognising substrates for ubiquitination, often via C- 
terminal extensions to the UBC domain (Gosink and Vierstra, 1995), but where a 
class IE2 is necessary for ubiquitination, a ubiquitin protein ligase (E3) may also be 
involved, and may be the enzyme recognising and binding to the substrate. The C- 
terminal extensions of class n E2s may be involved in substrate selection by binding 
a particular E3. E3s are more prevalent than previously thought, and bind tightly to 
substrates. They are much larger proteins than E2s, so have more domains which 
could be involved in substrate recognition. Different E3s may bind different 
substrates, and they are more divergent in sequence than E2s, which all show at least 
35% identity across their UBC domains. The "hect" domain E3s become linked to 
ubiquitin in the same way as E2s (Huibregtse et al., 1995) and show homology 
across the C-terminal domain, necessary for thiolester formation with ubiquitin, but 
have divergent N-terminal domains. Ubiquitin is transferred directly to the protein 
substrate from "hect" ubiquitin protein ligases (Scheffner et al, 1995), and E2 
enzymes may only be involved in these ubiquitinations by recognition of, and 
transfer of ubiquitin to, the E3. Some E2s may function solely as intermediates in the 
transfer of ubiquitin between El and E3 enzymes, or substrate selection may be a
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function of complexes between E2 and E3 enzymes. The substrate specificity of 
some E2s may be due to binding to a subset of E3s, each of which recognises a 
specific substrate. A large number of E3s would therefore be expected to be present 
within a eukaryote, and may have more developmental and/or tissue restricted 
expression than E2 enzymes.
6.2 UBIQUITIN IN DROSOPHILA DEVELOPMENT:
To allow specific spatial and temporal distribution of proteins which are key 
regulators of development, highly selective degradation is required. Drosophila 
melanogaster is a model system for development, and a lot is known about the 
proteins expressed early in embryogenesis, necessary to set up the embryonic axes. 
One example is the anterior determinant bicoid, whose gene product has a graded 
distribution in the embryo, dependent on its short half-life (Driever and Niisslein- 
Volhard, 1988). Ubiquitin-dependent degradation may control BICOID half-life, and 
has a proposed role in dorsal-ventral axis formation in the degradation of CACTUS 
protein to allow the DORSAL transcription factor to enter nuclei on the ventral side 
of embryos. Cactus and dorsal are homologues of 1KB and NF-KB respectively. 
Activation of NF-KB, in response to extracellular signals, is controlled by ubiquitin 
dependent degradation of several proteins (see 1.11.1.2). Other proteins involved in 
axis formation (review: St Johnston and Niisslein-Volhard, 1992) probably have 
short half-lives controlled by the ubiquitin pathway, resulting in spatial restriction to 
their necessary domains of expression.
Development of distinct tissues and cell types usually requires alterations in 
the protein composition of the cell, which occurs by protein synthesis and regulated 
degradation. Proteasomes undergo changes in subunit pattern during Drosophila 
development (Haas and Kloetzel, 1989): the simplest patterns are in early embryos, 
and subunit pattern becomes increasingly complex with ongoing development. The 
increase in complexity of proteasomes may be due to an increase in the number of 
cell types. Ubiquitin-dependent degradation also seems essential for programmed 
cell death (Schwartz etal., 1990; Haas etal., 1995).
6.2.1 OVARIAN AND EMBRYONIC DEVELOPMENT:
Adult females contain higher levels of E2 mRNA than males (see chapter 3), 
and this is probably due to levels of expression in the ovaries. The proteins
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controlling the axes in ovaries and polarity of developing oocytes are probably 
controlled in the same way as those for embryonic axes (see above), so E2 
expression may be important. The fat facets protein is required for embryos to reach 
cellularization (Fischer-Vize et al., 1992), and is localized at the posterior pole of 
oocytes, dependent on oskar, a gene necessary for posterior determination. The 
anchoring of a UCH2 family ubiquitin carboxyl terminal hydrolase to the posterior 
of the developing embryo suggests a role in cleaving ubiquitin from protein 
substrates that are degraded specifically at the posterior pole.
Expression patterns of uch-D suggest a role in oogenesis and early 
embryogenesis (Zhang et al, 1993), and mRNAs from ubiquitin monomer genes 
DUb52 and DUbSO are also abundant in ovaries (Cabrera et al., 1992; Barrio et al., 
1994). There is a high rate of ribosome synthesis during Drosophila oogenesis, and 
the fusion genes encode ribosomal proteins as well as ubiquitin. High levels of 
UCHD may be necessary to cleave the primary products of DUb52 and DUbSO, to 
allow ribosome assembly, and a high level of free ubiquitin to be present for the start 
of embryonic protein synthesis.
Levels of E2 mRNAs are high in early embryos. Proteasomes are also 
thought to be important for early stages of embryogenesis as they can be isolated 
from transcriptionally inactive embryos (Haass and Kloetzel, 1989) and synthesis of 
the 20S proteasome is developmentally regulated with the highest concentrations in 
embryos (Udvardy, 1993). Ubiquitin-dependent degradation in embryos may be 
involved in cell proliferation and morphogenesis; proteasomes accumulate in 
gastrulation in cells of the folds involved in morphogenetic movements (Klein et al., 
1990).
Ubiquitin dependent proteolysis controls the cell cycle, so alterations in 
ubiquitination might be responsible for the first ten mitotic divisions in the embryo 
which are fast and occur in a syncitium. Cyclins are not degraded during the first 
seven cell cycles (Edgar et al, 1994), but there is a progressive increase in 
degradation of cyclins at mitosis during cycles 8-13. During interphase 14, 
programmed degradation of maternal STRING protein leads to inhibitory 
phosphorylation of CDC2 and cell cycle arrest. String gene product is required for 
mitosis (Edgar and O'Farrall, 1989) and acts as a specific CDC2-activating 
phosphatase. As STRING is a specifically degraded protein controlling the cell 
cycle, it seems likely that it is degraded via the ubiquitin pathway. Pulses of zygotic 
string transcription trigger mitoses 14-16 (Edgar et al., 1994), so the protein must 
have a short, tightly controlled half-life, and the S.pombe STRING homologue
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CDC25 is degraded via the ubiquitin pathway (Nefsky and Beach, 1996). Control of 
early embryonic cell divisions may require activity of E2s, which could be one 
reason for the observation of high levels of mRNA for most known Drosophila E2s 
at this stage. In particular, both transcripts of Dhr6 are abundant. Dhr6 is the 
Drosophila homologue of yeast RAD6, which may have a cell cycle function, as 
RAD6 UBC domain can substitute for that of CDC34 (Kolman et al., 1992; Silver el 
al, 1992).
6.2.2 LARVAL DEVELOPMENT:
UbcDl, UbcD2, ben and Dhr6 2.1kb transcripts are abundant in larval stages 
of development. The hyperplastic discs (hyd) gene product has a role at this stage in 
controlling imaginal disc growth (see 1.8.4). The HYD protein is a "hect" domain E3 
which may bind to the ben gene product (Amani and Shearn, 1996). Transcription of 
ben may be enhanced in order for the encoded protein to bind to HYD, and mediate 
ubiquitination of substrate proteins in imaginal discs. The interaction between BEN 
and HYD may be specific for this function. The hyd transcript is specifically 
expressed in imaginal discs in larvae, and BEN could bind other spatially restricted 
E3s, in order to perform its other functions in nervous system and eye development 
(see below). It is not known whether other E2s also bind HYD. They may interact 
with other E3s and perform different roles.
6.2.3 EYE DEVELOPMENT:
A role for the ubiquitin pathway in eye development is implicated by mutants 
for bendless and fat facets genes. In ben mutants, the arrangement of photoreceptor 
rhabdomeres within each ommatidium is altered (Muralidhar and Thomas, 1993). 
The R7 photoreceptor rhabdomeres are shrunken and outer photoreceptor R1-R6 
rhabdomeres are loosely packed and further from the centre of each ommatidium 
than in a wild type eye. These morphological defects could be due to the fact axons 
of the photoreceptor neurons initially project normally, but fail to do so later in their 
pathways: ubiquitination is necessary for growth cone guidance. The eye defects of 
faf mutants are also neuronal in origin: more cells than normal become 
photoreceptors, resulting in more than the wild type eight photoreceptors in each eye 
facet (Fischer-Vize et al., 1992). FAF protein is thought to prevent cells becoming 
neurons by deubiquitinating a protein before it becomes degraded by the proteasome.
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The ben ubiquitin conjugating enzyme is active in the same cells as FAF, but their 
functions may not be related.
6.2.4 NERVOUS SYSTEM DEVELOPMENT:
All five Drosophila ubiquitin conjugating enzymes investigated were found 
to have enhanced, if not exclusive, expression of mRNA within the central nervous 
system (CNS). This implies that ubiquitination is important in the development of 
the CNS. Possible reasons for increased expression of E2 enzymes in the developing 
CNS are for roles in axon growth cone guidance, control of cell cycles, and 
involvement in programmed cell death.
The presence of a wild type bendless gene is necessary for the synaptic 
connection between the giant fibre and tergotrochanter muscle motor neuron (see 
1.7.3.3). This is a specific developmental event, and, as bendless is expressed 
throughout the central nervous system, may require the functions of a specific 
ubiquitin protein ligase recognised by BEN. The berr phenotype corresponds to a 
presynaptic defect (Euk Oh et al., 1994), probably involving growth cone 
dysfunction. As mRNA from all the Drosophila E2 genes investigated was shown to 
be concentrated in the CNS, it is possible all have roles in axon guidance of other 
neurons, and this may be a general function of the ubiquitin system. In Drosophila, 
mutations in the tyrosine kinase genes abl and drl affect growth cone guidance in the 
developing CNS (Callahan et al., 1995), and specific receptor tyrosine phosphatases 
are also necessary for guidance of specific axons (Desai et al., 1996; Krueger et al., 
1996). Ligands binding to these receptors could stimulate or repress axon growth by 
endocytosis of the receptor, and signal transduction via control of tyrosine 
phosphorylation. The ubiquitin pathway is involved in receptor mediated 
endocytosis (see 1.12.3), and E2s could function in growth cone guidance to 
ubiquitinate and mediate endocytosis of ligand-bound receptor tyrosine kinases of 
specific neurons.
In embryos that have developed past mitosis 16, string expression is seen 
mainly in proliferating neuroblasts of the central and peripheral nervous system 
(Edgar et al., 1994). If a major role of the ubiquitin system is to control cell cycles, 
then this could be another explanation for expression of E2 enzymes within the CNS.
Large numbers of cells die by programmed cell death during development of 
the Drosophila central nervous system. Zhou et al. (1995) investigated programmed 
cell death in the central nervous system midline, and found it plays a crucial role in 
differentiation and is lineage specific. Programmed cell death of Manduca sexta
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intersegmental muscles involves the ubiquitin system (see 1.12.6) and certain 
proteins involved in the pathway are induced during this process (Haas et al, 1995). 
E2s may be upregulated in the CNS in order to function in programmed cell death.
6.2.4.1 SHUTTLE CRAFT could be a substrate for ubiquitination by 
UBCD4:
When E225K. the bovine homologue of UbcD4, was used in a yeast two 
hybrid screen it was seen to bind to NF-X1 (Pickart, pers. comm.\ NF-X1 is a 
gamma interferon-inducible transcription factor implicated in the genetic control of 
human immunity. It is presumed to limit inflammatory responses by negatively 
regulating transcription of specific MHC class n molecules. E225K may ubiquitinate 
NF-X1, and experiments are currently being performed to determine if NF-X1 is 
ubiquitinated in vivo, and to observe binding of E225K to NF-X1 in vitro.
NF-X1 has a Drosophila homologue encoded by the shuttle craft (stc) gene 
(Stroumbakis et al. , 1996). It is an essential gene; mutant embryos die because they 
are incapable of coordinating muscle contractions required for hatching. STC protein 
is normally localized in the nuclei of repeated clusters of cells located in each 
neuromere along the length of the ventral nerve cord, and to distinct groups of cells 
within the brain lobes (Stroumbakis et al., 1996). In mutant stc embryos, 
morphological alterations are seen in specific motorneuronal axons. The STC protein 
may regulate the activity of a subset of genes that play a role in the guidance or 
spatial maintenance of axon tracts.
UbcD4 mRNA is present at low levels throughout the embryo during 
development, but is expressed at higher levels in the CNS. If it does bind and 
ubiquitinate STC, then this is another ubiquitination reaction that controls axon 
growth of specific neurons within the developing CNS. It is possible ubiquitination 
acts in axon guidance by activating transcription factors, rather than in receptor 
mediated endocytosis.
All Drosophila E2s show a concentration of mRNA in the CNS, BEN protein 
affects specific synaptic connections, and UBCD4 may ubiquitinate a protein 
involved in axon growth. A major role for ubiquitin conjugating enzymes in 
Drosophila development appears to be in growth cone guidance, to allow correct 
synaptic connections within the developing central nervous system. However, in 
order to directly determine the role of the E2s in development it is necessary to have 
mutants.
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6.3 MUTAGENESIS OF E2 ENZYMES:
Mutating the active site Cys of DHR6 to Ala or Set, and overexpression of 
the mutant protein resulted in a lethal phenotype (see chapter 5). Ubiquitin bound to 
mutant E2s, with Ser at the active site, was detectable in Western blots, and this 
concurred with the results of Sullivan and Vierstra (1993) who found ubiquitin 
bound irreversibly to the Ser residue of an E2 active site mutant. It is difficult to 
interpret the results of the experiments to determine the stage of development at 
which Drosophila die, due to the lethality of balancer chromosomes used in these 
experiments.
Overexpressing a dominant negative mutant E2 enzyme does not show the 
effect of having a mutant gene encoding the enzyme. In order to prove the DHR6 
protein performs essential functions it is still necessary to obtain Dhr6 mutants.
6.4 FUTURE WORK:
Few substrates of ubiquitin conjugating enzymes are known. They could 
provide a direct means for analysing the role of protein ubiquitination in 
development. STC may be confirmed as a substrate for ubiquitination by UBCD4, 
by performing binding studies and in vitro ubiquitination assays with purified 
enzymes. Further possible substrates for ubiquitination by UBCD4 or other known 
E2s could be identified by yeast two hybrid screens (Fields and Song, 1989) using 
these enzymes.
If many E3 enzymes are present within a eukaryote, and these are the main 
enzymes for substrate recognition for the ubiquitin pathway, then it would be 
interesting to identify further ubiquitin protein ligases in Drosophila. A screen could 
be performed using PCR amplifications with oligonucleotides designed to the 
conserved C-terminal domain of "hect" proteins. The E3 HYD may bind to the ben 
gene product, and protein binding studies between E2s and HYD/any other E3s 
discovered could be used to identify which enzymes interact with one another.
It is probable not all the E2s have been isolated from Drosophila as yet, and 
if screens for E3s fail to identify many new enzymes, then E2s may be confirmed as 
the main enzymes of the ubiquitin pathway for substrate selection. Further E2 
enzyme genes could be cloned by designing oligonucleotides to regions other than 
those used to clone UbcD4 and performing PCR amplifications.
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In order to determine the role of the E2s in development it is necessary to 
have mutants. Mutating the active site Cys of DHR6 and overexpression of the 
mutant protein results in lethality. In order to determine whether overexpression of 
mutant DHR6 is lethal in individual cells, transformed lines could be crossed to 
GAL4 lines expressing in specific cells of the eye and it could be observed if these 
cells die. Dhr6 is expressed in the CNS, and Julie Beattie, an Honours student in the 
laboratory, is expressing the mutant protein in the CNS by using the GAL4 line 31-1 
(Brand and Perrimon, 1993). This will indicate whether expression of Dhr6 is only 
important in the CNS. As ben" flies, which have defects in the CNS, have an 
increased likelihood of failing to eclose (Edgecomb, et al., 1993) it would be 
interesting to dissect the nervous system of flies in which mutant DHR6 protein has 
been overexpressed, as these flies also seem to die due to failure to eclose. Dhr6 
could be confirmed to be an essential gene by expressing antisense constructs, or 
creating flies mutant for the gene by P element insertional mutagenesis or by more 
conventional chemical mutagenesis methods. Creating mutant E2 genes could be 
used to investigate the hypothesis that they play important roles in nervous system 
development of Drosophila,
Putative target proteins for ubiquitin-dependent degradation in early 
embryogenesis include STRING and the proteins with short half lives, necessary for 
establishing embryonic axes. It would be interesting to determine whether these 
proteins are ubiquitinated in vivo, and to view interactions between them and known 
components of the Drosophila ubiquitin pathway.
The levels of Drosophila E2 enzyme mRNAs vary across development, 
indicating that transcription may be developmentally regulated. In situ hybridisation 
to E2 mRNA in embryos revealed high levels were present in the CNS, suggesting 
that there may be important roles for ubiquitination in nervous system development. 
Results from other laboratories working on bendless also indicate this to be the case. 
Further investigation into the roles of the ubiquitin system in CNS development 
could be informative. UbcD4, the new E2 discovered, is the homologue of bovine 
E225K> and may also have a role in CNS development if it is found to ubiquitinate 
STC. Although it is still necessary for flies with mutant E2 genes to be obtained, in 
order to directly determine their roles in development, preliminary experiments 
overexpressing active site mutants of DHR6 show Cys is essential at the active site. 
Overexpressing active site mutants was lethal, whereas overexpressing wild type 
DHR6 protein had no obvious effect on viability. Dhr6 is probably an essential gene.
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The results of experiments presented in this thesis concur with the hypothesis that 




APPENDIX I: Results of h.s. GAL4 X Dhr6 lines experiments
W1118 x h.s. GAL 4 (combined data from duplicate experiments)
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DhrfCys line 1 (Y) X h.s. GAL 4
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Dhr6Cys line 3 X h.s. GAL 4













































































































































Dhr6Cys line 4 X h.s. GAL 4
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Dhr6Cys line 5 X h.s. GAL 4
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Dhr6Cys line 6 X h.s. GAL 4












































































































































Dhr6Cys line 7 X h.s. GAL 4
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Dhr6Cys line 9 X h.s. GAL 4
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Dhr6Cys linelO (X) X h.s. GAL 4
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Dhr6A\a line 1 X h.s. GAL 4



























































































































































































































































































Dhr6Ala line 3 X h.s. GAL 4
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Dhr6Ser linel X h.s. GAL 4
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Dhr6Ser line 3 (X) X h.s. GAL 4
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Dhr6Ser line 4 X h.s. GAL 4
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Dhr6Ser line 5 X h.s. GAL 4
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APPENDIX II: Statistical analysis on the progeny from crosses of lines 
containing Dhr6 transgenes to heat shock and C22C GAL4 lines.
The StatView® Student program (Abacus Concepts Inc.) was used to apply 
the Goodness of Fit Chi-Square test to the data from the results of crossing Dhr6 
transformed lines to C22C and heat shock GAM lines.
The following formula was applied for Chi-Squared analysis:
Y2^-y (0-E)2 
E
O = observed values 
E = expected values
Degrees of freedom = the number of classes whose frequency may be 
assigned arbitrarily.
The same formula was applied where contingency table analysis was 
necessary. In these cases:
N = number of observations
r = number of rows of the contingency table
c = number of columns of the contingency table
Degrees of freedom = (r-l)(c-l)
and E = CR/N, the expected values
C = column total
R = row total
O = observed value
N = grand total
The StatView® Student program calculates values for X^ and the associated 
value for P (the probablity that data fit the hypothesis). If P was greater than 0.05 
then data were assumed to be not significantly different.
When many tests were performed between sets of data containing small 
numbers, in order to see if they could be pooled, at least 15% of the tests had to 
show a P value less than 0.05 before data were deemed to be significantly different, 
as in small data sets, numbers can be found to be significantly different by chance.
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Contingency table Chi-Square tests, comparing the ratios of Cy~:Cy + flies for 
a particular variable, were performed on the progeny from C22C crosses to lines 
containing Dhr6 transgenes and w^^, to see if data could be pooled. Once data 
had been pooled, Chi-Square was used to calculate the probability the ratio of Cy 
:Cy+ flies differed from 1:1.
In the same way, contingency table Chi-Square tests, comparing the ratios of 
Sb~:Sb+ flies for a particular variable, were performed to see if data from the 
progeny of h.s GAL4 crosses to lines containing Dhr6 transgenes and w * 118 could 
be pooled. The ratios ofSb~:Sb+ flies for males and females were compared first. If 
these were not significantly different, values for males and females were pooled. The 
significance of the effects of altering the length of the heat shock or the stage of 
development at which the heat shock was applied were also tested. Once data had 
been pooled, Chi-Square was used to calculate the probability the ratio of Sb~ :Sb+ 
flies differed from 1:1.
When contingency table analysis was performed comparing the ratios of Sb~ 
:Sb+ flies between the progeny from h.s GAL4 crosses to Dhr6Cys lines, these were 
found to be significantly different. The Dhr6Cys lines 5, 7, 8, and 10 often produced 
no Sb+ flies when progeny from crosses to h.s. GAL4 were heat shocked for 45min 
at early developmental stages. No further statistical analysis was performed on these 
lines. Statistical analysis to calculate the effects, on the ratio of Sb~:Sb+ flies, of 
overexpressing wild-type DHR6 protein at different stages and for different lengths 
of time was performed on the progeny from crosses to Dhr6Cys lines 2, 3, 4, 6 and 
9.
Contigency table Chi-square analysis was performed on the data from the 
experiment to test the percentage eclosion of flies overexpressing mutant DHR6 
protein (table Al). First the percentage eclosion of progeny after heat shocking at 
each stage was compared for the progeny from each cross, in order to see whether 
data from all stages could be pooled. Percentage eclosion was then compared 
between the progeny from different crosses.
The results of the experiment to test the effects of not heat shocking progeny 
from crosses of h.s. GAL4 to lines containing Dhr6 transgenes are shown in table 
A2. Contigency table Chi-square analysis was performed to compare the ratio of Sb~ 
:Sb+ flies between male and female progeny, then the ratios of Sb~:Sb+ progeny 
were compared between lines. Finally Chi-Square was used to calculate the 
























































































Table Al Percentage of flies eclosing, after heat-shocking progeny from 
1 ! 18 and Dhr6 Ala lines 1 and 3 crossed to h.s. GAL4, for 30min at 39°C.w
E = embryo; Lli = first instar larvae; L2i = second instar larvae; L3i = third instar larvae; EP = early 
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